1	Pediatr	NNP	MISC	Pediatr	nn	2	SENT_1	[p1l96t81r198b106],
2	Cardiol	NNP	MISC	Cardiol	_	0	SENT_1	[p1l210t81r316b106],
3	27:685	CD	NUMBER	27:685	number	4	SENT_1	[p1l329t82r493b110],
4	—	CD	NUMBER	—	num	5	SENT_1	[p1l329t82r493b110],
5	688	CD	NUMBER	688	dep	2	SENT_1	[p1l329t82r493b110],
6	,	,	O	,	_	0	SENT_1	[p1l329t82r493b110],
7	2006	CD	DATE	2006	num	8	SENT_1	[p1l507t82r571b106],
8	DOI	NNP	O	DOI	appos	5	SENT_1	[p1l97t123r168b147],
9	:	:	O	:	_	0	SENT_1	[p1l97t123r168b147],
10	10.1007	CD	NUMBER	10.1007	dep	5	SENT_1	[p1l186t122r561b153],
11	/	:	O	/	punct	12	SENT_1	[p1l186t122r561b153],
12	s0O246-005-1150-x	NN	O	s0o246-005-1150-x	dep	10	SENT_1	[p1l186t122r561b153],
13	Pediatric	NNP	O	Pediatric	nn	17	SENT_1	[p1l1737t96r2060b160],
14	Cardiology	NNP	O	Cardiology	nn	17	SENT_1	[p1l1651t173r2061b258],
15	©	NNP	O	©	nn	17	SENT_1	[p1l1584t277r1602b295],
16	Springer	NNP	ORGANIZATION	Springer	nn	17	SENT_1	[p1l1612t277r1697b300],
17	Science	NNP	ORGANIZATION	Science	dep	12	SENT_1	[p1l1704t277r1884b295],
18	+	CC	ORGANIZATION	+	_	0	SENT_1	[p1l1704t277r1884b295],
19	Business	NNP	ORGANIZATION	Business	nn	20	SENT_1	[p1l1704t277r1884b295],
20	Media	NNP	ORGANIZATION	Media	dep	12	SENT_1	[p1l1891t277r1960b298],
21	,	,	ORGANIZATION	,	_	0	SENT_1	[p1l1891t277r1960b298],
22	Inc.	NNP	ORGANIZATION	Inc.	appos	12	SENT_1	[p1l1969t277r2004b295],
23	2006	CD	DATE	2006	num	22	SENT_1	[p1l2011t277r2063b295],

1	1173C	NN	O	1173c	dep	7	SENT_2	[p1l99t394r229b430],
2	>	JJR	O	>	amod	4	SENT_2	[p1l242t400r270b424],
3	T	NN	O	t	nn	4	SENT_2	[p1l282t395r313b429],
4	Polymorphism	NN	O	polymorphism	dep	1	SENT_2	[p1l332t394r630b440],
5	in	IN	O	in	_	0	SENT_2	[p1l648t394r686b429],
6	VKORCI	NNP	O	VKORCI	prep_in	1	SENT_2	[p1l712t394r907b430],
7	Modulates	VBZ	O	modulate	_	0	SENT_2	[p1l927t395r1146b430],
8	the	DT	O	the	det	11	SENT_2	[p1l1164t395r1225b430],
9	Required	NNP	O	Required	nn	11	SENT_2	[p1l1244t394r1429b440],
10	Warfarin	NNP	O	Warfarin	nn	11	SENT_2	[p1l1447t394r1639b430],
11	Dose	NN	O	dose	nsubj	7	SENT_2	[p1l1657t395r1759b430],

1	K.	NNP	PERSON	K.	dep	109	SENT_3	[p1l96t518r135b547],
2	Kosaki	NNP	PERSON	Kosaki	dep	109	SENT_3	[p1l151t509r296b554],
3	,1	CD	NUMBER	,1	dep	109	SENT_3	[p1l151t509r296b554],
4	C.	NNP	PERSON	C.	dep	109	SENT_3	[p1l315t517r352b547],
5	Yamaghishi	NNP	PERSON	Yamaghishi	dep	109	SENT_3	[p1l369t509r596b555],
6	,1	CD	NUMBER	,1	dep	109	SENT_3	[p1l369t509r596b555],
7	R.	NNP	PERSON	R.	dep	109	SENT_3	[p1l614t518r653b547],
8	Sato	NNP	PERSON	Sato	dep	109	SENT_3	[p1l670t509r775b554],
9	,2	CD	NUMBER	,2	dep	109	SENT_3	[p1l670t509r775b554],
10	H.	NNP	PERSON	H.	dep	109	SENT_3	[p1l790t518r833b547],
11	Semejima	NNP	PERSON	Semejima	dep	109	SENT_3	[p1l850t509r1041b556],
12	,1	CD	NUMBER	,1	dep	109	SENT_3	[p1l850t509r1041b556],
13	H.	NNP	PERSON	H.	dep	109	SENT_3	[p1l1059t518r1102b547],
14	Fuijita	NNP	PERSON	Fuijita	dep	109	SENT_3	[p1l1118t509r1256b556],
15	,1	CD	NUMBER	,1	dep	109	SENT_3	[p1l1118t509r1256b556],
16	K.	NNP	PERSON	K.	dep	109	SENT_3	[p1l1274t518r1312b547],
17	Tamura	NNP	PERSON	Tamura	dep	109	SENT_3	[p1l1329t509r1490b554],
18	,1	CD	NUMBER	,1	dep	109	SENT_3	[p1l1329t509r1490b554],
19	K.	NNP	PERSON	K.	dep	109	SENT_3	[p1l1508t518r1546b547],
20	Maeyama	NNP	PERSON	Maeyama	dep	109	SENT_3	[p1l1563t509r1760b555],
21	,1	CD	NUMBER	,1	dep	109	SENT_3	[p1l1563t509r1760b555],
22	H.	NNP	PERSON	H.	dep	109	SENT_3	[p1l96t566r139b595],
23	Yamagishi	NNP	PERSON	Yamagishi	dep	109	SENT_3	[p1l156t557r362b603],
24	,1	CD	NUMBER	,1	dep	109	SENT_3	[p1l156t557r362b603],
25	A.	NN	PERSON	a.	dep	109	SENT_3	[p1l380t565r418b595],
26	Sugaya	NNP	PERSON	Sugaya	dep	109	SENT_3	[p1l436t557r589b603],
27	,3	CD	NUMBER	,3	dep	109	SENT_3	[p1l436t557r589b603],
28	H.	NNP	O	H.	dep	109	SENT_3	[p1l605t566r648b595],
29	Dod0	NNP	O	Dod0	dep	109	SENT_3	[p1l665t556r785b601],
30	,4	CD	NUMBER	,4	dep	109	SENT_3	[p1l665t556r785b601],
31	Y.	NNP	PERSON	Y.	dep	109	SENT_3	[p1l799t566r838b595],
32	Tanigawara	NNP	PERSON	Tanigawara	dep	109	SENT_3	[p1l855t557r1088b603],
33	,2	CD	NUMBER	,2	dep	109	SENT_3	[p1l855t557r1088b603],
34	T.	NNP	O	T.	dep	109	SENT_3	[p1l1103t566r1139b595],
35	Takahashil	NNP	O	Takahashil	dep	109	SENT_3	[p1l1156t557r1349b595],
36	1Department	NN	O	1department	dep	109	SENT_3	[p1l99t617r280b655],
37	of	IN	O	of	dep	109	SENT_3	[p1l292t624r323b648],
38	Pediatrics	NNP	O	Pediatrics	dep	109	SENT_3	[p1l331t624r476b653],
39	,	,	O	,	_	0	SENT_3	[p1l331t624r476b653],
40	Keio	NNP	ORGANIZATION	Keio	dep	109	SENT_3	[p1l490t624r557b648],
41	University	NNP	ORGANIZATION	University	dep	109	SENT_3	[p1l570t624r716b655],
42	School	NNP	ORGANIZATION	School	dep	109	SENT_3	[p1l729t624r823b648],
43	of	IN	ORGANIZATION	of	dep	109	SENT_3	[p1l836t624r867b648],
44	Medicine	NNP	ORGANIZATION	Medicine	dep	109	SENT_3	[p1l876t624r1012b653],
45	,	,	O	,	_	0	SENT_3	[p1l876t624r1012b653],
46	35	CD	NUMBER	35	dep	109	SENT_3	[p1l1027t624r1057b648],
47	Shinanomachi	NN	O	shinanomachus	dep	109	SENT_3	[p1l1071t624r1279b653],
48	,	,	O	,	_	0	SENT_3	[p1l1071t624r1279b653],
49	Shinjuku-ku	NN	O	shinjuku-ku	dep	109	SENT_3	[p1l1293t624r1474b655],
50	,	,	O	,	_	0	SENT_3	[p1l1293t624r1474b655],
51	Tokyo	NNP	LOCATION	Tokyo	dep	109	SENT_3	[p1l1487t624r1579b655],
52	160-8582	CD	NUMBER	160-8582	dep	109	SENT_3	[p1l1595t624r1725b653],
53	,	,	O	,	_	0	SENT_3	[p1l1595t624r1725b653],
54	Japan	NNP	LOCATION	Japan	dep	109	SENT_3	[p1l1738t624r1821b655],
55	2Department	NNP	O	2Department	dep	109	SENT_3	[p1l97t660r280b697],
56	of	IN	O	of	dep	109	SENT_3	[p1l292t666r322b691],
57	Pharmacy	NNP	O	Pharmacy	dep	109	SENT_3	[p1l331t666r480b697],
58	,	,	O	,	_	0	SENT_3	[p1l331t666r480b697],
59	Keio	NNP	ORGANIZATION	Keio	dep	109	SENT_3	[p1l493t666r560b691],
60	University	NNP	ORGANIZATION	University	dep	109	SENT_3	[p1l573t666r718b697],
61	School	NNP	ORGANIZATION	School	dep	109	SENT_3	[p1l731t666r826b691],
62	of	IN	ORGANIZATION	of	dep	109	SENT_3	[p1l838t666r869b691],
63	Medicine	NNP	ORGANIZATION	Medicine	dep	109	SENT_3	[p1l878t666r1014b695],
64	,	,	O	,	_	0	SENT_3	[p1l878t666r1014b695],
65	35	CD	NUMBER	35	dep	109	SENT_3	[p1l1029t667r1058b691],
66	Shinanomachi	NN	O	shinanomachus	dep	109	SENT_3	[p1l1072t666r1280b695],
67	,	,	O	,	_	0	SENT_3	[p1l1072t666r1280b695],
68	Shinjuku-ku	NN	O	shinjuku-ku	dep	109	SENT_3	[p1l1294t666r1475b697],
69	,	,	O	,	_	0	SENT_3	[p1l1294t666r1475b697],
70	Tokyo	NNP	LOCATION	Tokyo	dep	109	SENT_3	[p1l1488t666r1580b697],
71	160-8582	CD	NUMBER	160-8582	dep	109	SENT_3	[p1l1595t667r1726b695],
72	,	,	O	,	_	0	SENT_3	[p1l1595t667r1726b695],
73	Japan	NNP	LOCATION	Japan	dep	109	SENT_3	[p1l1738t667r1821b697],
74	3Department	NNP	O	3Department	dep	109	SENT_3	[p1l97t702r280b739],
75	of	IN	O	of	dep	109	SENT_3	[p1l292t708r323b732],
76	Cardiology	NNP	O	Cardiology	dep	109	SENT_3	[p1l333t708r497b739],
77	,	,	O	,	_	0	SENT_3	[p1l333t708r497b739],
78	Tokyo	NNP	LOCATION	Tokyo	dep	109	SENT_3	[p1l511t708r603b739],
79	Metropolitan	NNP	O	Metropolitan	dep	109	SENT_3	[p1l616t708r805b739],
80	Kiyose	NNP	O	Kiyose	dep	109	SENT_3	[p1l817t708r913b739],
81	Children	NNP	O	Children	dep	109	SENT_3	[p1l926t708r1070b733],
82	’s	POS	O	’s	dep	109	SENT_3	[p1l926t708r1070b733],
83	Hospital	NNP	O	Hospital	dep	109	SENT_3	[p1l1083t708r1211b739],
84	,	,	O	,	_	0	SENT_3	[p1l1083t708r1211b739],
85	l-3-l	JJ	O	l-3-l	dep	109	SENT_3	[p1l1228t709r1292b732],
86	Umezono	NNP	O	Umezono	dep	109	SENT_3	[p1l1308t709r1452b737],
87	,	,	O	,	_	0	SENT_3	[p1l1308t709r1452b737],
88	Kiyose	NNP	O	Kiyose	dep	109	SENT_3	[p1l1466t708r1571b739],
89	,	,	O	,	_	0	SENT_3	[p1l1466t708r1571b739],
90	Tokyo	NNP	LOCATION	Tokyo	dep	109	SENT_3	[p1l96t749r188b780],
91	139-8551	CD	NUMBER	139-8551	dep	109	SENT_3	[p1l204t750r335b779],
92	,	,	O	,	_	0	SENT_3	[p1l204t750r335b779],
93	Japan	NNP	LOCATION	Japan	dep	109	SENT_3	[p1l348t750r431b780],
94	4Department	NN	O	4department	dep	109	SENT_3	[p1l96t785r280b823],
95	of	IN	O	of	dep	109	SENT_3	[p1l292t791r323b816],
96	Cardiology	NNP	O	Cardiology	dep	109	SENT_3	[p1l333t792r497b823],
97	,	,	O	,	_	0	SENT_3	[p1l333t792r497b823],
98	National	NNP	ORGANIZATION	National	dep	109	SENT_3	[p1l511t792r635b816],
99	Center	NNP	ORGANIZATION	Center	dep	109	SENT_3	[p1l648t792r742b816],
100	for	IN	ORGANIZATION	for	dep	109	SENT_3	[p1l754t791r795b816],
101	Child	NNP	ORGANIZATION	Child	dep	109	SENT_3	[p1l808t792r884b816],
102	Health	NNP	ORGANIZATION	Health	dep	109	SENT_3	[p1l897t792r992b816],
103	and	CC	ORGANIZATION	and	dep	109	SENT_3	[p1l1005t792r1056b816],
104	Development	NNP	ORGANIZATION	Development	dep	109	SENT_3	[p1l1069t792r1264b823],
105	,	,	O	,	_	0	SENT_3	[p1l1069t792r1264b823],
106	2-10-1	CD	NUMBER	2-10-1	dep	109	SENT_3	[p1l1278t792r1362b816],
107	Okura	NNP	PERSON	Okura	dep	109	SENT_3	[p1l1378t792r1475b821],
108	,	,	O	,	_	0	SENT_3	[p1l1378t792r1475b821],
109	Setagaya-ku	NN	O	setagaya-ku	_	0	SENT_3	[p1l1490t791r1670b823],
110	,	,	O	,	_	0	SENT_3	[p1l1490t791r1670b823],

1	Tokyo	NNP	LOCATION	Tokyo	_	0	SENT_4	[p1l8t846r215b916],
2	204-0024	CD	NUMBER	204-0024	num	1	SENT_4	[p1l245t848r547b913],
3	,	,	O	,	_	0	SENT_4	[p1l245t848r547b913],
4	Japan	NNP	LOCATION	Japan	appos	1	SENT_4	[p1l576t848r764b916],

1	Abstract	JJ	O	abstract	amod	3	SENT_5	[p1l8t1087r343b1154],
2	The	DT	O	the	det	3	SENT_5	[p1l393t1086r544b1154],
3	response	NN	O	response	nsubj	8	SENT_5	[p1l582t1108r924b1173],
4	to	TO	O	to	_	0	SENT_5	[p1l961t1095r1038b1154],
5	warfarin	NN	O	warfarin	prep_to	3	SENT_5	[p1l1075t1086r1415b1154],
6	is	VBZ	O	be	cop	8	SENT_5	[p1l1451t1086r1508b1154],
7	highly	RB	O	highly	advmod	8	SENT_5	[p1l1546t1086r1790b1173],
8	variable	JJ	O	variable	_	0	SENT_5	[p1l1825t1086r2143b1154],
9	among	IN	O	among	_	0	SENT_5	[p1l10t1215r281b1279],
10	individuals	NNS	O	individual	prep_among	8	SENT_5	[p1l300t1192r735b1261],
11	and	CC	O	and	_	0	SENT_5	[p1l758t1192r904b1261],
12	such	JJ	O	such	amod	13	SENT_5	[p1l927t1192r1102b1261],
13	variability	NN	O	variability	nsubj	15	SENT_5	[p1l1122t1192r1528b1279],
14	is	VBZ	O	be	cop	15	SENT_5	[p1l1548t1193r1605b1261],
15	likely	JJ	O	likely	conj_and	8	SENT_5	[p1l1627t1192r1840b1279],
16	to	TO	O	to	aux	17	SENT_5	[p1l1861t1202r1937b1261],
17	have	VB	O	have	xcomp	15	SENT_5	[p1l1961t1193r2143b1261],
18	some	DT	O	some	det	20	SENT_5	[p1l11t1321r210b1368],
19	genetic	JJ	O	genetic	amod	20	SENT_5	[p1l235t1299r510b1386],
20	basis	NN	O	basis	dobj	17	SENT_5	[p1l533t1299r745b1368],
21	.	.	O	.	_	0	SENT_5	[p1l533t1299r745b1368],

1	We	PRP	O	we	nsubj	2	SENT_6	[p1l772t1302r903b1368],
2	evaluted	VBD	O	evalute	_	0	SENT_6	[p1l927t1299r1259b1368],
3	the	DT	O	the	det	4	SENT_6	[p1l1283t1299r1402b1368],
4	effect	NN	O	effect	dobj	2	SENT_6	[p1l1426t1299r1634b1368],
5	of	IN	O	of	_	0	SENT_6	[p1l1658t1299r1744b1368],
6	VKORCI	NNP	O	VKORCI	nn	7	SENT_6	[p1l1770t1302r2139b1368],
7	polymorphisms	NNS	O	polymorphism	prep_of	4	SENT_6	[p1l7t1407r624b1493],
8	on	IN	O	on	_	0	SENT_6	[p1l678t1429r776b1475],
9	warfarin	NN	O	warfarin	nn	10	SENT_6	[p1l825t1407r1165b1475],
10	response	NN	O	response	prep_on	2	SENT_6	[p1l1216t1429r1556b1493],
11	among	IN	O	among	_	0	SENT_6	[p1l1609t1429r1879b1493],
12	Japanese	JJ	MISC	japanese	prep_among	2	SENT_6	[p1l1929t1409r2141b1493, p1l8t1535r197b1596],
13	,	,	O	,	_	0	SENT_6	[p1l1929t1409r2141b1493, p1l8t1535r197b1596],
14	taking	VBG	O	take	partmod	2	SENT_6	[p1l269t1513r519b1600],
15	advantage	NN	O	advantage	dobj	14	SENT_6	[p1l589t1513r994b1600],
16	of	IN	O	of	_	0	SENT_6	[p1l1066t1513r1152b1581],
17	its	PRP$	O	its	poss	20	SENT_6	[p1l1211t1513r1299b1581],
18	unique	JJ	O	unique	amod	20	SENT_6	[p1l1368t1513r1638b1600],
19	population	NN	O	population	nn	20	SENT_6	[p1l1707t1513r2144b1600],
20	structure	NN	O	structure	prep_of	15	SENT_6	[p1l11t1631r361b1690],
21	in	IN	O	in	_	0	SENT_6	[p1l391t1621r464b1689],
22	which	WDT	O	which	rel	32	SENT_6	[p1l492t1621r727b1690],
23	CYP2C9	NN	O	cyp2c9	nn	24	SENT_6	[p1l757t1623r1108b1690],
24	*	NN	O	*	nsubj	32	SENT_6	[p1l1143t1621r1228b1689],
25	2	CD	NUMBER	2	dep	24	SENT_6	[p1l1143t1621r1228b1689],
26	and	CC	O	and	_	0	SENT_6	[p1l1259t1621r1404b1690],
27	*	CD	NUMBER	*	number	28	SENT_6	[p1l1437t1622r1518b1690],
28	3	CD	NUMBER	3	num	29	SENT_6	[p1l1437t1622r1518b1690],
29	alleles	NNS	O	allele	nsubj	32	SENT_6	[p1l1553t1621r1788b1690],
30	are	VBP	O	be	cop	32	SENT_6	[p1l1819t1644r1937b1690],
31	relatively	RB	O	relatively	advmod	32	SENT_6	[p1l1967t1621r2142b1690, p1l9t1729r223b1815],
32	rare	JJ	O	rare	rcmod	15	SENT_6	[p1l287t1751r463b1797],
33	.	.	O	.	_	0	SENT_6	[p1l287t1751r463b1797],

1	Thirty-one	CD	NUMBER	thirty-one	num	2	SENT_7	[p1l532t1729r959b1815],
2	patients	NNS	O	patient	nsubjpass	15	SENT_7	[p1l1022t1729r1334b1816],
3	(	IN	O	(	_	0	SENT_7	[p1l1401t1729r1661b1816],
4	12-34	CD	NUMBER	12-34	num	5	SENT_7	[p1l1401t1729r1661b1816],
5	years	NNS	NUMBER	year	prep_(	2	SENT_7	[p1l1725t1751r1927b1815],
6	old	JJ	O	old	amod	5	SENT_7	[p1l1995t1729r2140b1812],
7	;	:	O	;	_	0	SENT_7	[p1l1995t1729r2140b1812],
8	median	NN	O	median	dep	5	SENT_7	[p1l7t1835r321b1918],
9	,	,	O	,	_	0	SENT_7	[p1l7t1835r321b1918],
10	22	CD	NUMBER	22	num	11	SENT_7	[p1l362t1836r481b1922],
11	)	NN	O	)	appos	8	SENT_7	[p1l362t1836r481b1922],
12	on	IN	O	on	_	0	SENT_7	[p1l521t1858r619b1904],
13	warfarin	NN	O	warfarin	prep_on	11	SENT_7	[p1l654t1835r994b1904],
14	were	VBD	O	be	auxpass	15	SENT_7	[p1l1030t1858r1212b1904],
15	recruited	VBN	O	recruit	_	0	SENT_7	[p1l1249t1835r1601b1904],
16	from	IN	O	from	_	0	SENT_7	[p1l1638t1835r1830b1904],
17	a	DT	O	a	det	20	SENT_7	[p1l1868t1857r1910b1904],
18	pediatric	JJ	O	pediatric	amod	20	SENT_7	[p1l1945t1835r2142b1922, p1l10t1943r187b2011],
19	cardiology	NN	O	cardiology	nn	20	SENT_7	[p1l216t1943r637b2030],
20	clinic	NN	O	clinic	prep_from	15	SENT_7	[p1l666t1943r893b2011],
21	.	.	O	.	_	0	SENT_7	[p1l666t1943r893b2011],

1	Genotyping	NN	O	genotyping	nsubj	16	SENT_8	[p1l930t1943r1402b2030],
2	of	IN	O	of	_	0	SENT_8	[p1l1433t1943r1519b2011],
3	the	DT	O	the	det	7	SENT_8	[p1l1540t1943r1660b2011],
4	C	NN	O	c	amod	7	SENT_8	[p1l1692t1944r1753b2011],
5	>	JJR	O	>	dep	4	SENT_8	[p1l1777t1955r1829b2000],
6	T	NN	O	t	nn	7	SENT_8	[p1l1851t1945r1910b2010],
7	polymorphism	NN	O	polymorphism	prep_of	1	SENT_8	[p1l1939t1943r2141b2030, p1l7t2049r413b2136],
8	at	IN	O	at	_	0	SENT_8	[p1l455t2059r529b2118],
9	position	NN	O	position	prep_at	7	SENT_8	[p1l568t2049r890b2136],
10	1173	CD	DATE	1173	num	9	SENT_8	[p1l940t2051r1110b2118],
11	in	IN	O	in	_	0	SENT_8	[p1l1155t2049r1229b2117],
12	intron	NN	O	intron	prep_in	9	SENT_8	[p1l1269t2049r1515b2118],
13	1	CD	NUMBER	1	num	12	SENT_8	[p1l1564t2051r1588b2117],
14	of	IN	O	of	_	0	SENT_8	[p1l1641t2049r1727b2118],
15	VKORCI	NNP	ORGANIZATION	VKORCI	prep_of	12	SENT_8	[p1l1770t2052r2139b2118],
16	revealed	VBD	O	reveal	_	0	SENT_8	[p1l9t2156r336b2225],
17	that	IN	O	that	complm	25	SENT_8	[p1l359t2157r516b2225],
18	26	CD	NUMBER	26	num	19	SENT_8	[p1l539t2158r627b2225],
19	patients	NNS	O	patient	nsubj	25	SENT_8	[p1l650t2157r962b2243],
20	(	IN	O	(	_	0	SENT_8	[p1l988t2157r1215b2244],
21	84	CD	PERCENT	84	num	22	SENT_8	[p1l988t2157r1215b2244],
22	%	NN	PERCENT	%	prep_(	19	SENT_8	[p1l988t2157r1215b2244],
23	)	CD	NUMBER	)	dep	22	SENT_8	[p1l988t2157r1215b2244],
24	were	VBD	O	be	cop	25	SENT_8	[p1l1238t2179r1421b2225],
25	T	NN	O	t	ccomp	16	SENT_8	[p1l1444t2157r1533b2244],
26	/	:	O	/	punct	41	SENT_8	[p1l1444t2157r1533b2244],
27	T	NN	O	t	nn	28	SENT_8	[p1l1538t2159r1597b2224],
28	homozygotes	NNS	O	homozygote	dep	41	SENT_8	[p1l1619t2156r2142b2243],
29	at	IN	O	at	dep	41	SENT_8	[p1l10t2273r84b2331],
30	nucleotide	NN	O	nucleotide	pobj	29	SENT_8	[p1l112t2263r520b2331],
31	1173	CD	DATE	1173	num	30	SENT_8	[p1l559t2265r755b2346],
32	,	,	O	,	_	0	SENT_8	[p1l559t2265r755b2346],
33	Whereas	IN	O	whereas	mark	41	SENT_8	[p1l787t2263r1104b2332],
34	5	CD	PERCENT	5	number	35	SENT_8	[p1l1138t2266r1174b2331],
35	(	CD	PERCENT	(	nsubj	41	SENT_8	[p1l1208t2263r1435b2350],
36	16	CD	PERCENT	16	num	37	SENT_8	[p1l1208t2263r1435b2350],
37	%	NN	PERCENT	%	dep	35	SENT_8	[p1l1208t2263r1435b2350],
38	)	CD	NUMBER	)	dep	35	SENT_8	[p1l1208t2263r1435b2350],
39	were	VBD	O	be	cop	41	SENT_8	[p1l1465t2285r1647b2332],
40	C/T	NN	O	c/t	nn	41	SENT_8	[p1l1678t2263r1833b2350],
41	heterozygotes	NNS	O	heterozygote	dep	25	SENT_8	[p1l1862t2263r2142b2331, p1l8t2380r320b2457],
42	.	.	O	.	_	0	SENT_8	[p1l1862t2263r2142b2331, p1l8t2380r320b2457],

1	Complete	JJ	O	complete	amod	3	SENT_9	[p1l388t2370r768b2457],
2	linkage	NN	O	linkage	nn	3	SENT_9	[p1l829t2370r1113b2457],
3	disequilibrium	NN	O	disequilibrium	nsubjpass	5	SENT_9	[p1l1174t2370r1747b2457],
4	was	VBD	O	be	auxpass	5	SENT_9	[p1l1806t2392r1952b2438],
5	observed	VBN	O	observe	_	0	SENT_9	[p1l2015t2370r2142b2438, p1l11t2477r258b2546],
6	between	IN	O	between	_	0	SENT_9	[p1l303t2477r625b2546],
7	the	DT	O	the	det	8	SENT_9	[p1l671t2477r790b2546],
8	ll73C	NN	O	ll73c	prep_between	5	SENT_9	[p1l845t2479r1087b2546],
9	>	JJR	O	>	amod	11	SENT_9	[p1l1152t2490r1204b2535],
10	T	NN	O	t	nn	11	SENT_9	[p1l1267t2480r1326b2545],
11	polymorphism	NN	O	polymorphism	dep	8	SENT_9	[p1l1371t2477r1952b2564],
12	and	CC	O	and	_	0	SENT_9	[p1l1999t2477r2144b2546],
13	another	DT	O	another	det	14	SENT_9	[p1l10t2585r317b2653],
14	polymorphism	NN	O	polymorphism	prep_between	5	SENT_9	[p1l365t2585r968b2672],
15	,	,	O	,	_	0	SENT_9	[p1l365t2585r968b2672],
16	the	DT	O	the	det	17	SENT_9	[p1l1022t2585r1141b2653],
17	3730G	NN	O	3730g	appos	14	SENT_9	[p1l1194t2586r1454b2654],
18	>	JJR	O	>	dep	17	SENT_9	[p1l1521t2597r1573b2642],
19	A	DT	O	a	dep	18	SENT_9	[p1l1640t2585r1731b2667],
20	,	,	O	,	_	0	SENT_9	[p1l1640t2585r1731b2667],
21	in	IN	O	in	_	0	SENT_9	[p1l1784t2585r1858b2652],
22	the	DT	O	the	det	26	SENT_9	[p1l1908t2585r2027b2653],
23	3	CD	NUMBER	3	num	24	SENT_9	[p1l2081t2583r2144b2653],
24	’	NN	O	’	npadvmod	25	SENT_9	[p1l2081t2583r2144b2653],
25	untranslated	JJ	O	untranslated	amod	26	SENT_9	[p1l8t2691r508b2760],
26	region	NN	O	region	prep_in	14	SENT_9	[p1l561t2691r829b2778],
27	.	.	O	.	_	0	SENT_9	[p1l561t2691r829b2778],

1	The	DT	O	the	det	3	SENT_10	[p1l887t2691r1038b2760],
2	C/T	NN	O	c/t	nn	3	SENT_10	[p1l1093t2691r1248b2778],
3	heterozyogtes	NNS	O	heterozyogte	npadvmod	10	SENT_10	[p1l1300t2691r1844b2778],
4	at	IN	O	at	_	0	SENT_10	[p1l1899t2701r1972b2760],
5	the	DT	O	the	det	6	SENT_10	[p1l2024t2691r2143b2760],
6	1173C	NN	O	1173c	prep_at	10	SENT_10	[p1l18t2800r260b2867],
7	>	JJR	O	>	amod	9	SENT_10	[p1l327t2811r378b2856],
8	T	NN	O	t	nn	9	SENT_10	[p1l444t2801r502b2866],
9	polymorphism	NN	O	polymorphism	dep	6	SENT_10	[p1l548t2799r1130b2885],
10	tended	VBD	O	tend	dep	20	SENT_10	[p1l1177t2798r1441b2867],
11	to	TO	O	to	aux	12	SENT_10	[p1l1489t2808r1565b2867],
12	require	VB	O	require	xcomp	10	SENT_10	[p1l1615t2799r1894b2885],
13	more	JJR	O	more	amod	14	SENT_10	[p1l1940t2821r2143b2867],
14	warfarin	NN	O	warfarin	dobj	12	SENT_10	[p1l7t2905r347b2973],
15	than	IN	O	than	_	0	SENT_10	[p1l368t2905r545b2973],
16	the	DT	O	the	det	17	SENT_10	[p1l565t2905r684b2973],
17	T	NN	O	t	prep_than	12	SENT_10	[p1l705t2905r795b2992],
18	/	:	O	/	punct	20	SENT_10	[p1l705t2905r795b2992],
19	T	NN	O	t	nn	20	SENT_10	[p1l799t2908r858b2972],
20	homozygotes	NNS	O	homozygote	_	0	SENT_10	[p1l878t2905r1424b2992],
21	,	,	O	,	_	0	SENT_10	[p1l878t2905r1424b2992],
22	when	WRB	O	when	advmod	26	SENT_10	[p1l1446t2905r1656b2974],
23	adjusted	VBN	O	adjust	csubj	26	SENT_10	[p1l1677t2905r2009b2992],
24	for	IN	O	for	_	0	SENT_10	[p1l2029t2905r2144b2973],
25	international	JJ	O	international	prep_for	23	SENT_10	[p1l8t3013r523b3081],
26	normalized	VBD	O	normalize	dep	20	SENT_10	[p1l557t3012r1003b3081],
27	ratio	NN	O	ratio	nn	33	SENT_10	[p1l1038t3013r1223b3081],
28	(	CD	NUMBER	(	num	27	SENT_10	[p1l1261t3013r1334b3100],
29	[	CD	NUMBER	[	number	30	SENT_10	[p1l1261t3013r1334b3100],
30	9	CD	NUMBER	9	dep	27	SENT_10	[p1l1261t3013r1334b3100],
31	=	JJ	O	=	amod	33	SENT_10	[p1l1387t3038r1442b3057],
32	0.003	CD	NUMBER	0.003	tmod	31	SENT_10	[p1l1495t3013r1755b3099],
33	)	NN	O	)	dobj	26	SENT_10	[p1l1495t3013r1755b3099],
34	.	.	O	.	_	0	SENT_10	[p1l1495t3013r1755b3099],

1	Both	CC	O	both	preconj	3	SENT_11	[p1l1798t3013r1989b3081],
2	the	DT	O	the	det	3	SENT_11	[p1l2024t3013r2143b3081],
3	1173C	NN	O	1173c	nsubj	14	SENT_11	[p1l18t3120r260b3188],
4	>	JJR	O	>	amod	6	SENT_11	[p1l309t3131r361b3177],
5	T	NN	O	t	nn	6	SENT_11	[p1l409t3122r467b3186],
6	polymorphism	NN	O	polymorphism	dep	3	SENT_11	[p1l496t3119r1078b3206],
7	and	CC	O	and	_	0	SENT_11	[p1l1108t3119r1253b3187],
8	the	DT	O	the	det	9	SENT_11	[p1l1284t3119r1403b3187],
9	3730G	NN	O	3730g	conj_and	3	SENT_11	[p1l1435t3120r1694b3188],
10	>	JJR	O	>	amod	12	SENT_11	[p1l1743t3131r1795b3177],
11	A	DT	O	a	det	12	SENT_11	[p1l1841t3119r1911b3186],
12	polymorphism	NN	O	polymorphism	dep	9	SENT_11	[p1l1939t3119r2141b3206, p1l7t3226r413b3313],
13	are	VBP	O	be	cop	14	SENT_11	[p1l466t3249r584b3295],
14	likely	JJ	O	likely	_	0	SENT_11	[p1l635t3226r848b3313],
15	to	TO	O	to	aux	17	SENT_11	[p1l899t3236r976b3295],
16	be	VB	O	be	cop	17	SENT_11	[p1l1029t3226r1117b3295],
17	inert	JJ	O	inert	xcomp	14	SENT_11	[p1l1168t3226r1351b3295],
18	from	IN	O	from	_	0	SENT_11	[p1l1401t3226r1594b3295],
19	a	DT	O	a	det	21	SENT_11	[p1l1646t3249r1688b3295],
20	functional	JJ	O	functional	amod	21	SENT_11	[p1l1739t3226r2144b3295],
21	standpoint	NN	O	standpoint	prep_from	17	SENT_11	[p2l11t17r456b104],
22	.	.	O	.	_	0	SENT_11	[p2l11t17r456b104],

1	Rather	RB	O	rather	advmod	20	SENT_12	[p2l513t17r808b99],
2	,	,	O	,	_	0	SENT_12	[p2l513t17r808b99],
3	based	VBN	O	base	_	0	SENT_12	[p2l861t17r1084b85],
4	on	IN	O	on	prepc_based_on	20	SENT_12	[p2l1136t39r1233b85],
5	the	DT	O	the	det	8	SENT_12	[p2l1283t17r1402b85],
6	complete	JJ	O	complete	amod	8	SENT_12	[p2l1451t17r1809b104],
7	linkage	NN	O	linkage	nn	8	SENT_12	[p2l1858t17r2143b104],
8	disequilibrium	NN	O	disequilibrium	pobj	20	SENT_12	[p2l9t123r582b210],
9	between	IN	O	between	_	0	SENT_12	[p2l617t123r938b192],
10	ll73C	NN	O	ll73c	prep_between	8	SENT_12	[p2l982t124r1223b192],
11	>	JJR	O	>	amod	12	SENT_12	[p2l1278t136r1329b181],
12	T	NN	O	t	dep	10	SENT_12	[p2l1382t126r1441b191],
13	and	CC	O	and	_	0	SENT_12	[p2l1477t123r1622b192],
14	373OG	NN	O	373og	dep	15	SENT_12	[p2l1659t124r1918b192],
15	>	JJR	O	>	prep_between	8	SENT_12	[p2l1971t135r2022b181],
16	A	DT	O	a	det	17	SENT_12	[p2l2074t123r2144b191],
17	polymorphisms	NNS	O	polymorphism	dep	15	SENT_12	[p2l8t230r647b317],
18	,	,	O	,	_	0	SENT_12	[p2l8t230r647b317],
19	we	PRP	O	we	nsubj	20	SENT_12	[p2l672t253r777b299],
20	suspect	VBP	O	suspect	_	0	SENT_12	[p2l801t240r1084b317],
21	that	IN	O	that	complm	34	SENT_12	[p2l1107t230r1264b299],
22	the	DT	O	the	det	24	SENT_12	[p2l1286t230r1405b299],
23	actual	JJ	O	actual	amod	24	SENT_12	[p2l1429t230r1666b299],
24	change	NN	O	change	nsubj	34	SENT_12	[p2l1688t230r1964b317],
25	that	WDT	O	that	nsubj	26	SENT_12	[p2l1987t230r2144b299],
26	deﬁnes	VBZ	O	deﬁnes	rcmod	24	SENT_12	[p2l9t337r277b406],
27	the	DT	O	the	det	29	SENT_12	[p2l336t337r455b406],
28	relative	JJ	O	relative	amod	29	SENT_12	[p2l513t338r802b406],
29	resistance	NN	O	resistance	dobj	26	SENT_12	[p2l860t338r1242b406],
30	to	TO	O	to	_	0	SENT_12	[p2l1301t347r1377b406],
31	warfarin	NN	O	warfarin	prep_to	26	SENT_12	[p2l1434t338r1774b406],
32	may	MD	O	may	aux	34	SENT_12	[p2l1829t360r1998b424],
33	be	VB	O	be	cop	34	SENT_12	[p2l2055t337r2143b406],
34	present	JJ	DATE	present	ccomp	20	SENT_12	[p2l8t454r295b531],
35	in	IN	O	in	_	0	SENT_12	[p2l323t444r396b511],
36	the	DT	O	the	det	37	SENT_12	[p2l425t444r544b512],
37	proximity	NN	O	proximity	prep_in	34	SENT_12	[p2l572t444r963b531],
38	of	IN	O	of	_	0	SENT_12	[p2l993t444r1080b512],
39	these	DT	O	these	det	41	SENT_12	[p2l1100t444r1296b512],
40	two	CD	NUMBER	two	num	41	SENT_12	[p2l1326t454r1470b512],
41	polymorphisms	NNS	O	polymorphism	prep_of	37	SENT_12	[p2l1499t444r2136b531],
42	.	.	O	.	_	0	SENT_12	[p2l1499t444r2136b531],

1	Key	NN	O	key	nn	2	SENT_13	[p2l8t648r161b732],
2	words	NNS	O	word	_	0	SENT_13	[p2l202t648r450b714],
3	:	:	O	:	_	0	SENT_13	[p2l202t648r450b714],
4	Warfarin	NNP	O	Warfarin	nn	11	SENT_13	[p2l503t645r867b714],
5	—	NNP	O	—	nn	11	SENT_13	[p2l907t687r1003b690],
6	Pharmacogenetics	NNP	O	Pharmacogenetics	nn	11	SENT_13	[p2l1041t645r1761b732],
7	—	NNP	O	—	nn	11	SENT_13	[p2l1800t687r1896b690],
8	Polymorphism	NN	O	polymorphism	nn	11	SENT_13	[p2l1935t645r2141b732, p2l7t751r413b838],
9	—	NN	O	—	nn	11	SENT_13	[p2l445t793r542b797],
10	Vitamin	NN	O	vitamin	nn	11	SENT_13	[p2l572t752r896b820],
11	K	NN	O	k	dep	2	SENT_13	[p2l932t754r1005b819],

1	Warfarin	NNP	O	Warfarin	nsubj	5	SENT_14	[p2l7t965r373b1034],
2	is	VBZ	O	be	cop	5	SENT_14	[p2l409t965r465b1034],
3	an	DT	O	a	det	5	SENT_14	[p2l504t988r598b1034],
4	anticoagulant	JJ	O	anticoagulant	amod	5	SENT_14	[p2l635t965r1180b1052],
5	agent	NN	O	agent	_	0	SENT_14	[p2l1217t975r1431b1052],
6	used	VBN	O	use	partmod	5	SENT_14	[p2l1466t965r1643b1034],
7	for	IN	O	for	_	0	SENT_14	[p2l1680t965r1796b1034],
8	the	DT	O	the	det	9	SENT_14	[p2l1831t965r1950b1034],
9	prevention	NN	O	prevention	prep_for	6	SENT_14	[p2l1986t988r2141b1052, p2l8t1072r305b1141],
10	of	IN	O	of	_	0	SENT_14	[p2l357t1072r443b1141],
11	thromboembolic	JJ	O	thromboembolic	amod	12	SENT_14	[p2l484t1072r1146b1141],
12	events	NNS	O	event	prep_of	9	SENT_14	[p2l1195t1082r1437b1141],
13	in	IN	O	in	_	0	SENT_14	[p2l1487t1072r1561b1140],
14	patients	NNS	O	patient	prep_in	6	SENT_14	[p2l1609t1072r1921b1159],
15	with	IN	O	with	_	0	SENT_14	[p2l1971t1072r2144b1141],
16	chronic	JJ	O	chronic	amod	17	SENT_14	[p2l8t1179r305b1247],
17	conditions	NNS	O	condition	prep_with	14	SENT_14	[p2l376t1179r813b1261],
18	,	,	O	,	_	0	SENT_14	[p2l376t1179r813b1261],
19	such	JJ	O	such	_	0	SENT_14	[p2l891t1179r1065b1247],
20	as	IN	O	as	_	0	SENT_14	[p2l1138t1201r1214b1247],
21	the	DT	O	the	det	22	SENT_14	[p2l1288t1179r1407b1247],
22	implantation	NN	O	implantation	prep_such_as	14	SENT_14	[p2l1479t1179r1993b1266],
23	of	IN	O	of	_	0	SENT_14	[p2l2067t1179r2153b1247],
24	mechanical	JJ	O	mechanical	amod	26	SENT_14	[p2l7t1285r454b1354],
25	prosthetic	JJ	O	prosthetic	amod	26	SENT_14	[p2l476t1285r872b1372],
26	valves	NNS	O	valve	prep_of	22	SENT_14	[p2l893t1285r1154b1354],
27	.	.	O	.	_	0	SENT_14	[p2l893t1285r1154b1354],

1	The	DT	O	the	det	3	SENT_15	[p2l1182t1285r1333b1354],
2	clinical	JJ	O	clinical	amod	3	SENT_15	[p2l1355t1285r1634b1354],
3	effectiveness	NN	O	effectiveness	_	0	SENT_15	[p2l1658t1285r2142b1354],

1	Correspondence	NN	O	correspondence	nsubjpass	15	SENT_16	[p2l13t1528r501b1598],
2	to	TO	O	to	_	0	SENT_16	[p2l533t1539r611b1583],
3	:	:	O	:	_	0	SENT_16	[p2l533t1539r611b1583],
4	K.	NNP	PERSON	K.	nn	5	SENT_16	[p2l642t1530r716b1582],
5	Kosaki	NNP	PERSON	Kosaki	prep_to	1	SENT_16	[p2l749t1528r994b1594],
6	,	,	O	,	_	0	SENT_16	[p2l749t1528r994b1594],
7	email	NN	O	email	appos	5	SENT_16	[p2l1025t1529r1213b1583],
8	:	:	O	:	_	0	SENT_16	[p2l1025t1529r1213b1583],
9	kkosaki@sc.itc.keio.ac.jp	NN	O	kkosaki@sc.itc.keio.ac.jp	dep	5	SENT_16	[p2l1243t1528r2054b1598],
10	of	IN	O	of	_	0	SENT_16	[p2l10t1768r97b1836],
11	warfarin	NN	O	warfarin	prep_of	9	SENT_16	[p2l127t1768r468b1837],
12	has	VBZ	O	have	aux	15	SENT_16	[p2l509t1768r639b1836],
13	been	VBN	O	be	auxpass	15	SENT_16	[p2l682t1768r864b1836],
14	well	RB	O	well	advmod	15	SENT_16	[p2l903t1768r1061b1837],
15	established	VBN	O	establish	_	0	SENT_16	[p2l1102t1768r1559b1836],
16	.	.	O	.	_	0	SENT_16	[p2l1102t1768r1559b1836],

1	However	RB	O	however	advmod	9	SENT_17	[p2l1606t1770r1987b1851],
2	,	,	O	,	_	0	SENT_17	[p2l1606t1770r1987b1851],
3	the	DT	O	the	det	5	SENT_17	[p2l2032t1768r2151b1836],
4	therapeutic	JJ	O	therapeutic	amod	5	SENT_17	[p2l8t1874r456b1961],
5	range	NN	O	range	nsubj	9	SENT_17	[p2l486t1896r705b1961],
6	of	IN	O	of	_	0	SENT_17	[p2l737t1874r823b1943],
7	warfarin	NN	O	warfarin	prep_of	5	SENT_17	[p2l842t1874r1183b1943],
8	is	VBZ	O	be	cop	9	SENT_17	[p2l1212t1874r1269b1943],
9	narrow	JJ	O	narrow	_	0	SENT_17	[p2l1299t1896r1610b1957],
10	,	,	O	,	_	0	SENT_17	[p2l1299t1896r1610b1957],
11	and	CC	O	and	_	0	SENT_17	[p2l1644t1874r1790b1943],
12	bleeding	NN	O	bleeding	nsubj	14	SENT_17	[p2l1819t1874r2152b1961],
13	often	RB	O	often	advmod	14	SENT_17	[p2l10t1982r212b2050],
14	complicates	VBZ	O	complicate	conj_and	9	SENT_17	[p2l255t1982r721b2069],
15	anticoagulation	NN	O	anticoagulation	dobj	14	SENT_17	[p2l767t1982r1392b2069],
16	with	IN	O	with	_	0	SENT_17	[p2l1433t1982r1608b2050],
17	warfarin	NN	O	warfarin	prep_with	14	SENT_17	[p2l1648t1982r1990b2050],
18	[	CD	NUMBER	[	number	19	SENT_17	[p2l2036t1983r2146b2068],
19	4	CD	NUMBER	4	num	20	SENT_17	[p2l2036t1983r2146b2068],
20	]	NN	O	]	dep	14	SENT_17	[p2l2036t1983r2146b2068],
21	.	.	O	.	_	0	SENT_17	[p2l2036t1983r2146b2068],

1	Currently	RB	DATE	currently	advmod	5	SENT_18	[p2l9t2088r416b2175],
2	,	,	O	,	_	0	SENT_18	[p2l9t2088r416b2175],
3	therapy	NN	O	therapy	nsubjpass	5	SENT_18	[p2l445t2088r748b2175],
4	is	VBZ	O	be	auxpass	5	SENT_18	[p2l772t2088r829b2157],
5	individualized	VBN	O	individualize	dep	12	SENT_18	[p2l854t2088r1416b2157],
6	by	IN	O	by	_	0	SENT_18	[p2l1439t2088r1535b2175],
7	monitoring	VBG	O	monitor	agent	5	SENT_18	[p2l1558t2088r2008b2175],
8	the	DT	O	the	det	10	SENT_18	[p2l2032t2088r2151b2157],
9	prothrombin	NN	O	prothrombin	nn	10	SENT_18	[p2l7t2195r524b2282],
10	time	NN	O	time	dobj	7	SENT_18	[p2l601t2196r771b2264],
11	international	JJ	O	international	amod	10	SENT_18	[p2l848t2196r1365b2264],
12	normalized	VBD	O	normalize	_	0	SENT_18	[p2l1440t2195r1887b2264],
13	ratio	NN	O	ratio	nn	16	SENT_18	[p2l1964t2196r2150b2264],
14	(	CD	NUMBER	(	num	16	SENT_18	[p2l10t2302r275b2389],
15	INR	NN	O	inr	nn	16	SENT_18	[p2l10t2302r275b2389],
16	)	NN	O	)	nsubj	12	SENT_18	[p2l10t2302r275b2389],
17	,	,	O	,	_	0	SENT_18	[p2l10t2302r275b2389],
18	a	DT	O	a	det	19	SENT_18	[p2l309t2324r350b2370],
19	measure	NN	O	measure	appos	16	SENT_18	[p2l377t2324r705b2370],
20	of	IN	O	of	_	0	SENT_18	[p2l736t2302r823b2370],
21	anticoagulation	JJ	O	anticoagulation	amod	25	SENT_18	[p2l842t2302r1467b2389],
22	status	NN	O	status	nn	25	SENT_18	[p2l1497t2312r1724b2370],
23	[	NN	O	[	nn	25	SENT_18	[p2l1757t2303r1867b2388],
24	5	CD	NUMBER	5	num	25	SENT_18	[p2l1757t2303r1867b2388],
25	]	NN	O	]	prep_of	19	SENT_18	[p2l1757t2303r1867b2388],
26	.	.	O	.	_	0	SENT_18	[p2l1757t2303r1867b2388],

1	The	DT	O	the	det	3	SENT_19	[p2l177t2410r328b2478],
2	required	VBN	O	require	amod	3	SENT_19	[p2l368t2410r701b2496],
3	dose	NN	O	dose	nsubj	8	SENT_19	[p2l740t2410r916b2478],
4	of	IN	O	of	_	0	SENT_19	[p2l958t2410r1045b2478],
5	warfarin	NN	O	warfarin	prep_of	3	SENT_19	[p2l1073t2410r1415b2478],
6	is	VBZ	O	be	cop	8	SENT_19	[p2l1453t2410r1510b2478],
7	highly	RB	O	highly	advmod	8	SENT_19	[p2l1549t2410r1795b2497],
8	variable	JJ	O	variable	_	0	SENT_19	[p2l1833t2410r2151b2478],
9	among	IN	O	among	_	0	SENT_19	[p2l9t2538r281b2603],
10	individuals	NNS	O	individual	prep_among	8	SENT_19	[p2l326t2516r785b2599],
11	,	,	O	,	_	0	SENT_19	[p2l326t2516r785b2599],
12	and	CC	O	and	_	0	SENT_19	[p2l836t2516r982b2585],
13	the	DT	O	the	det	14	SENT_19	[p2l1028t2516r1148b2585],
14	response	NN	O	response	nsubj	19	SENT_19	[p2l1194t2538r1536b2603],
15	to	TO	O	to	_	0	SENT_19	[p2l1584t2526r1661b2585],
16	warfarin	NN	O	warfarin	prep_to	14	SENT_19	[p2l1707t2516r2049b2585],
17	is	VBZ	O	be	cop	19	SENT_19	[p2l2094t2516r2151b2585],
18	largely	RB	O	largely	advmod	19	SENT_19	[p2l8t2624r275b2710],
19	genetically	RB	O	genetically	conj_and	8	SENT_19	[p2l312t2624r734b2710],
20	determined	VBN	O	determine	dep	19	SENT_19	[p2l771t2623r1217b2692],
21	[	NN	O	[	nn	23	SENT_19	[p2l1258t2625r1369b2710],
22	8	CD	NUMBER	8	num	23	SENT_19	[p2l1258t2625r1369b2710],
23	]	NN	O	]	dobj	20	SENT_19	[p2l1258t2625r1369b2710],
24	.	.	O	.	_	0	SENT_19	[p2l1258t2625r1369b2710],

1	Genetic	JJ	O	genetic	amod	2	SENT_20	[p2l1413t2624r1719b2692],
2	variations	NNS	O	variation	nsubjpass	34	SENT_20	[p2l1754t2624r2150b2692],
3	in	IN	O	in	_	0	SENT_20	[p2l7t2730r81b2797],
4	cytochrome	NN	O	cytochrome	nn	6	SENT_20	[p2l123t2730r591b2817],
5	P-450	NN	O	p-450	nn	6	SENT_20	[p2l632t2732r857b2799],
6	2C9	NN	O	2c9	prep_in	2	SENT_20	[p2l900t2731r1079b2813],
7	,	,	O	,	_	0	SENT_20	[p2l900t2731r1079b2813],
8	the	DT	O	the	det	9	SENT_20	[p2l1125t2730r1244b2798],
9	activity	NN	O	activity	nsubj	12	SENT_20	[p2l1287t2730r1579b2817],
10	of	IN	O	of	_	0	SENT_20	[p2l1622t2730r1708b2798],
11	which	WDT	O	which	prep_of	9	SENT_20	[p2l1739t2730r1975b2798],
12	terminates	VBZ	O	terminate	rcmod	2	SENT_20	[p2l2016t2740r2150b2798, p2l7t2837r315b2906],
13	the	DT	O	the	det	15	SENT_20	[p2l352t2837r471b2906],
14	anticoagulant	JJ	O	anticoagulant	amod	15	SENT_20	[p2l509t2837r1056b2924],
15	effect	NN	O	effect	dobj	12	SENT_20	[p2l1092t2838r1301b2906],
16	of	IN	O	of	_	0	SENT_20	[p2l1338t2837r1425b2906],
17	warfarin	NN	O	warfarin	prep_of	15	SENT_20	[p2l1450t2837r1790b2906],
18	by	IN	O	by	_	0	SENT_20	[p2l1827t2837r1922b2924],
19	catalyzing	VBG	O	catalyze	prepc_by	12	SENT_20	[p2l1958t2847r2150b2906, p2l8t2944r243b3031],
20	the	DT	O	the	det	21	SENT_20	[p2l279t2944r399b3013],
21	conversion	NN	O	conversion	dobj	19	SENT_20	[p2l435t2944r867b3013],
22	of	IN	O	of	_	0	SENT_20	[p2l905t2944r991b3013],
23	the	DT	O	the	det	27	SENT_20	[p2l1018t2944r1138b3013],
24	pharmacologically	RB	O	pharmacologically	advmod	26	SENT_20	[p2l1173t2944r1913b3031],
25	more	RBR	O	more	advmod	26	SENT_20	[p2l1947t2967r2151b3013],
26	potent	JJ	O	potent	amod	27	SENT_20	[p2l7t3061r266b3139],
27	S-enantiomer	NN	O	s-enantiomer	prep_of	21	SENT_20	[p2l323t3052r857b3120],
28	to	TO	O	to	_	0	SENT_20	[p2l913t3061r990b3120],
29	its	PRP$	O	its	poss	31	SENT_20	[p2l1047t3052r1135b3120],
30	inactive	JJ	O	inactive	amod	31	SENT_20	[p2l1192t3052r1498b3120],
31	metabolites	NNS	O	metabolite	prep_to	27	SENT_20	[p2l1554t3052r2035b3134],
32	,	,	O	,	_	0	SENT_20	[p2l1554t3052r2035b3134],
33	is	VBZ	O	be	auxpass	34	SENT_20	[p2l2094t3052r2151b3120],
34	known	VBN	O	know	_	0	SENT_20	[p2l8t3158r281b3227],
35	to	TO	O	to	aux	36	SENT_20	[p2l314t3168r391b3227],
36	lead	VB	O	lead	xcomp	34	SENT_20	[p2l427t3158r588b3227],
37	to	TO	O	to	_	0	SENT_20	[p2l623t3168r699b3227],
38	signiﬁcant	JJ	O	signiﬁcant	amod	39	SENT_20	[p2l737t3158r1142b3245],
39	differences	NNS	O	difference	prep_to	36	SENT_20	[p2l1176t3158r1594b3227],
40	in	IN	O	in	_	0	SENT_20	[p2l1630t3158r1704b3226],
41	patient	NN	O	patient	nn	42	SENT_20	[p2l1735t3158r2014b3245],
42	response	NN	O	response	prep_in	39	SENT_20	[p2l2047t3181r2150b3227, p2l10t3288r274b3352],
43	to	TO	O	to	_	0	SENT_20	[p2l311t3275r387b3334],
44	warfarim	NN	O	warfarim	prep_to	36	SENT_20	[p2l424t3266r791b3334],
45	[	CD	NUMBER	[	number	46	SENT_20	[p2l830t3267r917b3352],
46	9	CD	NUMBER	9	dep	44	SENT_20	[p2l830t3267r917b3352],
47	,	,	O	,	_	0	SENT_20	[p2l830t3267r917b3352],
48	11	CD	NUMBER	11	num	49	SENT_20	[p2l966t3267r1092b3352],
49	]	NN	O	]	appos	44	SENT_20	[p2l966t3267r1092b3352],
50	.	.	O	.	_	0	SENT_20	[p2l966t3267r1092b3352],

1	Two	CD	NUMBER	two	num	4	SENT_21	[p2l1134t3268r1310b3334],
2	common	JJ	O	common	amod	4	SENT_21	[p2l1349t3288r1697b3334],
3	variant	JJ	O	variant	amod	4	SENT_21	[p2l1732t3266r2017b3334],
4	alleles	NNS	O	allele	nsubj	5	SENT_21	[p2l2054t3266r2150b3334, p2l8t3372r173b3441],
5	(	VBP	O	(	_	0	SENT_21	[p2l275t3372r953b3459],
6	polymorphisms	NNS	O	polymorphism	nsubjpass	12	SENT_21	[p2l275t3372r953b3459],
7	)	CD	NUMBER	)	num	6	SENT_21	[p2l275t3372r953b3459],
8	of	IN	O	of	_	0	SENT_21	[p2l1056t3372r1143b3441],
9	CYPZC9	NN	O	cypzc9	prep_of	6	SENT_21	[p2l1234t3373r1585b3441],
10	have	VBP	O	have	aux	12	SENT_21	[p2l1687t3372r1870b3441],
11	been	VBN	O	be	auxpass	12	SENT_21	[p2l1970t3372r2152b3441],
12	identiﬁed	VBN	O	identiﬁed	ccomp	5	SENT_21	[p2l7t3481r398b3551],
13	.	.	O	.	_	0	SENT_21	[p2l7t3481r398b3551],

1	The	DT	O	the	det	2	SENT_22	[p2l437t3482r589b3551],
2	*	NN	O	*	dep	8	SENT_22	[p2l629t3482r713b3550],
3	2	CD	NUMBER	2	num	4	SENT_22	[p2l629t3482r713b3550],
4	allele	NN	O	allele	dep	2	SENT_22	[p2l750t3482r950b3551],
5	(	CD	NUMBER	(	num	6	SENT_22	[p2l987t3482r1324b3570],
6	Rl44C	NN	O	rl44c	dep	8	SENT_22	[p2l987t3482r1324b3570],
7	)	CD	NUMBER	)	number	8	SENT_22	[p2l987t3482r1324b3570],
8	[	CD	NUMBER	[	dep	15	SENT_22	[p2l1363t3483r1451b3569],
9	9	CD	NUMBER	9	num	10	SENT_22	[p2l1363t3483r1451b3569],
10	]	NN	O	]	dep	8	SENT_22	[p2l1363t3483r1451b3569],
11	and	CC	O	and	_	0	SENT_22	[p2l1490t3481r1636b3551],
12	the	DT	O	the	det	13	SENT_22	[p2l1671t3481r1790b3551],
13	*	NN	O	*	conj_and	8	SENT_22	[p2l1831t3482r1912b3551],
14	3	CD	NUMBER	3	dep	13	SENT_22	[p2l1831t3482r1912b3551],
15	allele	NN	O	allele	dep	17	SENT_22	[p2l1951t3482r2151b3551],
16	(	CD	NUMBER	(	num	15	SENT_22	[p2l10t3588r306b3675],
17	I359L	NN	O	i359l	dep	22	SENT_22	[p2l10t3588r306b3675],
18	)	CD	NUMBER	)	num	17	SENT_22	[p2l10t3588r306b3675],
19	[	CD	NUMBER	[	num	21	SENT_22	[p2l359t3589r493b3674],
20	ll	NN	O	ll	nn	21	SENT_22	[p2l359t3589r493b3674],
21	]	NN	O	]	nsubj	22	SENT_22	[p2l359t3589r493b3674],
22	reduce	VB	O	reduce	dep	32	SENT_22	[p2l546t3588r805b3656],
23	enzymatic	JJ	O	enzymatic	amod	24	SENT_22	[p2l854t3588r1255b3675],
24	activity	NN	O	activity	dobj	22	SENT_22	[p2l1305t3588r1597b3675],
25	by	IN	O	by	_	0	SENT_22	[p2l1644t3588r1740b3675],
26	30	CD	PERCENT	30	num	27	SENT_22	[p2l1791t3588r1955b3657],
27	%	NN	PERCENT	%	prep_by	22	SENT_22	[p2l1791t3588r1955b3657],
28	and	CC	O	and	_	0	SENT_22	[p2l2007t3588r2152b3656],
29	80	CD	PERCENT	80	num	30	SENT_22	[p2l11t3696r199b3778],
30	%	NN	PERCENT	%	prep_by	22	SENT_22	[p2l11t3696r199b3778],
31	,	,	O	,	_	0	SENT_22	[p2l11t3696r199b3778],
32	respectively	RB	O	respectively	_	0	SENT_22	[p2l273t3695r756b3782],
33	.	.	O	.	_	0	SENT_22	[p2l273t3695r756b3782],

1	Carriers	NNS	O	carrier	nsubj	6	SENT_23	[p2l833t3695r1153b3764],
2	of	IN	O	of	_	0	SENT_23	[p2l1227t3695r1313b3764],
3	these	DT	O	these	det	5	SENT_23	[p2l1374t3695r1571b3764],
4	polymorphic	JJ	O	polymorphic	amod	5	SENT_23	[p2l1641t3695r2152b3782],
5	alleles	NNS	O	allele	prep_of	1	SENT_23	[p3l9t18r246b86],
6	have	VBP	O	have	_	0	SENT_23	[p3l268t18r451b86],
7	a	DT	O	a	det	11	SENT_23	[p3l474t40r517b86],
8	low	JJ	O	low	amod	11	SENT_23	[p3l538t18r679b86],
9	warfarin	NN	O	warfarin	nn	11	SENT_23	[p3l699t18r1040b86],
10	metabolism	NN	O	metabolism	nn	11	SENT_23	[p3l1060t18r1525b86],
11	[	NN	O	[	dobj	6	SENT_23	[p3l1549t19r1605b104],
12	1	CD	NUMBER	1	number	13	SENT_23	[p3l1549t19r1605b104],
13	1	CD	NUMBER	1	num	14	SENT_23	[p3l1627t19r1683b104],
14	]	NN	O	]	dep	11	SENT_23	[p3l1627t19r1683b104],
15	and	CC	O	and	_	0	SENT_23	[p3l1710t18r1878b101],
16	,	,	O	,	_	0	SENT_23	[p3l1710t18r1878b101],
17	hence	RB	O	hence	dep	6	SENT_23	[p3l1903t18r2148b100],
18	,	,	O	,	_	0	SENT_23	[p3l1903t18r2148b100],
19	have	VBP	O	have	conj_and	6	SENT_23	[p3l8t124r191b193],
20	smaller	JJR	O	smaller	amod	22	SENT_23	[p3l227t124r510b193],
21	dose	NN	O	dose	nn	22	SENT_23	[p3l544t124r721b193],
22	requirements	NNS	O	requirement	dobj	19	SENT_23	[p3l754t124r1295b211],
23	,	,	O	,	_	0	SENT_23	[p3l754t124r1295b211],
24	[	NN	O	[	appos	22	SENT_23	[p3l1336t125r1422b210],
25	1	CD	NUMBER	1	num	24	SENT_23	[p3l1336t125r1422b210],
26	,	,	O	,	_	0	SENT_23	[p3l1336t125r1422b210],
27	15	CD	NUMBER	15	num	28	SENT_23	[p3l1468t126r1595b210],
28	]	NN	O	]	appos	24	SENT_23	[p3l1468t126r1595b210],
29	.	.	O	.	_	0	SENT_23	[p3l1468t126r1595b210],

1	The	DT	O	the	det	2	SENT_24	[p3l1633t124r1784b193],
2	frequencies	NNS	O	frequency	nsubjpass	13	SENT_24	[p3l1818t124r2150b211, p3l8t233r147b301],
3	of	IN	O	of	_	0	SENT_24	[p3l180t233r267b301],
4	the	DT	O	the	det	5	SENT_24	[p3l286t233r406b301],
5	*	NN	O	*	prep_of	2	SENT_24	[p3l441t233r526b300],
6	2	CD	NUMBER	2	num	5	SENT_24	[p3l441t233r526b300],
7	and	CC	O	and	_	0	SENT_24	[p3l557t233r703b301],
8	*	CD	NUMBER	*	number	9	SENT_24	[p3l737t233r818b301],
9	3	CD	NUMBER	3	num	10	SENT_24	[p3l737t233r818b301],
10	alleles	NNS	O	allele	nsubjpass	13	SENT_24	[p3l853t233r1090b301],
11	have	VBP	O	have	aux	13	SENT_24	[p3l1120t233r1302b301],
12	been	VBN	O	be	auxpass	13	SENT_24	[p3l1333t233r1515b301],
13	estimated	VBN	O	estimate	_	0	SENT_24	[p3l1545t233r1925b301],
14	to	TO	O	to	aux	17	SENT_24	[p3l1954t242r2032b301],
15	be	VB	O	be	cop	17	SENT_24	[p3l2063t233r2151b301],
16	11	CD	PERCENT	11	num	17	SENT_24	[p3l17t340r175b408],
17	%	NN	PERCENT	%	xcomp	13	SENT_24	[p3l17t340r175b408],
18	and	CC	O	and	_	0	SENT_24	[p3l237t339r383b408],
19	7	CD	PERCENT	7	num	20	SENT_24	[p3l445t340r563b408],
20	%	NN	PERCENT	%	nsubj	24	SENT_24	[p3l445t340r563b408],
21	respectively	RB	O	respectively	advmod	20	SENT_24	[p3l624t340r1087b426],
22	among	IN	O	among	_	0	SENT_24	[p3l1147t362r1418b426],
23	Caucasians	NNPS	MISC	Caucasians	prep_among	20	SENT_24	[p3l1479t340r1925b408],
24	[	VBP	O	[	conj_and	13	SENT_24	[p3l1989t341r2146b426],
25	12	CD	NUMBER	12	num	26	SENT_24	[p3l1989t341r2146b426],
26	]	CD	NUMBER	]	dobj	24	SENT_24	[p3l1989t341r2146b426],
27	.	.	O	.	_	0	SENT_24	[p3l1989t341r2146b426],

1	However	RB	O	however	advmod	6	SENT_25	[p3l9t449r389b529],
2	,	,	O	,	_	0	SENT_25	[p3l9t449r389b529],
3	both	DT	O	both	det	4	SENT_25	[p3l420t446r604b514],
4	variants	NNS	O	variant	nsubj	6	SENT_25	[p3l629t446r947b514],
5	are	VBP	O	be	cop	6	SENT_25	[p3l976t468r1095b514],
6	rare	JJ	O	rare	_	0	SENT_25	[p3l1122t468r1278b514],
7	among	IN	O	among	_	0	SENT_25	[p3l1307t468r1578b533],
8	Japanese	JJ	MISC	japanese	amod	11	SENT_25	[p3l1604t448r1958b533],
9	[	NN	O	[	nn	11	SENT_25	[p3l1989t447r2146b532],
10	14	CD	NUMBER	14	num	11	SENT_25	[p3l1989t447r2146b532],
11	]	NN	O	]	prep_among	6	SENT_25	[p3l1989t447r2146b532],
12	.	.	O	.	_	0	SENT_25	[p3l1989t447r2146b532],

1	Hence	RB	O	hence	advmod	9	SENT_26	[p3l9t556r280b636],
2	,	,	O	,	_	0	SENT_26	[p3l9t556r280b636],
3	polymorphisms	NNS	O	polymorphism	nsubj	9	SENT_26	[p3l318t553r937b640],
4	in	IN	O	in	_	0	SENT_26	[p3l975t554r1049b621],
5	CYPZC9	NN	O	cypzc9	prep_in	3	SENT_26	[p3l1087t555r1438b622],
6	alone	RB	O	alone	advmod	9	SENT_26	[p3l1479t554r1691b622],
7	can	MD	O	can	aux	9	SENT_26	[p3l1728t563r2000b622],
8	not	RB	O	not	neg	9	SENT_26	[p3l1728t563r2000b622],
9	account	VB	O	account	_	0	SENT_26	[p3l2037t576r2150b622, p3l8t670r234b728],
10	for	IN	O	for	_	0	SENT_26	[p3l267t660r383b728],
11	the	DT	O	the	det	13	SENT_26	[p3l416t660r536b728],
12	interindividual	JJ	O	interindividual	amod	13	SENT_26	[p3l570t660r1158b728],
13	variability	NN	O	variability	prep_for	9	SENT_26	[p3l1190t660r1598b747],
14	among	IN	O	among	_	0	SENT_26	[p3l1633t682r1904b747],
15	Japanese	JJ	MISC	japanese	prep_among	9	SENT_26	[p3l1936t662r2150b747, p3l8t790r174b836],
16	in	IN	O	in	_	0	SENT_26	[p3l236t767r310b835],
17	the	DT	O	the	det	19	SENT_26	[p3l372t767r492b836],
18	warfarin	NN	O	warfarin	nn	19	SENT_26	[p3l553t767r893b836],
19	dosages	NNS	O	dosage	prep_in	15	SENT_26	[p3l956t767r1262b854],
20	required	VBN	O	require	partmod	19	SENT_26	[p3l1325t767r1658b854],
21	to	TO	O	to	aux	22	SENT_26	[p3l1720t777r1797b836],
22	achieve	VB	O	achieve	xcomp	20	SENT_26	[p3l1862t767r2151b836],
23	therapeutic	JJ	O	therapeutic	amod	24	SENT_26	[p3l8t875r456b962],
24	anticoagulation	NN	O	anticoagulation	dobj	22	SENT_26	[p3l571t875r1216b962],
25	.	.	O	.	_	0	SENT_26	[p3l571t875r1216b962],

1	Additional	JJ	O	additional	amod	2	SENT_27	[p3l1334t875r1767b943],
2	factors	NNS	O	factor	nsubj	4	SENT_27	[p3l1881t875r2151b943],
3	probably	RB	O	probably	advmod	4	SENT_27	[p3l7t981r369b1068],
4	contribute	VBP	O	contribute	_	0	SENT_27	[p3l399t981r810b1050],
5	to	TO	O	to	_	0	SENT_27	[p3l842t991r919b1050],
6	interindividual	JJ	O	interindividual	amod	7	SENT_27	[p3l951t981r1539b1050],
7	variability	NN	O	variability	prep_to	4	SENT_27	[p3l1569t981r1997b1068],
8	.	.	O	.	_	0	SENT_27	[p3l1569t981r1997b1068],

1	Recently	RB	DATE	recently	advmod	8	SENT_28	[p3l179t1088r547b1175],
2	,	,	O	,	_	0	SENT_28	[p3l179t1088r547b1175],
3	a	DT	O	a	det	6	SENT_28	[p3l581t1110r623b1156],
4	positional	JJ	O	positional	amod	6	SENT_28	[p3l650t1088r1046b1175],
5	cloning	NN	O	cloning	nn	6	SENT_28	[p3l1075t1088r1367b1175],
6	approach	NN	O	approach	nsubjpass	8	SENT_28	[p3l1396t1088r1771b1175],
7	was	VBD	O	be	auxpass	8	SENT_28	[p3l1798t1110r1945b1156],
8	used	VBN	O	use	_	0	SENT_28	[p3l1974t1088r2152b1156],
9	to	TO	O	to	aux	10	SENT_28	[p3l8t1205r85b1264],
10	identify	VB	O	identify	xcomp	8	SENT_28	[p3l123t1195r426b1282],
11	a	DT	O	a	det	13	SENT_28	[p3l463t1218r505b1264],
12	novel	JJ	O	novel	amod	13	SENT_28	[p3l541t1195r755b1264],
13	gene	NN	O	gene	dobj	10	SENT_28	[p3l792t1218r991b1282],
14	,	,	O	,	_	0	SENT_28	[p3l792t1218r991b1282],
15	vitamin	NN	O	vitamin	nn	20	SENT_28	[p3l1034t1201r1317b1264],
16	K	NN	O	k	nn	20	SENT_28	[p3l1353t1199r1426b1263],
17	epoxide	NN	O	epoxide	nn	20	SENT_28	[p3l1454t1196r1750b1282],
18	reductase	NN	O	reductase	nn	20	SENT_28	[p3l1788t1196r2152b1264],
19	complex	NN	O	complex	nn	20	SENT_28	[p3l10t1303r332b1390],
20	subunit	NN	O	subunit	appos	13	SENT_28	[p3l371t1303r652b1371],
21	1	CD	NUMBER	1	number	22	SENT_28	[p3l696t1305r730b1370],
22	(	CD	NUMBER	(	num	23	SENT_28	[p3l779t1303r1238b1390],
23	VKORCD	NNP	O	VKORCD	dep	20	SENT_28	[p3l779t1303r1238b1390],
24	,	,	O	,	_	0	SENT_28	[p3l779t1303r1238b1390],
25	that	DT	O	that	nsubj	30	SENT_28	[p3l1283t1303r1442b1371],
26	is	VBZ	O	be	cop	30	SENT_28	[p3l1482t1303r1539b1371],
27	at	IN	O	at	advmod	30	SENT_28	[p3l1583t1312r1657b1371],
28	least	JJS	O	least	pobj	27	SENT_28	[p3l1698t1303r1875b1371],
29	partly	RB	O	partly	advmod	30	SENT_28	[p3l1915t1303r2152b1390],
30	responsible	JJ	O	responsible	rcmod	13	SENT_28	[p3l8t1409r454b1496],
31	for	IN	O	for	_	0	SENT_28	[p3l507t1409r624b1478],
32	the	DT	O	the	det	34	SENT_28	[p3l677t1409r796b1478],
33	warfarin	NN	O	warfarin	nn	34	SENT_28	[p3l849t1409r1189b1478],
34	response	NN	O	response	prep_for	30	SENT_28	[p3l1243t1431r1585b1496],
35	[	CD	NUMBER	[	number	36	SENT_28	[p3l1641t1410r1729b1495],
36	6	CD	NUMBER	6	dep	34	SENT_28	[p3l1641t1410r1729b1495],
37	,	,	O	,	_	0	SENT_28	[p3l1641t1410r1729b1495],
38	10	CD	NUMBER	10	num	39	SENT_28	[p3l1794t1411r1921b1495],
39	]	NN	O	]	appos	34	SENT_28	[p3l1794t1411r1921b1495],
40	.	.	O	.	_	0	SENT_28	[p3l1794t1411r1921b1495],

1	Five	CD	NUMBER	five	num	5	SENT_29	[p3l1981t1409r2151b1478],
2	different	JJ	O	different	amod	3	SENT_29	[p3l8t1517r342b1585],
3	heterozygous	JJ	O	heterozygous	amod	5	SENT_29	[p3l376t1517r902b1604],
4	missense	NN	O	missense	nn	5	SENT_29	[p3l936t1517r1279b1585],
5	mutations	NNS	O	mutation	nsubjpass	8	SENT_29	[p3l1313t1517r1715b1585],
6	have	VBP	O	have	aux	8	SENT_29	[p3l1751t1517r1934b1585],
7	been	VBN	O	be	auxpass	8	SENT_29	[p3l1970t1517r2152b1585],
8	found	VBN	O	find	_	0	SENT_29	[p3l8t1623r244b1692],
9	in	IN	O	in	_	0	SENT_29	[p3l272t1623r346b1691],
10	probands	NNS	O	proband	prep_in	8	SENT_29	[p3l373t1623r749b1710],
11	suffering	VBG	O	suffer	partmod	10	SENT_29	[p3l781t1623r1123b1710],
12	from	IN	O	from	_	0	SENT_29	[p3l1151t1623r1345b1692],
13	warfarin	NN	O	warfarin	nn	14	SENT_29	[p3l1372t1623r1713b1692],
14	resistance	NN	O	resistance	prep_from	11	SENT_29	[p3l1742t1623r2147b1692],
15	.	.	O	.	_	0	SENT_29	[p3l1742t1623r2147b1692],

1	Furthermore	RB	O	furthermore	advmod	6	SENT_30	[p3l10t1731r546b1813],
2	,	,	O	,	_	0	SENT_30	[p3l10t1731r546b1813],
3	an	DT	O	a	det	5	SENT_30	[p3l595t1753r689b1799],
4	Italian	JJ	MISC	italian	amod	5	SENT_30	[p3l733t1731r993b1799],
5	group	NN	O	group	nsubj	6	SENT_30	[p3l1037t1753r1272b1817],
6	demonstrated	VBD	O	demonstrate	_	0	SENT_30	[p3l1317t1730r1863b1799],
7	that	IN	O	that	_	0	SENT_30	[p3l1908t1731r2066b1799],
8	a	DT	O	a	det	9	SENT_30	[p3l2111t1753r2152b1799],
9	686	CD	NUMBER	686	prep_that	6	SENT_30	[p3l9t1856r116b1909],

1	common	JJ	O	common	amod	2	SENT_31	[p3l7t2102r355b2148],
2	polymorphism	NN	O	polymorphism	nsubj	7	SENT_31	[p3l390t2079r973b2166],
3	at	IN	O	at	_	0	SENT_31	[p3l1010t2089r1084b2148],
4	the	DT	O	the	det	6	SENT_31	[p3l1119t2079r1239b2148],
5	VKORCI	NN	O	vkorcus	nn	6	SENT_31	[p3l1287t2082r1657b2148],
6	locus	NN	O	locus	prep_at	2	SENT_31	[p3l1698t2080r1899b2148],
7	modulates	VBZ	O	modulate	_	0	SENT_31	[p3l1935t2079r2143b2148, p3l7t2187r236b2255],
8	the	DT	O	the	det	11	SENT_31	[p3l299t2187r418b2255],
9	mean	JJ	O	mean	amod	11	SENT_31	[p3l479t2209r693b2255],
10	daily	JJ	SET	daily	amod	11	SENT_31	[p3l756t2187r949b2273],
11	dose	NN	O	dose	dobj	7	SENT_31	[p3l1012t2187r1187b2255],
12	of	IN	O	of	_	0	SENT_31	[p3l1252t2187r1338b2255],
13	drugs	NNS	O	drug	prep_of	11	SENT_31	[p3l1392t2187r1609b2274],
14	required	VBN	O	require	partmod	13	SENT_31	[p3l1673t2187r2004b2273],
15	to	TO	O	to	aux	16	SENT_31	[p3l2067t2196r2143b2255],
16	acquire	VB	O	acquire	xcomp	14	SENT_31	[p3l9t2293r297b2380],
17	the	DT	O	the	det	20	SENT_31	[p3l342t2293r461b2362],
18	target	NN	O	target	nn	20	SENT_31	[p3l507t2303r737b2380],
19	anticoagulation	NN	O	anticoagulation	nn	20	SENT_31	[p3l782t2293r1404b2380],
20	intensity	NN	O	intensity	iobj	16	SENT_31	[p3l1448t2293r1787b2380],
21	[	CD	NUMBER	[	number	22	SENT_31	[p3l1834t2295r1944b2379],
22	3	CD	NUMBER	3	num	23	SENT_31	[p3l1834t2295r1944b2379],
23	]	NN	O	]	dobj	16	SENT_31	[p3l1834t2295r1944b2379],
24	.	.	O	.	_	0	SENT_31	[p3l1834t2295r1944b2379],

1	The	DT	O	the	det	3	SENT_32	[p3l1993t2293r2144b2362],
2	mean	NN	O	mean	nn	3	SENT_32	[p3l6t2423r220b2469],
3	dose	NN	O	dose	nsubj	7	SENT_32	[p3l249t2401r424b2469],
4	of	IN	O	of	_	0	SENT_32	[p3l454t2401r540b2469],
5	warfarin	NN	O	warfarin	prep_of	3	SENT_32	[p3l557t2401r897b2469],
6	was	VBD	O	be	cop	7	SENT_32	[p3l923t2423r1070b2469],
7	lower	JJR	O	lower	_	0	SENT_32	[p3l1099t2401r1317b2469],
8	(	CD	NUMBER	(	number	9	SENT_32	[p3l1346t2401r1488b2488],
9	3.5	CD	NUMBER	3.5	num	11	SENT_32	[p3l1346t2401r1488b2488],
10	mg/day	NN	O	mg/day	nn	11	SENT_32	[p3l1516t2401r1845b2488],
11	)	NN	O	)	npadvmod	20	SENT_32	[p3l1516t2401r1845b2488],
12	among	IN	O	among	_	0	SENT_32	[p3l1875t2423r2146b2488],
13	patients	NNS	O	patient	prep_among	7	SENT_32	[p3l6t2507r319b2594],
14	with	IN	O	with	_	0	SENT_32	[p3l363t2507r537b2576],
15	the	DT	O	the	det	18	SENT_32	[p3l582t2507r701b2576],
16	VKORCI	NNP	O	VKORCI	nn	18	SENT_32	[p3l758t2510r1128b2576],
17	1173T/T	NN	O	1173t/t	nn	18	SENT_32	[p3l1186t2507r1518b2594],
18	genotype	NN	O	genotype	prep_with	13	SENT_32	[p3l1563t2517r1922b2594],
19	than	IN	O	than	dep	7	SENT_32	[p3l1967t2507r2145b2576],
20	among	IN	O	among	_	0	SENT_32	[p3l9t2637r279b2701],
21	those	DT	O	those	prep_among	7	SENT_32	[p3l325t2615r532b2683],
22	carrying	VBG	O	carry	partmod	21	SENT_32	[p3l580t2615r909b2701],
23	the	DT	O	the	det	27	SENT_32	[p3l955t2615r1074b2683],
24	C/T	NN	O	c/t	nn	27	SENT_32	[p3l1123t2615r1279b2702],
25	(	NN	O	(	nn	27	SENT_32	[p3l1328t2615r1469b2702],
26	4.8	CD	NUMBER	4.8	num	27	SENT_32	[p3l1328t2615r1469b2702],
27	mg/day	NN	O	mg/day	dobj	22	SENT_32	[p3l1518t2614r1846b2702],
28	)	CD	NUMBER	)	tmod	22	SENT_32	[p3l1518t2614r1846b2702],
29	or	CC	O	or	_	0	SENT_32	[p3l1897t2637r1979b2683],
30	the	DT	O	the	det	36	SENT_32	[p3l2026t2615r2145b2683],
31	C/C	NNP	O	C/C	nn	36	SENT_32	[p3l9t2722r169b2809],
32	genotype	NN	O	genotype	nn	36	SENT_32	[p3l205t2731r564b2808],
33	(	NN	O	(	nn	36	SENT_32	[p3l601t2722r745b2809],
34	6.2	CD	NUMBER	6.2	num	36	SENT_32	[p3l601t2722r745b2809],
35	mg/day	NN	O	mg/day	nn	36	SENT_32	[p3l780t2721r1130b2809],
36	)	NN	O	)	tmod	22	SENT_32	[p3l780t2721r1130b2809],
37	.	.	O	.	_	0	SENT_32	[p3l780t2721r1130b2809],

1	In	IN	O	in	_	0	SENT_33	[p3l1172t2724r1255b2789],
2	the	DT	O	the	det	4	SENT_33	[p3l1290t2722r1409b2790],
3	current	JJ	DATE	current	amod	4	SENT_33	[p3l1445t2731r1731b2790],
4	study	NN	O	study	prep_in	7	SENT_33	[p3l1768t2721r2002b2808],
5	,	,	O	,	_	0	SENT_33	[p3l1768t2721r2002b2808],
6	we	PRP	O	we	nsubj	7	SENT_33	[p3l2039t2744r2144b2790],
7	evaluted	VBD	O	evalute	_	0	SENT_33	[p3l7t2828r340b2896],
8	the	DT	O	the	det	9	SENT_33	[p3l390t2828r509b2896],
9	eﬁfect	NN	O	eﬁfect	dobj	7	SENT_33	[p3l559t2828r767b2896],
10	of	IN	O	of	_	0	SENT_33	[p3l817t2828r904b2896],
11	VKORCI	NNP	O	VKORCI	nn	12	SENT_33	[p3l956t2830r1326b2897],
12	polymorphisms	NNS	O	polymorphism	prep_of	9	SENT_33	[p3l1378t2828r1995b2915],
13	on	IN	O	on	_	0	SENT_33	[p3l2047t2850r2145b2896],
14	warfarin	NN	O	warfarin	nn	15	SENT_33	[p3l6t2935r347b3004],
15	response	NN	O	response	prep_on	7	SENT_33	[p3l376t2958r717b3022],
16	among	IN	O	among	_	0	SENT_33	[p3l750t2958r1020b3022],
17	Japanese	JJ	MISC	japanese	prep_among	7	SENT_33	[p3l1048t2938r1424b3022],
18	,	,	O	,	_	0	SENT_33	[p3l1048t2938r1424b3022],
19	taking	VBG	O	take	partmod	7	SENT_33	[p3l1458t2935r1708b3022],
20	advantage	NN	O	advantage	dobj	19	SENT_33	[p3l1739t2935r2144b3022],
21	of	IN	O	of	_	0	SENT_33	[p3l9t3043r96b3111],
22	its	PRP$	O	its	poss	25	SENT_33	[p3l121t3043r209b3111],
23	unique	JJ	O	unique	amod	25	SENT_33	[p3l245t3043r516b3129],
24	population	NN	O	population	nn	25	SENT_33	[p3l550t3043r989b3130],
25	structure	NN	O	structure	prep_of	20	SENT_33	[p3l1026t3052r1377b3111],
26	in	IN	O	in	_	0	SENT_33	[p3l1413t3043r1486b3110],
27	which	WDT	O	which	rel	37	SENT_33	[p3l1520t3043r1756b3111],
28	CYPZC9	NN	O	cypzc9	nn	29	SENT_33	[p3l1792t3044r2143b3111],
29	*	NN	O	*	nsubj	37	SENT_33	[p3l12t3149r97b3217],
30	2	CD	NUMBER	2	dep	29	SENT_33	[p3l12t3149r97b3217],
31	and	CC	O	and	_	0	SENT_33	[p3l135t3149r280b3218],
32	*	CD	NUMBER	*	number	33	SENT_33	[p3l320t3149r401b3218],
33	3	CD	NUMBER	3	num	34	SENT_33	[p3l320t3149r401b3218],
34	alleles	NNS	O	allele	nsubj	37	SENT_33	[p3l442t3149r677b3218],
35	are	VBP	O	be	cop	37	SENT_33	[p3l715t3171r834b3218],
36	relatively	RB	O	relatively	advmod	37	SENT_33	[p3l870t3149r1234b3236],
37	rare	JJ	O	rare	rcmod	20	SENT_33	[p3l1269t3171r1446b3218],
38	.	.	O	.	_	0	SENT_33	[p3l1269t3171r1446b3218],

1	Materials	NNPS	O	Materials	_	0	SENT_34	[p3l7t3406r387b3473],
2	and	CC	O	and	_	0	SENT_34	[p3l424t3407r560b3473],
3	Methods	NNS	O	method	conj_and	1	SENT_34	[p3l593t3407r934b3473],

1	Patient	NN	O	patient	_	0	SENT_35	[p3l8t3624r291b3689],
2	Population	NNP	O	Population	dep	1	SENT_35	[p3l325t3621r747b3707],

1	A	DT	O	a	det	2	SENT_36	[p4l6t74r62b128],
2	group	NN	O	group	_	0	SENT_36	[p4l107t92r293b144],
3	of	IN	O	of	_	0	SENT_36	[p4l341t74r410b129],
4	31	CD	NUMBER	31	num	5	SENT_36	[p4l450t76r512b129],
5	patients	NNS	O	patient	prep_of	2	SENT_36	[p4l563t74r813b144],
6	between	IN	O	between	_	0	SENT_36	[p4l858t74r1115b129],
7	the	DT	O	the	det	8	SENT_36	[p4l1160t74r1256b129],
8	ages	NNS	O	age	prep_between	5	SENT_36	[p4l1302t92r1433b144],
9	of	IN	O	of	_	0	SENT_36	[p4l1481t74r1550b129],
10	12	CD	NUMBER	12	nn	13	SENT_36	[p4l1595t76r1659b128],
11	and	CC	O	and	_	0	SENT_36	[p4l1706t74r1822b129],
12	34	CD	DURATION	34	conj_and	10	SENT_36	[p4l1870t76r1939b129],
13	years	NNS	NUMBER	year	prep_of	8	SENT_36	[p4l1983t92r2145b144],
14	(	RB	O	(	advmod	15	SENT_36	[p4l8t167r282b236],
15	median	JJ	O	median	amod	2	SENT_36	[p4l8t167r282b236],
16	,	,	O	,	_	0	SENT_36	[p4l8t167r282b236],
17	22	CD	NUMBER	22	num	18	SENT_36	[p4l312t167r408b236],
18	)	NN	O	)	nsubjpass	20	SENT_36	[p4l312t167r408b236],
19	were	VBD	O	be	auxpass	20	SENT_36	[p4l436t185r581b222],
20	recruited	VBN	O	recruit	dep	2	SENT_36	[p4l610t167r891b222],
21	from	IN	O	from	_	0	SENT_36	[p4l919t167r1073b222],
22	the	DT	O	the	det	25	SENT_36	[p4l1101t167r1197b222],
23	pediatric	JJ	O	pediatric	amod	25	SENT_36	[p4l1224t167r1503b236],
24	cardiology	NN	O	cardiology	nn	25	SENT_36	[p4l1530t167r1867b236],
25	clinic	NN	O	clinic	prep_from	20	SENT_36	[p4l1894t167r2059b222],
26	at	IN	O	at	_	0	SENT_36	[p4l2088t175r2146b222],
27	Keio	NNP	ORGANIZATION	Keio	nn	29	SENT_36	[p4l7t260r158b315],
28	University	NNP	ORGANIZATION	University	nn	29	SENT_36	[p4l184t260r515b329],
29	Hospital	NNP	ORGANIZATION	Hospital	prep_at	25	SENT_36	[p4l539t260r827b330],
30	.	.	O	.	_	0	SENT_36	[p4l539t260r827b330],

1	The	DT	O	the	det	3	SENT_37	[p4l855t260r976b315],
2	study	NN	O	study	nn	3	SENT_37	[p4l1002t260r1172b329],
3	protocol	NN	O	protocol	nsubjpass	5	SENT_37	[p4l1193t260r1464b330],
4	was	VBD	O	be	auxpass	5	SENT_37	[p4l1486t278r1604b315],
5	approved	VBN	O	approve	_	0	SENT_37	[p4l1629t260r1928b330],
6	by	IN	O	by	_	0	SENT_37	[p4l1950t260r2026b329],
7	the	DT	O	the	det	10	SENT_37	[p4l2050t260r2145b315],
8	institutional	JJ	O	institutional	amod	10	SENT_37	[p4l6t353r393b408],
9	review	NN	O	review	nn	10	SENT_37	[p4l418t353r622b408],
10	board	NN	O	board	agent	5	SENT_37	[p4l646t353r852b419],
11	,	,	O	,	_	0	SENT_37	[p4l646t353r852b419],
12	and	CC	O	and	_	0	SENT_37	[p4l881t353r997b408],
13	all	PDT	O	all	predet	15	SENT_37	[p4l1024t353r1098b408],
14	the	DT	O	the	det	15	SENT_37	[p4l1124t353r1219b408],
15	participants	NNS	O	participant	nsubj	25	SENT_37	[p4l1245t353r1621b423],
16	or	CC	O	or	_	0	SENT_37	[p4l1650t371r1716b408],
17	the	DT	O	the	det	20	SENT_37	[p4l1742t353r1837b408],
18	parent	NN	O	parent	nn	20	SENT_37	[p4l1862t353r2145b423],
19	(	NN	O	(	nn	20	SENT_37	[p4l1862t353r2145b423],
20	s	NNS	O	s	nsubj	25	SENT_37	[p4l1862t353r2145b423],
21	)	CD	NUMBER	)	dep	20	SENT_37	[p4l1862t353r2145b423],
22	of	IN	O	of	_	0	SENT_37	[p4l8t446r78b501],
23	the	DT	O	the	det	24	SENT_37	[p4l96t446r192b501],
24	participants	NNS	O	participant	prep_of	21	SENT_37	[p4l215t446r593b515],
25	provided	VBD	O	provide	conj_and	5	SENT_37	[p4l618t446r901b515],
26	written	VBN	O	write	amod	28	SENT_37	[p4l925t446r1150b501],
27	informed	VBN	O	inform	amod	28	SENT_37	[p4l1175t446r1466b501],
28	consent	NN	O	consent	dobj	25	SENT_37	[p4l1491t454r1748b501],
29	.	.	O	.	_	0	SENT_37	[p4l1491t454r1748b501],

1	All	DT	O	all	det	2	SENT_38	[p4l1776t446r1872b500],
2	patients	NNS	O	patient	nsubj	5	SENT_38	[p4l1896t446r2145b515],
3	had	VBD	O	have	aux	5	SENT_38	[p4l7t539r124b594],
4	been	VBN	O	be	aux	5	SENT_38	[p4l145t539r291b594],
5	receiving	VBG	O	receive	_	0	SENT_38	[p4l312t539r594b609],
6	oral	JJ	O	oral	amod	7	SENT_38	[p4l615t539r739b594],
7	administration	NN	O	administration	dobj	5	SENT_38	[p4l761t539r1227b594],
8	of	IN	O	of	_	0	SENT_38	[p4l1250t539r1319b594],
9	warfarin	NN	O	warfarin	prep_of	7	SENT_38	[p4l1332t539r1603b594],
10	at	IN	O	at	_	0	SENT_38	[p4l1625t547r1684b594],
11	an	DT	O	a	det	13	SENT_38	[p4l1706t557r1781b594],
12	unchanged	JJ	O	unchanged	amod	13	SENT_38	[p4l1801t539r2145b609],
13	dose	NN	O	dose	prep_at	5	SENT_38	[p4l7t632r148b687],
14	for	IN	O	for	_	0	SENT_38	[p4l183t632r276b687],
15	at	IN	DURATION	at	quantmod	17	SENT_38	[p4l310t640r368b687],
16	least	JJS	DURATION	least	mwe	15	SENT_38	[p4l403t632r545b687],
17	6	CD	DURATION	6	num	18	SENT_38	[p4l580t634r612b687],
18	months	NNS	NUMBER	month	prep_for	13	SENT_38	[p4l646t632r883b687],
19	at	IN	O	at	_	0	SENT_38	[p4l919t640r978b687],
20	the	DT	O	the	det	21	SENT_38	[p4l1012t632r1107b687],
21	time	NN	O	time	prep_at	5	SENT_38	[p4l1143t632r1279b687],
22	of	IN	O	of	_	0	SENT_38	[p4l1315t632r1384b687],
23	the	DT	O	the	det	24	SENT_38	[p4l1411t632r1507b687],
24	study	NN	O	study	prep_of	21	SENT_38	[p4l1543t632r1729b702],
25	.	.	O	.	_	0	SENT_38	[p4l1543t632r1729b702],

1	All	DT	O	all	det	2	SENT_39	[p4l1766t632r1862b686],
2	patients	NNS	O	patient	nsubj	3	SENT_39	[p4l1896t632r2146b702],
3	weighed	VBD	O	weigh	_	0	SENT_39	[p4l6t725r264b795],
4	more	JJR	O	more	mwe	5	SENT_39	[p4l293t743r456b780],
5	than	IN	O	than	quantmod	6	SENT_39	[p4l488t725r630b780],
6	40	CD	NUMBER	40	num	7	SENT_39	[p4l660t727r731b780],
7	kg	NN	O	kg	dobj	3	SENT_39	[p4l763t725r855b795],
8	.	.	O	.	_	0	SENT_39	[p4l763t725r855b795],

1	The	DT	O	the	det	4	SENT_40	[p4l890t725r1011b780],
2	underlying	JJ	O	underlying	amod	4	SENT_40	[p4l1041t725r1382b795],
3	heart	NN	O	heart	nn	4	SENT_40	[p4l1413t725r1576b780],
4	defects	NNS	O	defect	nsubjpass	12	SENT_40	[p4l1606t725r1821b780],
5	had	VBD	O	have	aux	7	SENT_40	[p4l1853t725r1970b780],
6	been	VBN	O	be	auxpass	7	SENT_40	[p4l2001t725r2146b780],
7	documented	VBN	O	document	_	0	SENT_40	[p4l7t818r395b873],
8	in	IN	O	in	_	0	SENT_40	[p4l425t818r484b872],
9	each	DT	O	each	det	10	SENT_40	[p4l513t818r655b873],
10	case	NN	O	case	prep_in	7	SENT_40	[p4l683t836r812b873],
11	and	CC	O	and	_	0	SENT_40	[p4l842t818r959b873],
12	included	VBD	O	include	conj_and	7	SENT_40	[p4l987t818r1256b873],
13	18	CD	NUMBER	18	num	14	SENT_40	[p4l1293t819r1354b873],
14	patients	NNS	O	patient	nsubj	37	SENT_40	[p4l1385t818r1635b888],
15	with	IN	O	with	_	0	SENT_40	[p4l1664t818r1802b873],
16	prosthetic	JJ	O	prosthetic	amod	17	SENT_40	[p4l1830t818r2147b888],
17	valves	NNS	O	valve	prep_with	14	SENT_40	[p4l6t911r216b977],
18	,	,	O	,	_	0	SENT_40	[p4l6t911r216b977],
19	10	CD	NUMBER	10	num	20	SENT_40	[p4l263t913r327b966],
20	patients	NNS	O	patient	conj_and	14	SENT_40	[p4l365t911r614b981],
21	with	IN	O	with	_	0	SENT_40	[p4l652t911r791b966],
22	prosthetic	JJ	O	prosthetic	amod	23	SENT_40	[p4l827t911r1144b981],
23	vessels	NNS	O	vessel	prep_with	20	SENT_40	[p4l1180t911r1405b977],
24	,	,	O	,	_	0	SENT_40	[p4l1180t911r1405b977],
25	2	CD	NUMBER	2	num	26	SENT_40	[p4l1446t913r1480b965],
26	patients	NNS	O	patient	conj_and	14	SENT_40	[p4l1517t911r1766b981],
27	with	IN	O	with	_	0	SENT_40	[p4l1803t911r1942b966],
28	atrial	JJ	O	atrial	amod	29	SENT_40	[p4l1981t911r2146b966],
29	ﬁbrillation	NN	O	ﬁbrillation	prep_with	26	SENT_40	[p4l7t1004r359b1070],
30	,	,	O	,	_	0	SENT_40	[p4l7t1004r359b1070],
31	and	CC	O	and	_	0	SENT_40	[p4l384t1004r501b1059],
32	1	CD	NUMBER	1	num	33	SENT_40	[p4l529t1006r549b1058],
33	patient	NN	O	patient	conj_and	14	SENT_40	[p4l576t1004r798b1074],
34	with	IN	O	with	_	0	SENT_40	[p4l817t1004r957b1059],
35	coronary	JJ	O	coronary	amod	36	SENT_40	[p4l977t1022r1264b1074],
36	aneurysm	NN	O	aneurysm	prep_with	33	SENT_40	[p4l1286t1022r1593b1074],
37	due	JJ	O	due	xcomp	12	SENT_40	[p4l1613t1004r1724b1059],
38	to	TO	O	to	_	0	SENT_40	[p4l1747t1012r1808b1059],
39	Kawasaki	NNP	LOCATION	Kawasaki	nn	40	SENT_40	[p4l1831t1004r2146b1059],
40	disease	NN	O	disease	prep_to	37	SENT_40	[p4l7t1096r243b1151],
41	.	.	O	.	_	0	SENT_40	[p4l7t1096r243b1151],

1	Genotyping	VBG	O	genotype	_	0	SENT_41	[p4l11t1321r453b1406],

1	Genomic	JJ	O	genomic	amod	2	SENT_42	[p4l8t1537r297b1592],
2	DNA	NN	O	dna	nsubjpass	4	SENT_42	[p4l327t1537r505b1591],
3	was	VBD	O	be	auxpass	4	SENT_42	[p4l534t1555r651b1592],
4	isolated	VBN	O	isolate	_	0	SENT_42	[p4l683t1537r928b1592],
5	from	IN	O	from	_	0	SENT_42	[p4l959t1537r1113b1591],
6	whole	JJ	O	whole	amod	8	SENT_42	[p4l1142t1537r1329b1592],
7	blood	NN	O	blood	nn	8	SENT_42	[p4l1360t1536r1543b1592],
8	samples	NNS	O	sample	prep_from	4	SENT_42	[p4l1576t1537r1822b1606],
9	using	VBG	O	use	partmod	8	SENT_42	[p4l1853t1537r2020b1606],
10	the	DT	O	the	det	12	SENT_42	[p4l2050t1537r2145b1591],
11	QIAamp	NN	O	qiaamp	nn	12	SENT_42	[p4l8t1629r288b1699],
12	Blood	NN	O	blood	dobj	9	SENT_42	[p4l311t1629r502b1684],
13	Kit	NN	O	kit	nn	15	SENT_42	[p4l523t1629r627b1684],
14	(	CD	NUMBER	(	num	15	SENT_42	[p4l650t1629r1004b1699],
15	QIAGEN	NNP	ORGANIZATION	QIAGEN	dep	12	SENT_42	[p4l650t1629r1004b1699],
16	,	,	O	,	_	0	SENT_42	[p4l650t1629r1004b1699],
17	Hilden	NNP	PERSON	Hilden	nn	19	SENT_42	[p4l1030t1629r1261b1695],
18	,	,	O	,	_	0	SENT_42	[p4l1030t1629r1261b1695],
19	Germany	NNP	LOCATION	Germany	conj_and	12	SENT_42	[p4l1287t1629r1626b1699],
20	)	CD	NUMBER	)	num	19	SENT_42	[p4l1287t1629r1626b1699],
21	;	:	O	;	_	0	SENT_42	[p4l1287t1629r1626b1699],
22	CYP2C9	CD	NUMBER	cyp2c9	num	23	SENT_42	[p4l1651t1629r2008b1684],
23	*	NN	O	*	dep	19	SENT_42	[p4l1651t1629r2008b1684],
24	2	CD	NUMBER	2	number	28	SENT_42	[p4l1651t1629r2008b1684],
25	and	CC	O	and	_	0	SENT_42	[p4l2030t1629r2146b1684],
26	CYP2C9	CD	NUMBER	cyp2c9	num	29	SENT_42	[p4l8t1723r362b1777],
27	*	CD	NUMBER	*	number	28	SENT_42	[p4l8t1723r362b1777],
28	3	CD	NUMBER	3	num	29	SENT_42	[p4l8t1723r362b1777],
29	polymorphisms	NNS	O	polymorphism	dep	23	SENT_42	[p4l385t1722r877b1792],
30	and	CC	O	and	_	0	SENT_42	[p4l900t1722r1016b1777],
31	1173C	NN	O	1173c	conj_and	12	SENT_42	[p4l1045t1723r1238b1777],
32	>	JJR	O	>	amod	33	SENT_42	[p4l1275t1732r1316b1768],
33	T	NN	O	t	dep	31	SENT_42	[p4l1334t1724r1381b1776],
34	in	IN	O	in	_	0	SENT_42	[p4l1401t1723r1461b1776],
35	intron	NN	O	intron	prep_in	9	SENT_42	[p4l1482t1723r1678b1777],
36	1	CD	NUMBER	1	num	35	SENT_42	[p4l1706t1724r1726b1776],
37	of	IN	O	of	_	0	SENT_42	[p4l1756t1722r1825b1777],
38	VKORCI	NN	ORGANIZATION	vkorcus	prep_of	35	SENT_42	[p4l1848t1724r2143b1778],
39	and	CC	O	and	_	0	SENT_42	[p4l8t1815r124b1871],
40	373OG	NN	O	373og	conj_and	38	SENT_42	[p4l151t1817r358b1871],
41	>	JJR	O	>	dep	51	SENT_42	[p4l397t1826r439b1862],
42	A	DT	O	a	det	43	SENT_42	[p4l477t1816r533b1870],
43	polymorphisms	NNS	O	polymorphism	nsubjpass	58	SENT_42	[p4l556t1816r1048b1885],
44	in	IN	O	in	_	0	SENT_42	[p4l1073t1816r1132b1870],
45	the	DT	O	the	det	49	SENT_42	[p4l1157t1816r1252b1871],
46	3	CD	NUMBER	3	num	47	SENT_42	[p4l1279t1814r1330b1871],
47	’	NN	O	’	npadvmod	48	SENT_42	[p4l1279t1814r1330b1871],
48	untranslated	JJ	O	untranslated	amod	49	SENT_42	[p4l1354t1816r1753b1871],
49	region	NN	O	region	prep_in	43	SENT_42	[p4l1777t1816r1977b1885],
50	were	VBD	O	be	auxpass	51	SENT_42	[p4l2000t1834r2146b1871],
51	genotyped	VBN	O	genotype	dep	9	SENT_42	[p4l7t1908r336b1978],
52	using	VBG	O	use	xcomp	51	SENT_42	[p4l375t1908r543b1978],
53	polymerase	NN	O	polymerase	nn	55	SENT_42	[p4l583t1908r943b1978],
54	chain	NN	O	chain	nn	55	SENT_42	[p4l985t1908r1155b1963],
55	reactions	NNS	O	reaction	dobj	52	SENT_42	[p4l1196t1908r1481b1963],
56	and	CC	O	and	_	0	SENT_42	[p4l1524t1908r1640b1963],
57	previously	RB	DATE	previously	advmod	58	SENT_42	[p4l1681t1908r2009b1978],
58	described	VBN	O	describe	dep	9	SENT_42	[p4l2050t1908r2144b1963, p4l9t2001r230b2056],
59	primers	NNS	O	primer	dobj	58	SENT_42	[p4l262t2002r502b2071],
60	[	CD	NUMBER	[	num	62	SENT_42	[p4l538t2002r626b2070],
61	3	CD	NUMBER	3	num	62	SENT_42	[p4l538t2002r626b2070],
62	]	NN	O	]	dobj	51	SENT_42	[p4l538t2002r626b2070],
63	.	.	O	.	_	0	SENT_42	[p4l538t2002r626b2070],

1	The	DT	O	the	det	3	SENT_43	[p4l663t2001r784b2056],
2	ampliﬁed	JJ	O	ampliﬁed	amod	3	SENT_43	[p4l818t2001r1111b2071],
3	fragments	NNS	O	fragment	nsubjpass	5	SENT_43	[p4l1143t2001r1458b2071],
4	were	VBD	O	be	auxpass	5	SENT_43	[p4l1490t2019r1636b2057],
5	analyzed	VBN	O	analyze	_	0	SENT_43	[p4l1670t2001r1948b2071],
6	using	VBG	O	use	xcomp	5	SENT_43	[p4l1979t2002r2147b2071],
7	an	DT	O	a	det	8	SENT_43	[p4l8t2113r83b2149],
8	autosequencer	NN	O	autosequencer	nsubj	11	SENT_43	[p4l112t2103r566b2164],
9	(	CD	NUMBER	(	num	11	SENT_43	[p4l595t2095r752b2164],
10	ABI	NNP	O	ABI	nn	11	SENT_43	[p4l595t2095r752b2164],
11	PRISM	NNP	O	PRISM	xcomp	6	SENT_43	[p4l780t2096r1023b2150],
12	3100	CD	NUMBER	3100	num	11	SENT_43	[p4l1055t2096r1218b2161],
13	,	,	O	,	_	0	SENT_43	[p4l1055t2096r1218b2161],
14	Applied	NNP	O	Applied	nn	15	SENT_43	[p4l1247t2094r1501b2164],
15	Biosystems	NNP	O	Biosystems	appos	11	SENT_43	[p4l1530t2095r1922b2164],
16	)	NN	O	)	dep	15	SENT_43	[p4l1530t2095r1922b2164],
17	.	.	O	.	_	0	SENT_43	[p4l1530t2095r1922b2164],

1	Statistical	JJ	O	statistical	amod	2	SENT_44	[p4l10t2334r408b2402],
2	Analysis	NN	O	analysis	_	0	SENT_44	[p4l437t2334r767b2421],

1	For	IN	O	for	_	0	SENT_45	[p4l8t2553r125b2606],
2	each	DT	O	each	det	3	SENT_45	[p4l147t2551r289b2605],
3	patient	NN	O	patient	prep_for	17	SENT_45	[p4l310t2551r550b2620],
4	,	,	O	,	_	0	SENT_45	[p4l310t2551r550b2620],
5	the	DT	O	the	det	9	SENT_45	[p4l576t2551r671b2605],
6	average	JJ	O	average	amod	9	SENT_45	[p4l695t2569r936b2620],
7	prescribed	JJ	O	prescribed	amod	9	SENT_45	[p4l958t2550r1285b2620],
8	daily	JJ	SET	daily	amod	9	SENT_45	[p4l1308t2551r1462b2620],
9	dose	NN	O	dose	nsubjpass	17	SENT_45	[p4l1485t2550r1626b2606],
10	of	IN	O	of	_	0	SENT_45	[p4l1651t2551r1720b2605],
11	warfarin	NN	O	warfarin	prep_of	9	SENT_45	[p4l1734t2551r2006b2606],
12	and	CC	O	and	_	0	SENT_45	[p4l2030t2551r2146b2606],
13	the	DT	O	the	det	15	SENT_45	[p4l7t2643r102b2698],
14	average	JJ	O	average	amod	15	SENT_45	[p4l128t2661r368b2712],
15	INR	NN	O	inr	conj_and	11	SENT_45	[p4l392t2645r538b2697],
16	were	VBD	O	be	auxpass	17	SENT_45	[p4l559t2661r705b2698],
17	obtained	VBN	O	obtain	_	0	SENT_45	[p4l730t2643r1022b2698],
18	.	.	O	.	_	0	SENT_45	[p4l730t2643r1022b2698],

1	The	DT	O	the	det	3	SENT_46	[p4l1050t2643r1171b2698],
2	average	JJ	O	average	amod	3	SENT_46	[p4l1196t2661r1436b2712],
3	INR	NN	O	inr	nsubjpass	5	SENT_46	[p4l1460t2645r1606b2697],
4	was	VBD	O	be	auxpass	5	SENT_46	[p4l1627t2661r1744b2698],
5	obtained	VBN	O	obtain	_	0	SENT_46	[p4l1770t2643r2047b2698],
6	by	IN	O	by	_	0	SENT_46	[p4l2070t2643r2146b2712],
7	dividing	VBG	O	divide	agent	5	SENT_46	[p4l7t2736r264b2806],
8	the	DT	O	the	det	9	SENT_46	[p4l285t2736r380b2791],
9	total	NN	O	total	dobj	7	SENT_46	[p4l402t2737r548b2791],
10	of	IN	O	of	_	0	SENT_46	[p4l570t2736r639b2791],
11	all	DT	O	all	dep	12	SENT_46	[p4l653t2737r727b2791],
12	available	JJ	O	available	amod	14	SENT_46	[p4l749t2736r1030b2791],
13	INR	NN	O	inr	nn	14	SENT_46	[p4l1052t2738r1198b2791],
14	measurements	NNS	O	measurement	prep_of	9	SENT_46	[p4l1216t2744r1666b2791],
15	by	IN	O	by	_	0	SENT_46	[p4l1689t2736r1765b2806],
16	the	DT	O	the	det	17	SENT_46	[p4l1785t2736r1880b2791],
17	number	NN	O	number	prep_by	7	SENT_46	[p4l1902t2736r2147b2791],
18	of	IN	O	of	_	0	SENT_46	[p4l8t2830r78b2884],
19	visits	NNS	O	visit	prep_of	17	SENT_46	[p4l105t2830r280b2884],
20	.	.	O	.	_	0	SENT_46	[p4l105t2830r280b2884],

1	Differences	NNS	O	difference	nsubjpass	8	SENT_47	[p4l320t2830r673b2884],
2	in	IN	O	in	_	0	SENT_47	[p4l710t2830r769b2884],
3	baseline	NN	O	baseline	nn	4	SENT_47	[p4l805t2830r1056b2884],
4	characteristics	NNS	O	characteristic	prep_in	1	SENT_47	[p4l1092t2830r1542b2884],
5	among	IN	O	among	_	0	SENT_47	[p4l1579t2848r1795b2899],
6	genotypes	NNS	O	genotype	prep_among	4	SENT_47	[p4l1831t2838r2146b2899],
7	were	VBD	O	be	auxpass	8	SENT_47	[p4l6t2940r152b2977],
8	evaluated	VBN	O	evaluate	_	0	SENT_47	[p4l177t2922r479b2977],
9	using	VBG	O	use	xcomp	8	SENT_47	[p4l504t2922r671b2991],
10	the	DT	O	the	det	11	SENT_47	[p4l695t2922r791b2977],
11	Mann	NNP	O	Mann	dobj	9	SENT_47	[p4l816t2922r1317b2991],
12	.	.	O	.	_	0	SENT_47	[p4l816t2922r1317b2991],

1	—	NN	O	—	_	0	SENT_48	[p4l816t2922r1317b2991],
2	.	.	O	.	_	0	SENT_48	[p4l816t2922r1317b2991],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_49	[p4l816t2922r1317b2991],
2	U-test	NNP	O	U-test	nsubj	7	SENT_49	[p4l1349t2925r1533b2977],
3	and	CC	O	and	_	0	SENT_49	[p4l1558t2922r1674b2977],
4	the	DT	O	the	det	5	SENT_49	[p4l1699t2922r1794b2977],
5	chi-square	JJ	O	chi-square	nsubj	7	SENT_49	[p4l1819t2922r2146b2991],
6	test	NN	O	test	dep	7	SENT_49	[p4l7t3023r116b3070],
7	for	IN	O	for	_	0	SENT_49	[p4l142t3015r234b3070],
8	continuous	JJ	O	continuous	amod	11	SENT_49	[p4l259t3015r610b3070],
9	and	CC	O	and	_	0	SENT_49	[p4l638t3015r754b3070],
10	discrete	JJ	O	discrete	amod	11	SENT_49	[p4l780t3015r1019b3070],
11	variables	NNS	O	variable	pobj	7	SENT_49	[p4l1045t3015r1346b3081],
12	,	,	O	,	_	0	SENT_49	[p4l1045t3015r1346b3081],
13	respectively	RB	O	respectively	advmod	7	SENT_49	[p4l1374t3015r1758b3085],
14	.	.	O	.	_	0	SENT_49	[p4l1374t3015r1758b3085],

1	Analysis	NN	O	analysis	nsubjpass	8	SENT_50	[p4l1786t3015r2056b3084],
2	of	IN	O	of	_	0	SENT_50	[p4l2085t3015r2154b3070],
3	covariance	NN	O	covariance	nn	6	SENT_50	[p4l7t3109r347b3163],
4	(	CD	NUMBER	(	num	6	SENT_50	[p4l372t3109r759b3178],
5	ANCOVA	NN	O	ancova	nn	6	SENT_50	[p4l372t3109r759b3178],
6	)	NN	O	)	prep_of	1	SENT_50	[p4l372t3109r759b3178],
7	was	VBD	O	be	auxpass	8	SENT_50	[p4l783t3126r900b3163],
8	performed	VBN	O	perform	_	0	SENT_50	[p4l924t3109r1257b3178],
9	using	VBG	O	use	xcomp	8	SENT_50	[p4l1279t3109r1447b3178],
10	the	DT	O	the	det	12	SENT_50	[p4l1470t3109r1566b3163],
11	average	JJ	O	average	amod	12	SENT_50	[p4l1591t3127r1831b3178],
12	INR	NN	O	inr	dobj	9	SENT_50	[p4l1856t3111r2001b3163],
13	as	IN	O	as	_	0	SENT_50	[p4l2026t3127r2087b3163],
14	a	DT	O	a	det	15	SENT_50	[p4l2113t3127r2146b3163],
15	covariate	NN	O	covariate	prep_as	9	SENT_50	[p4l7t3201r297b3256],
16	to	TO	O	to	aux	17	SENT_50	[p4l328t3209r389b3256],
17	examine	VB	O	examine	infmod	15	SENT_50	[p4l420t3201r681b3256],
18	how	WRB	O	how	advmod	26	SENT_50	[p4l710t3201r845b3256],
19	the	DT	O	the	det	22	SENT_50	[p4l874t3201r969b3256],
20	VKORC	NNP	O	VKORC	nn	22	SENT_50	[p4l1009t3203r1304b3256],
21	]	CD	NUMBER	]	num	22	SENT_50	[p4l1009t3203r1304b3256],
22	1173C	NN	O	1173c	nsubj	26	SENT_50	[p4l1345t3202r1538b3256],
23	>	JJR	O	>	amod	25	SENT_50	[p4l1582t3211r1624b3247],
24	T	NN	O	t	nn	25	SENT_50	[p4l1668t3203r1715b3255],
25	genotype	NN	O	genotype	dep	22	SENT_50	[p4l1746t3209r2032b3270],
26	affected	VBD	O	affect	ccomp	17	SENT_50	[p4l2063t3201r2144b3256, p4l7t3294r194b3349],
27	the	DT	O	the	det	30	SENT_50	[p4l225t3294r321b3349],
28	average	JJ	O	average	amod	30	SENT_50	[p4l353t3312r594b3364],
29	daily	JJ	SET	daily	amod	30	SENT_50	[p4l625t3294r779b3363],
30	dose	NN	O	dose	dobj	26	SENT_50	[p4l811t3294r951b3349],
31	of	IN	O	of	_	0	SENT_50	[p4l985t3294r1054b3349],
32	prescribed	VBN	O	prescribe	amod	33	SENT_50	[p4l1077t3294r1405b3364],
33	warfarin	NN	O	warfarin	prep_of	30	SENT_50	[p4l1435t3294r1723b3349],
34	.	.	O	.	_	0	SENT_50	[p4l1435t3294r1723b3349],

1	All	DT	O	all	det	2	SENT_51	[p4l1757t3294r1853b3348],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_51	[p4l1886t3294r2146b3363],
3	were	VBD	O	be	auxpass	4	SENT_51	[p4l6t3405r152b3442],
4	performed	VBN	O	perform	_	0	SENT_51	[p4l179t3387r512b3457],
5	using	VBG	O	use	xcomp	4	SENT_51	[p4l539t3387r707b3457],
6	SAS	NNP	O	SAS	nsubj	8	SENT_51	[p4l737t3387r870b3442],
7	8.0	CD	NUMBER	8.0	num	8	SENT_51	[p4l902t3389r991b3442],
8	software	NN	O	software	xcomp	5	SENT_51	[p4l1022t3387r1306b3442],
9	.	.	O	.	_	0	SENT_51	[p4l1022t3387r1306b3442],

1	Results	NNS	O	result	_	0	SENT_52	[p4l7t3586r289b3652],

1	VKORCI	NNP	O	VKORCI	nn	2	SENT_53	[p5l19t83r389b149],
2	Polymorphisms	NNPS	O	Polymorphisms	_	0	SENT_53	[p5l430t81r1029b168],
3	and	CC	O	and	_	0	SENT_53	[p5l1064t81r1208b149],
4	C	NNP	O	C	nn	5	SENT_53	[p5l1242t83r1303b149],
5	YP2C9	NNP	O	YP2C9	conj_and	2	SENT_53	[p5l1317t83r1592b149],
6	Haplotypes	NNS	O	haplotype	dep	2	SENT_53	[p5l1627t81r2071b167],

1	VKOBCI	NNP	O	VKOBCI	nn	2	SENT_54	[p5l19t297r384b363],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	4	SENT_54	[p5l451t294r1068b381],
3	were	VBD	O	be	auxpass	4	SENT_54	[p5l1132t317r1314b363],
4	investigated	VBN	O	investigate	_	0	SENT_54	[p5l1378t294r1851b381],
5	in	IN	O	in	_	0	SENT_54	[p5l1914t294r1988b362],
6	all	DT	O	all	det	7	SENT_54	[p5l2053t294r2145b363],
7	patients	NNS	O	patient	prep_in	4	SENT_54	[p5l6t401r319b487],
8	using	VBG	O	use	partmod	7	SENT_54	[p5l362t401r572b487],
9	direct	JJ	O	direct	amod	12	SENT_54	[p5l615t400r838b469],
10	cycle	NN	O	cycle	nn	12	SENT_54	[p5l880t401r1071b487],
11	sequence	NN	O	sequence	nn	12	SENT_54	[p5l1118t423r1467b487],
12	analysis	NN	O	analysis	dobj	8	SENT_54	[p5l1513t401r1822b487],
13	for	IN	O	for	_	0	SENT_54	[p5l1866t401r1982b469],
14	the	DT	O	the	det	17	SENT_54	[p5l2026t401r2145b469],
15	Pediatric	NNP	O	Pediatric	nn	17	SENT_54	[p5l796t525r1078b580],
16	Cardiology	NNP	O	Cardiology	nn	17	SENT_54	[p5l1108t525r1465b595],
17	Vol	NNP	O	Vol	prep_for	12	SENT_54	[p5l1491t526r1621b580],
18	.	.	O	.	_	0	SENT_54	[p5l1491t526r1621b580],

1	27	CD	NUMBER	27	_	0	SENT_55	[p5l1654t527r1743b592],
2	,	,	O	,	_	0	SENT_55	[p5l1654t527r1743b592],
3	No.	NN	O	no.	appos	1	SENT_55	[p5l1774t527r1891b580],
4	6	CD	NUMBER	6	num	3	SENT_55	[p5l1925t527r1975b592],
5	,	,	O	,	_	0	SENT_55	[p5l1925t527r1975b592],
6	2006	CD	DATE	2006	appos	1	SENT_55	[p5l2006t527r2152b581],

1	two	CD	NUMBER	two	num	2	SENT_56	[p5l9t775r154b834],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_56	[p5l199t765r839b852],
3	:	:	O	:	_	0	SENT_56	[p5l199t765r839b852],
4	a	DT	O	a	det	8	SENT_56	[p5l890t788r932b834],
5	C	NN	O	c	amod	8	SENT_56	[p5l977t767r1039b834],
6	>	JJR	O	>	dep	5	SENT_56	[p5l1103t768r1236b833],
7	T	NN	O	t	nn	8	SENT_56	[p5l1103t768r1236b833],
8	transition	NN	O	transition	dep	2	SENT_56	[p5l1281t765r1666b834],
9	at	IN	O	at	_	0	SENT_56	[p5l1712t775r1786b834],
10	position	NN	O	position	prep_at	8	SENT_56	[p5l1828t765r2153b852],
11	1173	CD	DATE	1173	number	12	SENT_56	[p5l17t873r189b940],
12	(	CD	NUMBER	(	num	14	SENT_56	[p5l254t872r712b959],
13	rs9934438	NN	O	rs9934438	nn	14	SENT_56	[p5l254t872r712b959],
14	)	NN	O	)	dep	21	SENT_56	[p5l254t872r712b959],
15	in	IN	O	in	_	0	SENT_56	[p5l771t872r845b939],
16	intron	NN	O	intron	prep_in	14	SENT_56	[p5l903t872r1149b940],
17	1	CD	NUMBER	1	num	16	SENT_56	[p5l1216t874r1241b939],
18	and	CC	O	and	_	0	SENT_56	[p5l1310t872r1455b940],
19	a	DT	O	a	det	20	SENT_56	[p5l1515t894r1557b940],
20	373OG	NN	O	373og	conj_and	16	SENT_56	[p5l1618t873r1878b941],
21	>	JJR	O	>	dep	2	SENT_56	[p5l1955t884r2007b929],
22	A	DT	O	a	det	23	SENT_56	[p5l2083t872r2153b939],
23	transition	NN	O	transition	dep	21	SENT_56	[p5l9t979r395b1048],
24	in	IN	O	in	_	0	SENT_56	[p5l487t979r561b1047],
25	the	DT	O	the	det	26	SENT_56	[p5l656t978r775b1048],
26	3	CD	NUMBER	3	prep_in	23	SENT_56	[p5l873t977r1181b1048],
27	’	SYM	O	’	dep	23	SENT_56	[p5l873t977r1181b1048],
28	-	:	O	-	_	0	SENT_56	[p5l873t977r1181b1048],
29	UTR	NN	O	utr	nn	32	SENT_56	[p5l873t977r1181b1048],
30	(	CD	NUMBER	(	num	32	SENT_56	[p5l1276t979r1614b1066],
31	rs7294	NN	O	rs7294	nn	32	SENT_56	[p5l1276t979r1614b1066],
32	)	NN	O	)	dep	23	SENT_56	[p5l1276t979r1614b1066],
33	.	.	O	.	_	0	SENT_56	[p5l1276t979r1614b1066],

1	Twenty-six	CD	NUMBER	twenty-six	num	2	SENT_57	[p5l1713t979r2152b1066],
2	patients	NNS	O	patient	nsubj	9	SENT_57	[p5l7t1085r321b1172],
3	(	IN	O	(	_	0	SENT_57	[p5l366t1085r594b1172],
4	84	CD	PERCENT	84	num	5	SENT_57	[p5l366t1085r594b1172],
5	%	NN	PERCENT	%	prep_(	2	SENT_57	[p5l366t1085r594b1172],
6	)	CD	NUMBER	)	dep	5	SENT_57	[p5l366t1085r594b1172],
7	were	VBD	O	be	cop	9	SENT_57	[p5l636t1107r819b1153],
8	T/T	NN	O	t/t	nn	9	SENT_57	[p5l862t1085r1015b1172],
9	homozygotes	NNS	O	homozygote	_	0	SENT_57	[p5l1057t1085r1582b1172],
10	at	IN	O	at	_	0	SENT_57	[p5l1627t1094r1701b1153],
11	nucleotide	NN	O	nucleotide	prep_at	9	SENT_57	[p5l1742t1085r2152b1153],
12	1173	CD	DATE	1173	num	11	SENT_57	[p5l18t1192r215b1273],
13	,	,	O	,	_	0	SENT_57	[p5l18t1192r215b1273],
14	whereas	IN	O	whereas	mark	22	SENT_57	[p5l247t1190r566b1259],
15	5	CD	PERCENT	5	number	16	SENT_57	[p5l601t1193r637b1259],
16	(	CD	PERCENT	(	nsubj	22	SENT_57	[p5l671t1190r899b1277],
17	16	CD	PERCENT	16	num	18	SENT_57	[p5l671t1190r899b1277],
18	%	NN	PERCENT	%	dep	16	SENT_57	[p5l671t1190r899b1277],
19	)	CD	NUMBER	)	dep	16	SENT_57	[p5l671t1190r899b1277],
20	were	VBD	O	be	cop	22	SENT_57	[p5l930t1213r1113b1259],
21	C/T	NN	O	c/t	nn	22	SENT_57	[p5l1145t1190r1301b1277],
22	heterozygotes	NNS	O	heterozygote	advcl	9	SENT_57	[p5l1331t1190r1899b1277],
23	.	.	O	.	_	0	SENT_57	[p5l1331t1190r1899b1277],

1	None	NN	O	none	nsubj	6	SENT_58	[p5l1933t1193r2152b1259],
2	of	IN	O	of	_	0	SENT_58	[p5l10t1297r98b1365],
3	the	DT	O	the	det	4	SENT_58	[p5l117t1297r237b1365],
4	patients	NNS	O	patient	prep_of	1	SENT_58	[p5l266t1297r579b1383],
5	were	VBD	O	be	cop	6	SENT_58	[p5l608t1319r791b1365],
6	homozygous	JJ	O	homozygous	_	0	SENT_58	[p5l821t1297r1326b1383],
7	for	IN	O	for	_	0	SENT_58	[p5l1356t1297r1472b1365],
8	the	DT	O	the	det	10	SENT_58	[p5l1502t1296r1621b1365],
9	C	NN	O	c	nn	10	SENT_58	[p5l1652t1298r1714b1365],
10	allele	NN	O	allele	prep_for	6	SENT_58	[p5l1745t1297r1966b1365],
11	.	.	O	.	_	0	SENT_58	[p5l1745t1297r1966b1365],

1	The	DT	O	the	det	3	SENT_59	[p5l2001t1296r2152b1365],
2	calculated	JJ	O	calculated	amod	3	SENT_59	[p5l8t1402r409b1471],
3	frequency	NN	O	frequency	nsubj	10	SENT_59	[p5l478t1403r869b1489],
4	of	IN	O	of	_	0	SENT_59	[p5l939t1403r1025b1471],
5	the	DT	O	the	det	7	SENT_59	[p5l1085t1403r1204b1471],
6	T	NN	O	t	nn	7	SENT_59	[p5l1273t1405r1332b1470],
7	allele	NN	O	allele	prep_of	3	SENT_59	[p5l1401t1403r1601b1471],
8	was	VBD	O	be	cop	10	SENT_59	[p5l1669t1425r1816b1471],
9	91.2	CD	PERCENT	91.2	num	10	SENT_59	[p5l1886t1403r2149b1485],
10	%	NN	PERCENT	%	_	0	SENT_59	[p5l1886t1403r2149b1485],
11	,	,	O	,	_	0	SENT_59	[p5l1886t1403r2149b1485],
12	whereas	IN	O	whereas	mark	20	SENT_59	[p5l7t1508r326b1576],
13	that	DT	O	that	nsubj	20	SENT_59	[p5l372t1508r530b1576],
14	of	IN	O	of	_	0	SENT_59	[p5l576t1508r663b1576],
15	the	DT	O	the	det	17	SENT_59	[p5l698t1508r818b1576],
16	C	NN	O	c	nn	17	SENT_59	[p5l865t1509r927b1577],
17	allele	NN	O	allele	prep_of	13	SENT_59	[p5l973t1508r1174b1576],
18	was	VBD	O	be	cop	20	SENT_59	[p5l1218t1530r1364b1576],
19	8.8	CD	PERCENT	8.8	num	20	SENT_59	[p5l1413t1508r1625b1577],
20	%	NN	PERCENT	%	advcl	10	SENT_59	[p5l1413t1508r1625b1577],
21	.	.	O	.	_	0	SENT_59	[p5l1413t1508r1625b1577],

1	All	DT	O	all	det	2	SENT_60	[p5l1674t1508r1794b1575],
2	patients	NNS	O	patient	nsubj	13	SENT_60	[p5l1838t1508r2151b1595],
3	with	IN	O	with	_	0	SENT_60	[p5l7t1614r182b1683],
4	a	DT	O	a	det	6	SENT_60	[p5l233t1637r275b1683],
5	T/T	NN	O	t/t	nn	6	SENT_60	[p5l324t1615r477b1701],
6	genotype	NN	O	genotype	prep_with	2	SENT_60	[p5l527t1624r887b1701],
7	at	IN	O	at	_	0	SENT_60	[p5l939t1624r1013b1683],
8	the	DT	O	the	det	9	SENT_60	[p5l1061t1614r1181b1683],
9	1173C	NN	O	1173c	prep_at	6	SENT_60	[p5l1241t1616r1483b1683],
10	>	JJR	O	>	amod	12	SENT_60	[p5l1553t1627r1605b1672],
11	T	NN	O	t	nn	12	SENT_60	[p5l1674t1617r1732b1682],
12	polymorphism	NN	O	polymorphism	dep	9	SENT_60	[p5l1781t1614r2151b1701, p5l7t1721r249b1808],
13	had	VBD	O	have	_	0	SENT_60	[p5l310t1721r457b1789],
14	a	DT	O	a	det	16	SENT_60	[p5l520t1743r562b1789],
15	G/G	NN	O	g/g	nn	16	SENT_60	[p5l625t1721r807b1808],
16	genotype	NN	O	genotype	dobj	13	SENT_60	[p5l868t1730r1227b1808],
17	at	IN	O	at	_	0	SENT_60	[p5l1291t1730r1365b1789],
18	the	DT	O	the	det	19	SENT_60	[p5l1427t1721r1546b1789],
19	373OG	NN	O	373og	prep_at	16	SENT_60	[p5l1612t1722r1872b1790],
20	>	JJR	O	>	amod	22	SENT_60	[p5l1952t1733r2003b1778],
21	A	DT	O	a	det	22	SENT_60	[p5l2083t1721r2153b1788],
22	polymorphism	NN	O	polymorphism	dep	19	SENT_60	[p5l8t1826r613b1913],
23	,	,	O	,	_	0	SENT_60	[p5l8t1826r613b1913],
24	and	CC	O	and	_	0	SENT_60	[p5l650t1826r795b1895],
25	those	DT	O	those	nsubj	36	SENT_60	[p5l827t1826r1035b1895],
26	with	IN	O	with	_	0	SENT_60	[p5l1066t1826r1240b1895],
27	a	DT	O	a	det	29	SENT_60	[p5l1272t1848r1314b1895],
28	T/C	NN	O	t/c	nn	29	SENT_60	[p5l1345t1826r1503b1913],
29	genotype	NN	O	genotype	prep_with	25	SENT_60	[p5l1535t1836r1894b1913],
30	at	IN	O	at	_	0	SENT_60	[p5l1928t1836r2001b1895],
31	the	DT	O	the	det	32	SENT_60	[p5l2032t1826r2152b1895],
32	1173C	NN	O	1173c	prep_at	29	SENT_60	[p5l18t1935r260b2003],
33	>	JJR	O	>	amod	35	SENT_60	[p5l307t1946r359b1991],
34	T	NN	O	t	nn	35	SENT_60	[p5l404t1936r462b2002],
35	polymorphism	NN	O	polymorphism	dep	32	SENT_60	[p5l487t1933r1072b2021],
36	had	VBD	O	have	conj_and	13	SENT_60	[p5l1097t1933r1245b2003],
37	a	DT	O	a	det	39	SENT_60	[p5l1272t1956r1314b2003],
38	G/A	NN	O	g/a	nn	39	SENT_60	[p5l1342t1934r1518b2022],
39	genotype	NN	O	genotype	dobj	36	SENT_60	[p5l1545t1943r1904b2021],
40	at	IN	O	at	_	0	SENT_60	[p5l1933t1943r2007b2003],
41	the	DT	O	the	det	42	SENT_60	[p5l2033t1933r2152b2003],
42	373OG	NN	O	373og	prep_at	39	SENT_60	[p5l12t2040r272b2108],
43	>	JJR	O	>	amod	45	SENT_60	[p5l318t2052r370b2097],
44	A	DT	O	a	det	45	SENT_60	[p5l416t2039r486b2107],
45	polymorphism	NN	O	polymorphism	dep	42	SENT_60	[p5l513t2039r1117b2126],
46	.	.	O	.	_	0	SENT_60	[p5l513t2039r1117b2126],

1	In	IN	O	in	_	0	SENT_61	[p5l1151t2042r1234b2107],
2	other	JJ	O	other	amod	3	SENT_61	[p5l1265t2039r1472b2108],
3	words	NNS	O	word	prep_in	9	SENT_61	[p5l1498t2039r1763b2122],
4	,	,	O	,	_	0	SENT_61	[p5l1498t2039r1763b2122],
5	complete	JJ	O	complete	amod	7	SENT_61	[p5l1794t2039r2152b2126],
6	linkage	NN	O	linkage	nn	7	SENT_61	[p5l9t2145r295b2232],
7	disequilibrium	NN	O	disequilibrium	nsubjpass	9	SENT_61	[p5l363t2145r939b2232],
8	was	VBD	O	be	auxpass	9	SENT_61	[p5l1004t2168r1151b2214],
9	observed	VBN	O	observe	_	0	SENT_61	[p5l1222t2145r1574b2214],
10	between	IN	O	between	_	0	SENT_61	[p5l1642t2145r1965b2214],
11	the	DT	O	the	det	12	SENT_61	[p5l2033t2145r2152b2214],
12	1173C	NN	O	1173c	prep_between	9	SENT_61	[p5l18t2252r260b2320],
13	>	JJR	O	>	amod	15	SENT_61	[p5l339t2263r392b2309],
14	T	NN	O	t	nn	15	SENT_61	[p5l470t2254r528b2318],
15	polymorphism	NN	O	polymorphism	dep	12	SENT_61	[p5l586t2251r1169b2338],
16	and	CC	O	and	_	0	SENT_61	[p5l1230t2251r1376b2319],
17	the	DT	O	the	det	18	SENT_61	[p5l1435t2251r1554b2319],
18	373OG	NN	O	373og	prep_between	9	SENT_61	[p5l1617t2252r1877b2320],
19	>	JJR	O	>	amod	21	SENT_61	[p5l1954t2263r2007b2309],
20	A	DT	O	a	det	21	SENT_61	[p5l2083t2251r2153b2318],
21	polymorphism	NN	O	polymorphism	dep	18	SENT_61	[p5l7t2357r612b2444],
22	.	.	O	.	_	0	SENT_61	[p5l7t2357r612b2444],

1	Two	CD	NUMBER	two	num	2	SENT_62	[p5l178t2466r354b2532],
2	patients	NNS	O	patient	nsubj	3	SENT_62	[p5l410t2464r723b2551],
3	had	VBD	O	have	_	0	SENT_62	[p5l779t2464r926b2532],
4	an	DT	O	a	det	5	SENT_62	[p5l982t2486r1076b2532],
5	arginine	NN	O	arginine	dobj	3	SENT_62	[p5l1132t2464r1453b2551],
6	at	IN	O	at	_	0	SENT_62	[p5l1509t2473r1583b2532],
7	position	NN	O	position	prep_at	5	SENT_62	[p5l1636t2464r1960b2551],
8	144	CD	NUMBER	144	num	7	SENT_62	[p5l2024t2465r2153b2531],
9	within	IN	O	within	_	0	SENT_62	[p5l7t2569r259b2638],
10	exon	NN	O	exon	prep_within	3	SENT_62	[p5l305t2592r494b2638],
11	3	CD	NUMBER	3	num	10	SENT_62	[p5l542t2571r578b2638],
12	and	CC	O	and	_	0	SENT_62	[p5l630t2569r775b2638],
13	a	DT	O	a	det	14	SENT_62	[p5l822t2592r864b2638],
14	leucine	NN	O	leucine	prep_within	3	SENT_62	[p5l909t2569r1184b2638],
15	at	IN	O	at	_	0	SENT_62	[p5l1231t2579r1305b2638],
16	position	NN	O	position	prep_at	3	SENT_62	[p5l1349t2569r1673b2656],
17	359	CD	NUMBER	359	num	16	SENT_62	[p5l1722t2571r1854b2638],
18	within	IN	O	within	_	0	SENT_62	[p5l1901t2569r2152b2638],
19	exon	NN	O	exon	nn	22	SENT_62	[p5l9t2698r197b2744],
20	7	CD	NUMBER	7	num	22	SENT_62	[p5l234t2678r274b2744],
21	(	NN	O	(	nn	22	SENT_62	[p5l312t2676r787b2763],
22	CYP2C9	NN	O	cyp2c9	prep_within	3	SENT_62	[p5l312t2676r787b2763],
23	*	CD	NUMBER	*	number	24	SENT_62	[p5l312t2676r787b2763],
24	3	CD	NUMBER	3	num	26	SENT_62	[p5l312t2676r787b2763],
25	haplotype	NN	O	haplotype	nn	26	SENT_62	[p5l826t2676r1275b2763],
26	)	NN	O	)	dep	3	SENT_62	[p5l826t2676r1275b2763],
27	.	.	O	.	_	0	SENT_62	[p5l826t2676r1275b2763],

1	None	NN	O	none	nsubj	5	SENT_63	[p5l1314t2678r1534b2744],
2	of	IN	O	of	_	0	SENT_63	[p5l1572t2676r1658b2744],
3	the	DT	O	the	det	4	SENT_63	[p5l1684t2676r1804b2744],
4	patients	NNS	O	patient	prep_of	1	SENT_63	[p5l1838t2676r2151b2763],
5	carried	VBD	O	carry	_	0	SENT_63	[p5l8t2781r284b2850],
6	a	DT	O	a	det	7	SENT_63	[p5l318t2803r360b2850],
7	cysteine	NN	O	cysteine	dobj	5	SENT_63	[p5l391t2781r703b2868],
8	at	IN	O	at	_	0	SENT_63	[p5l737t2791r811b2850],
9	position	NN	O	position	prep_at	5	SENT_63	[p5l840t2781r1164b2868],
10	144	CD	NUMBER	144	num	9	SENT_63	[p5l1205t2783r1333b2849],
11	within	IN	O	within	_	0	SENT_63	[p5l1363t2781r1615b2850],
12	exon	NN	O	exon	prep_within	9	SENT_63	[p5l1647t2804r1835b2850],
13	3	CD	NUMBER	3	num	12	SENT_63	[p5l1870t2783r1906b2850],
14	or	CC	O	or	_	0	SENT_63	[p5l1943t2804r2026b2850],
15	an	DT	O	a	det	16	SENT_63	[p5l2059t2803r2152b2850],
16	isoleucine	NN	O	isoleucine	prep_at	5	SENT_63	[p5l8t2889r397b2958],
17	at	IN	O	at	_	0	SENT_63	[p5l431t2898r505b2958],
18	position	NN	O	position	prep_at	16	SENT_63	[p5l536t2889r861b2976],
19	359	CD	NUMBER	359	num	18	SENT_63	[p5l897t2890r1028b2958],
20	within	IN	O	within	_	0	SENT_63	[p5l1062t2888r1313b2958],
21	exon	NN	O	exon	nn	24	SENT_63	[p5l1346t2912r1535b2958],
22	7	CD	NUMBER	7	num	24	SENT_63	[p5l1569t2891r1608b2958],
23	(	NN	O	(	nn	24	SENT_63	[p5l1645t2889r2073b2977],
24	CYP2C9	NN	O	cyp2c9	prep_within	5	SENT_63	[p5l1645t2889r2073b2977],
25	*	CD	NUMBER	*	number	26	SENT_63	[p5l1645t2889r2073b2977],
26	3	CD	NUMBER	3	num	28	SENT_63	[p5l2113t2891r2149b2958],
27	haplotype	NN	O	haplotype	nn	28	SENT_63	[p5l8t2994r457b3081],
28	)	NN	O	)	dep	5	SENT_63	[p5l8t2994r457b3081],
29	.	.	O	.	_	0	SENT_63	[p5l8t2994r457b3081],

1	Statistical	JJ	O	statistical	amod	2	SENT_64	[p5l11t3251r410b3319],
2	Analysis	NN	O	analysis	_	0	SENT_64	[p5l439t3251r771b3337],

1	Gender	NN	MISC	gender	nsubj	13	SENT_65	[p6l10t71r327b153],
2	,	,	O	,	_	0	SENT_65	[p6l10t71r327b153],
3	age	NN	O	age	conj_and	1	SENT_65	[p6l369t93r521b158],
4	,	,	O	,	_	0	SENT_65	[p6l369t93r521b158],
5	weight	NN	O	weight	conj_and	1	SENT_65	[p6l560t71r844b158],
6	,	,	O	,	_	0	SENT_65	[p6l560t71r844b158],
7	and	CC	O	and	_	0	SENT_65	[p6l886t71r1032b139],
8	average	JJ	O	average	amod	9	SENT_65	[p6l1070t93r1371b158],
9	INR	NN	O	inr	conj_and	1	SENT_65	[p6l1410t74r1593b139],
10	were	VBD	O	be	cop	13	SENT_65	[p6l1627t93r1811b140],
11	not	RB	O	not	neg	13	SENT_65	[p6l1848t81r1980b139],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	13	SENT_65	[p6l2018t71r2150b158, p6l8t177r379b264],
13	different	JJ	O	different	_	0	SENT_65	[p6l429t177r762b246],
14	between	IN	O	between	_	0	SENT_65	[p6l810t177r1134b246],
15	ll73T/T	NN	O	ll73t/t	nn	16	SENT_65	[p6l1192t178r1524b264],
16	homozyogotes	NNS	O	homozyogote	prep_between	13	SENT_65	[p6l1574t177r2151b264],
17	and	CC	O	and	_	0	SENT_65	[p6l10t284r156b352],
18	C/T	NN	O	c/t	nn	19	SENT_65	[p6l190t284r346b371],
19	heterozygotes	NNS	O	heterozygote	nsubj	20	SENT_65	[p6l378t284r924b371],
20	(	VBP	O	(	conj_and	13	SENT_65	[p6l960t284r1214b371],
21	Table	NNP	O	Table	nn	23	SENT_65	[p6l960t284r1214b371],
22	l	NN	O	l	nn	23	SENT_65	[p6l1259t284r1344b371],
23	)	NN	O	)	dobj	20	SENT_65	[p6l1259t284r1344b371],
24	.	.	O	.	_	0	SENT_65	[p6l1259t284r1344b371],

1	The	DT	O	the	det	4	SENT_66	[p6l1382t284r1534b352],
2	mean	NN	O	mean	nn	4	SENT_66	[p6l1565t306r1780b352],
3	warfarin	NN	O	warfarin	nn	4	SENT_66	[p6l1811t284r2152b352],
4	dose	NN	O	dose	nsubj	6	SENT_66	[p6l9t389r185b458],
5	was	VBD	O	be	cop	6	SENT_66	[p6l232t411r378b458],
6	3.44	CD	NUMBER	3.44	_	0	SENT_66	[p6l430t391r589b458],
7	and	CC	O	and	_	0	SENT_66	[p6l637t389r782b458],
8	5.06	CD	NUMBER	5.06	num	9	SENT_66	[p6l833t391r991b458],
9	mg/day	NN	O	mg/day	conj_and	6	SENT_66	[p6l1037t389r1337b476],
10	in	IN	O	in	_	0	SENT_66	[p6l1383t389r1457b457],
11	ll73T/T	NN	O	ll73t/t	nn	12	SENT_66	[p6l1512t389r1845b476],
12	homozyogotes	NNS	O	homozyogote	prep_in	9	SENT_66	[p6l1891t389r2151b458, p6l8t506r352b584],
13	and	CC	O	and	_	0	SENT_66	[p6l411t496r557b566],
14	C/T	NN	O	c/t	nn	15	SENT_66	[p6l615t497r771b585],
15	heterozygotes	NNS	O	heterozygote	conj_and	12	SENT_66	[p6l827t496r1396b584],
16	,	,	O	,	_	0	SENT_66	[p6l827t496r1396b584],
17	respectively	RB	O	respectively	advmod	6	SENT_66	[p6l1456t497r1939b584],
18	.	.	O	.	_	0	SENT_66	[p6l1456t497r1939b584],

1	The	DT	O	the	det	2	SENT_67	[p6l2001t496r2152b566],
2	possibility	NN	O	possibility	nsubjpass	14	SENT_67	[p6l8t602r415b689],
3	that	IN	O	that	complm	8	SENT_67	[p6l483t602r642b671],
4	the	DT	O	the	det	7	SENT_67	[p6l710t602r829b671],
5	different	JJ	O	different	amod	7	SENT_67	[p6l899t602r1232b671],
6	VKORCI	NN	O	vkorcus	nn	7	SENT_67	[p6l1312t605r1682b671],
7	genotypes	NNS	O	genotype	nsubj	8	SENT_67	[p6l1756t612r2151b689],
8	modulate	VBP	O	modulate	dep	2	SENT_67	[p6l7t708r384b777],
9	the	DT	O	the	det	12	SENT_67	[p6l429t709r549b777],
10	warfarin	NN	O	warfarin	nn	12	SENT_67	[p6l593t709r935b777],
11	dose	NN	O	dose	nn	12	SENT_67	[p6l980t708r1157b777],
12	requirement	NN	O	requirement	dobj	8	SENT_67	[p6l1203t709r1686b795],
13	was	VBD	O	be	auxpass	14	SENT_67	[p6l1729t731r1876b777],
14	investigated	VBN	O	investigate	_	0	SENT_67	[p6l1922t709r2150b777, p6l9t814r280b901],
15	using	VBG	O	use	xcomp	14	SENT_67	[p6l324t814r535b901],
16	ANCOVA	NN	O	ancova	nn	17	SENT_67	[p6l577t814r1005b883],
17	analysis	NN	O	analysis	dobj	15	SENT_67	[p6l1051t814r1361b901],
18	adjusted	VBN	O	adjust	partmod	17	SENT_67	[p6l1408t814r1740b901],
19	for	IN	O	for	_	0	SENT_67	[p6l1785t814r1901b882],
20	INR	NN	O	inr	prep_for	18	SENT_67	[p6l1945t817r2147b882],
21	.	.	O	.	_	0	SENT_67	[p6l1945t817r2147b882],

1	The	DT	O	the	det	3	SENT_68	[p6l9t921r160b989],
2	F	NN	O	f	nn	3	SENT_68	[p6l199t925r263b988],
3	test	NN	O	test	nsubj	17	SENT_68	[p6l291t930r427b989],
4	for	IN	O	for	_	0	SENT_68	[p6l466t921r582b989],
5	the	DT	O	the	det	6	SENT_68	[p6l620t921r740b989],
6	equality	NN	O	equality	prep_for	3	SENT_68	[p6l780t921r1098b1007],
7	of	IN	O	of	_	0	SENT_68	[p6l1138t921r1225b989],
8	the	DT	O	the	det	9	SENT_68	[p6l1254t921r1374b989],
9	slopes	NNS	O	slope	prep_of	6	SENT_68	[p6l1415t921r1651b1008],
10	for	IN	O	for	_	0	SENT_68	[p6l1692t921r1808b989],
11	the	DT	O	the	det	14	SENT_68	[p6l1846t921r1966b989],
12	two	CD	NUMBER	two	num	14	SENT_68	[p6l2005t930r2150b989],
13	genotype	NN	O	genotype	nn	14	SENT_68	[p6l9t1036r368b1113],
14	groups	NNS	O	group	prep_for	9	SENT_68	[p6l406t1049r677b1113],
15	did	VBD	O	do	aux	17	SENT_68	[p6l715t1026r840b1095],
16	not	RB	O	not	neg	17	SENT_68	[p6l876t1036r1009b1095],
17	indicate	VB	O	indicate	dep	21	SENT_68	[p6l1044t1026r1356b1095],
18	any	DT	O	any	det	20	SENT_68	[p6l1395t1049r1537b1113],
19	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_68	[p6l1575t1026r1980b1113],
20	differences	NNS	O	difference	dobj	17	SENT_68	[p6l2017t1026r2150b1095, p6l9t1133r325b1201],
21	(	VBP	O	(	_	0	SENT_68	[p6l374t1133r446b1220],
22	p	NN	O	p	nsubj	23	SENT_68	[p6l374t1133r446b1220],
23	=	JJ	O	=	xcomp	21	SENT_68	[p6l498t1159r554b1178],
24	0.12	CD	NUMBER	0.12	num	25	SENT_68	[p6l608t1133r822b1219],
25	)	NN	O	)	nsubj	21	SENT_68	[p6l608t1133r822b1219],
26	.	.	O	.	_	0	SENT_68	[p6l608t1133r822b1219],

1	Hence	RB	O	hence	advmod	15	SENT_69	[p6l874t1135r1144b1215],
2	,	,	O	,	_	0	SENT_69	[p6l874t1135r1144b1215],
3	the	DT	O	the	det	4	SENT_69	[p6l1194t1133r1314b1201],
4	assumption	NN	O	assumption	nsubjpass	15	SENT_69	[p6l1362t1133r1819b1220],
5	of	IN	O	of	_	0	SENT_69	[p6l1867t1133r1953b1201],
6	parallel	JJ	O	parallel	amod	7	SENT_69	[p6l1988t1155r2150b1220, p6l10t1238r169b1307],
7	slopes	NNS	O	slope	prep_of	4	SENT_69	[p6l208t1238r444b1325],
8	for	IN	O	for	_	0	SENT_69	[p6l482t1238r598b1307],
9	the	DT	O	the	det	12	SENT_69	[p6l634t1238r754b1307],
10	genotype	NN	O	genotype	nn	12	SENT_69	[p6l792t1248r1150b1325],
11	regression	NN	O	regression	nn	12	SENT_69	[p6l1188t1238r1588b1325],
12	lines	NNS	O	line	prep_for	7	SENT_69	[p6l1625t1238r1800b1307],
13	was	VBD	O	be	auxpass	15	SENT_69	[p6l1836t1260r1983b1307],
14	not	RB	O	not	neg	15	SENT_69	[p6l2021t1248r2153b1307],
15	violated	VBN	O	violate	_	0	SENT_69	[p6l8t1345r347b1415],
16	.	.	O	.	_	0	SENT_69	[p6l8t1345r347b1415],

1	The	DT	O	the	det	3	SENT_70	[p6l396t1346r547b1415],
2	C/T	NN	O	c/t	nn	3	SENT_70	[p6l593t1346r749b1434],
3	heterozyogtes	NNS	O	heterozyogte	nsubj	10	SENT_70	[p6l792t1345r1338b1433],
4	at	IN	O	at	_	0	SENT_70	[p6l1385t1355r1459b1415],
5	the	DT	O	the	det	6	SENT_70	[p6l1501t1345r1621b1415],
6	ll73C	NN	O	ll73c	prep_at	3	SENT_70	[p6l1674t1347r1916b1415],
7	>	JJR	O	>	amod	9	SENT_70	[p6l1979t1358r2032b1403],
8	T	NN	O	t	nn	9	SENT_70	[p6l2094t1348r2152b1414],
9	polymorphism	NN	O	polymorphism	dep	6	SENT_70	[p6l8t1451r592b1538],
10	tended	VBD	O	tend	_	0	SENT_70	[p6l618t1451r884b1519],
11	to	TO	O	to	aux	12	SENT_70	[p6l911t1461r988b1519],
12	required	VBN	O	require	xcomp	10	SENT_70	[p6l1018t1451r1350b1538],
13	more	JJR	O	more	amod	14	SENT_70	[p6l1376t1473r1580b1519],
14	warfarin	NN	O	warfarin	dobj	12	SENT_70	[p6l1606t1451r1947b1519],
15	than	IN	O	than	_	0	SENT_70	[p6l1974t1451r2152b1519],
16	the	DT	O	the	det	18	SENT_70	[p6l9t1557r129b1626],
17	T/T	NN	O	t/t	nn	18	SENT_70	[p6l213t1558r366b1644],
18	homozygotes	NNS	O	homozygote	prep_than	12	SENT_70	[p6l450t1557r975b1644],
19	when	WRB	O	when	advmod	20	SENT_70	[p6l1059t1557r1269b1626],
20	adjusted	VBN	O	adjust	advcl	12	SENT_70	[p6l1354t1557r1687b1644],
21	for	IN	O	for	_	0	SENT_70	[p6l1771t1557r1887b1626],
22	INR	NN	O	inr	nn	24	SENT_70	[p6l1971t1560r2153b1625],
23	(	CD	NUMBER	(	num	24	SENT_70	[p6l10t1663r83b1750],
24	p	NN	O	p	prep_for	20	SENT_70	[p6l10t1663r83b1750],
25	=	JJ	O	=	amod	24	SENT_70	[p6l135t1689r192b1708],
26	0.003	CD	NUMBER	0.003	tmod	25	SENT_70	[p6l245t1665r476b1746],
27	;	:	O	;	_	0	SENT_70	[p6l245t1665r476b1746],
28	Fig	NN	O	fig	dobj	12	SENT_70	[p6l518t1663r667b1750],
29	.	.	O	.	_	0	SENT_70	[p6l518t1663r667b1750],

1	1	CD	NUMBER	1	_	0	SENT_71	[p6l718t1663r804b1750],
2	)	NN	O	)	dep	1	SENT_71	[p6l718t1663r804b1750],
3	.	.	O	.	_	0	SENT_71	[p6l718t1663r804b1750],

1	Discussion	NN	O	discussion	_	0	SENT_72	[p6l8t1884r421b1951],

1	Our	PRP$	O	we	poss	2	SENT_73	[p6l10t2100r166b2167],
2	data	NNS	O	datum	nsubj	3	SENT_73	[p6l200t2098r373b2167],
3	indicated	VBD	O	indicate	_	0	SENT_73	[p6l406t2098r771b2167],
4	that	IN	O	that	complm	23	SENT_73	[p6l805t2098r964b2167],
5	two	CD	NUMBER	two	num	8	SENT_73	[p6l997t2108r1142b2167],
6	different	JJ	O	different	amod	8	SENT_73	[p6l1178t2098r1512b2167],
7	patient	NN	O	patient	nn	8	SENT_73	[p6l1543t2098r1822b2185],
8	groups	NNS	O	group	nsubj	23	SENT_73	[p6l1856t2121r2149b2185],
9	,	,	O	,	_	0	SENT_73	[p6l1856t2121r2149b2185],
10	T/T	NN	O	t/t	nn	11	SENT_73	[p6l9t2205r162b2292],
11	homozygotes	NNS	O	homozygote	appos	8	SENT_73	[p6l224t2205r749b2292],
12	and	CC	O	and	_	0	SENT_73	[p6l815t2205r960b2273],
13	C/T	NN	O	c/t	nn	14	SENT_73	[p6l1025t2205r1182b2292],
14	heterozygotes	NNS	O	heterozygote	conj_and	11	SENT_73	[p6l1244t2205r1790b2292],
15	for	IN	O	for	_	0	SENT_73	[p6l1854t2205r1970b2273],
16	the	DT	O	the	det	21	SENT_73	[p6l2032t2205r2152b2273],
17	117	CD	NUMBER	117	num	18	SENT_73	[p6l18t2312r144b2379],
18	3C	NN	O	3c	npadvmod	19	SENT_73	[p6l153t2311r260b2379],
19	>	JJR	O	>	amod	21	SENT_73	[p6l313t2323r365b2368],
20	T	NN	O	t	nn	21	SENT_73	[p6l417t2313r475b2378],
21	polymorphism	NN	O	polymorphism	prep_for	11	SENT_73	[p6l507t2310r1113b2397],
22	,	,	O	,	_	0	SENT_73	[p6l507t2310r1113b2397],
23	responded	VBD	O	respond	ccomp	3	SENT_73	[p6l1150t2310r1561b2397],
24	to	TO	O	to	_	0	SENT_73	[p6l1594t2320r1671b2379],
25	warfarin	NN	O	warfarin	prep_to	23	SENT_73	[p6l1705t2310r2046b2379],
26	in	IN	O	in	_	0	SENT_73	[p6l2079t2310r2153b2378],
27	distinctive	JJ	O	distinctive	amod	28	SENT_73	[p6l9t2417r414b2485],
28	manners	NNS	O	manners	prep_in	23	SENT_73	[p6l476t2439r837b2485],
29	.	.	O	.	_	0	SENT_73	[p6l476t2439r837b2485],

1	The	DT	O	the	det	5	SENT_74	[p6l904t2417r1056b2485],
2	C/T	NN	O	c/t	nn	3	SENT_74	[p6l1120t2417r1277b2504],
3	heterozygotes	NNS	O	heterozygote	npadvmod	4	SENT_74	[p6l1339t2417r1885b2504],
4	more	RBR	O	more	advmod	5	SENT_74	[p6l1948t2439r2152b2485],
5	warfarin	NN	O	warfarin	nsubj	11	SENT_74	[p6l7t2522r349b2591],
6	than	IN	O	than	_	0	SENT_74	[p6l396t2522r574b2591],
7	the	DT	O	the	det	9	SENT_74	[p6l621t2522r741b2591],
8	T/T	NN	O	t/t	nn	9	SENT_74	[p6l789t2522r941b2609],
9	homozygotes	NNS	O	homozygote	prep_than	5	SENT_74	[p6l988t2522r1514b2609],
10	when	WRB	O	when	dep	9	SENT_74	[p6l1561t2522r1772b2591],
11	adjusted	VBN	O	adjust	_	0	SENT_74	[p6l1820t2522r2152b2609],
12	for	IN	O	for	_	0	SENT_74	[p6l9t2629r125b2697],
13	INR	NN	O	inr	prep_for	11	SENT_74	[p6l162t2631r363b2697],
14	.	.	O	.	_	0	SENT_74	[p6l162t2631r363b2697],

1	This	DT	O	this	det	2	SENT_75	[p6l405t2629r578b2697],
2	result	NN	O	result	nsubj	4	SENT_75	[p6l615t2629r834b2697],
3	was	VBD	O	be	cop	4	SENT_75	[p6l869t2651r1016b2697],
4	consistent	JJ	O	consistent	_	0	SENT_75	[p6l1054t2629r1451b2697],
5	with	IN	O	with	_	0	SENT_75	[p6l1485t2629r1660b2697],
6	those	DT	O	those	prep_with	4	SENT_75	[p6l1696t2628r1904b2697],
7	of	IN	O	of	_	0	SENT_75	[p6l1943t2629r2030b2697],
8	an	DT	O	a	det	10	SENT_75	[p6l2059t2651r2153b2697],
9	Italian	JJ	MISC	italian	amod	10	SENT_75	[p6l9t2734r269b2802],
10	study	NN	O	study	prep_of	6	SENT_75	[p6l309t2734r521b2821],
11	reporting	VBG	O	report	xcomp	4	SENT_75	[p6l558t2734r929b2821],
12	that	IN	O	that	complm	23	SENT_75	[p6l965t2734r1123b2802],
13	patients	NNS	O	patient	nsubj	23	SENT_75	[p6l1158t2734r1471b2821],
14	who	WP	O	who	nsubj	16	SENT_75	[p6l1508t2734r1674b2803],
15	are	VBP	O	be	cop	16	SENT_75	[p6l1715t2756r1833b2802],
16	heterozygous	JJ	O	heterozygous	rcmod	13	SENT_75	[p6l1870t2734r2150b2802, p6l8t2863r279b2927],
17	for	IN	O	for	_	0	SENT_75	[p6l334t2840r450b2909],
18	the	DT	O	the	det	19	SENT_75	[p6l503t2840r622b2909],
19	ll73C	NN	O	ll73c	prep_for	16	SENT_75	[p6l685t2842r928b2909],
20	>	JJR	O	>	amod	22	SENT_75	[p6l1000t2853r1052b2898],
21	T	NN	O	t	nn	22	SENT_75	[p6l1124t2843r1183b2908],
22	polymorphism	NN	O	polymorphism	dep	19	SENT_75	[p6l1235t2840r1818b2927],
23	require	VBP	O	require	ccomp	11	SENT_75	[p6l1872t2840r2152b2927],
24	more	JJR	O	more	amod	25	SENT_75	[p6l7t2969r211b3015],
25	warfarin	NN	O	warfarin	dobj	23	SENT_75	[p6l246t2947r587b3015],
26	than	IN	O	than	mark	29	SENT_75	[p6l623t2947r802b3015],
27	ll73T	NN	O	ll73t	nn	28	SENT_75	[p6l847t2948r1084b3015],
28	homozygotes	NNS	O	homozygote	nsubj	29	SENT_75	[p6l1120t2947r1646b3034],
29	[	VBP	O	[	advcl	4	SENT_75	[p6l1686t2948r1797b3033],
30	3	CD	NUMBER	3	num	31	SENT_75	[p6l1686t2948r1797b3033],
31	]	NN	O	]	dobj	29	SENT_75	[p6l1686t2948r1797b3033],
32	.	.	O	.	_	0	SENT_75	[p6l1686t2948r1797b3033],

1	The	DT	O	the	det	3	SENT_76	[p6l177t3052r329b3121],
2	genotype	NN	O	genotype	nn	3	SENT_76	[p6l386t3062r746b3139],
3	distribution	NN	O	distribution	nsubj	11	SENT_76	[p6l803t3052r1270b3121],
4	of	IN	O	of	_	0	SENT_76	[p6l1329t3052r1416b3121],
5	the	DT	O	the	det	6	SENT_76	[p6l1463t3052r1582b3121],
6	ll73C	NN	O	ll73c	prep_of	3	SENT_76	[p6l1648t3054r1891b3121],
7	>	JJR	O	>	amod	9	SENT_76	[p6l1967t3065r2019b3110],
8	T	NN	O	t	nn	9	SENT_76	[p6l2094t3055r2152b3120],
9	polymorphism	NN	O	polymorphism	dep	6	SENT_76	[p6l7t3159r592b3246],
10	was	VBD	O	be	cop	11	SENT_76	[p6l641t3181r788b3227],
11	different	JJ	O	different	_	0	SENT_76	[p6l841t3159r1175b3227],
12	between	IN	O	between	_	0	SENT_76	[p6l1226t3159r1548b3227],
13	Japanese	JJ	MISC	japanese	prep_between	11	SENT_76	[p6l1599t3161r1953b3246],
14	and	CC	O	and	advmod	13	SENT_76	[p6l2007t3159r2152b3227],

1	Kosaki	NNP	PERSON	Kosaki	_	0	SENT_77	[p6l9t3416r237b3471],
2	et	FW	O	et	nn	3	SENT_77	[p6l265t3424r320b3471],
3	al.	FW	O	al.	dep	1	SENT_77	[p6l349t3416r439b3471],
4	:	:	O	:	_	0	SENT_77	[p6l349t3416r439b3471],
5	VKORCI	NNP	O	VKORCI	nn	6	SENT_77	[p6l481t3418r777b3472],
6	Polymorphism	NN	O	polymorphism	dep	3	SENT_77	[p6l807t3416r1277b3486],
7	and	CC	O	and	_	0	SENT_77	[p6l1305t3416r1422b3471],
8	Warfarin	NN	O	warfarin	dep	3	SENT_77	[p6l1448t3416r1741b3472],

1	Table	NNP	O	Table	_	0	SENT_78	[p6l8t3659r184b3712],
2	1	CD	NUMBER	1	dep	1	SENT_78	[p6l215t3658r264b3712],
3	.	.	O	.	_	0	SENT_78	[p6l215t3658r264b3712],

1	Demographic	JJ	MISC	demographic	amod	2	SENT_79	[p6l307t3657r743b3726],
2	characteristics	NNS	O	characteristic	_	0	SENT_79	[p6l771t3657r1222b3712],
3	of	IN	O	of	_	0	SENT_79	[p6l1253t3657r1322b3712],
4	patients	NNS	O	patient	prep_of	2	SENT_79	[p6l1343t3657r1593b3726],
5	grouped	VBN	O	group	prep	4	SENT_79	[p6l1623t3657r1886b3726],
6	according	VBG	O	accord	pcomp	5	SENT_79	[p6l1915t3656r2150b3712, p7l8t19r105b88],

1	to	TO	O	to	_	0	SENT_80	[p7l134t27r195b74],
2	VKORC1	NN	O	vkorc1	nn	3	SENT_80	[p7l235t21r530b74],
3	genotype	NN	O	genotype	pobj	1	SENT_80	[p7l561t27r848b88],

1	VKORC1	NN	O	vkorc1	nn	2	SENT_81	[p7l699t203r1013b257],
2	genotype	NN	O	genotype	_	0	SENT_81	[p7l1048t210r1335b272],

1	T/T	NN	O	t/t	nn	3	SENT_82	[p7l700t368r822b439],
2	(	CD	NUMBER	(	num	3	SENT_82	[p7l851t368r909b439],
3	n	NN	O	n	_	0	SENT_82	[p7l851t368r909b439],
4	=	JJ	O	=	amod	3	SENT_82	[p7l951t389r996b405],
5	26	CD	NUMBER	26	tmod	4	SENT_82	[p7l1038t369r1133b438],
6	)	CD	NUMBER	)	num	9	SENT_82	[p7l1038t369r1133b438],
7	C/T	NN	O	c/t	nn	9	SENT_82	[p7l1241t368r1365b439],
8	(	NN	O	(	nn	9	SENT_82	[p7l1395t368r1453b439],
9	n	NN	O	n	dep	3	SENT_82	[p7l1395t368r1453b439],
10	=	JJ	O	=	quantmod	12	SENT_82	[p7l1494t389r1540b405],
11	5	CD	NUMBER	5	number	12	SENT_82	[p7l1585t368r1639b438],
12	)	CD	NUMBER	)	num	14	SENT_82	[p7l1585t368r1639b438],
13	Signiﬁcance	NN	O	signiﬁcance	nn	14	SENT_82	[p7l1749t366r2152b439],
14	“	NN	O	“	dep	9	SENT_82	[p7l1749t366r2152b439],

1	Age	NNP	O	Age	nn	3	SENT_83	[p7l7t508r133b578],
2	(	CD	NUMBER	(	num	3	SENT_83	[p7l163t493r403b578],
3	years	NNS	NUMBER	year	dep	7	SENT_83	[p7l163t493r403b578],
4	)	CD	NUMBER	)	dep	3	SENT_83	[p7l163t493r403b578],
5	b	NN	O	b	dep	7	SENT_83	[p7l163t493r403b578],
6	22.2	CD	NUMBER	22.2	num	5	SENT_83	[p7l724t510r853b563],
7	i	FW	O	i	dep	42	SENT_83	[p7l895t514r940b559],
8	5.7	CD	NUMBER	5.7	number	9	SENT_83	[p7l984t510r1073b563],
9	23.0	CD	NUMBER	23.0	dep	7	SENT_83	[p7l1247t510r1376b563],
10	:1	CD	NUMBER	:1	dep	9	SENT_83	[p7l1418t513r1463b559],
11	:	:	O	:	_	0	SENT_83	[p7l1418t513r1463b559],
12	6.1	CD	NUMBER	6.1	num	14	SENT_83	[p7l1507t510r1590b563],
13	NS	NN	O	n	nn	14	SENT_83	[p7l1746t509r1845b563],
14	Male/female	NN	O	male/female	dep	9	SENT_83	[p7l9t601r406b671],
15	17/9	CD	NUMBER	17/9	number	16	SENT_83	[p7l751t602r877b671],
16	3/2	CD	NUMBER	3/2	dep	14	SENT_83	[p7l1307t602r1401b671],
17	NS	NN	O	n	nn	23	SENT_83	[p7l1746t602r1845b657],
18	Body	NN	O	body	nn	23	SENT_83	[p7l9t694r176b764],
19	weight	NN	O	weight	nn	23	SENT_83	[p7l203t694r413b764],
20	(	CD	NUMBER	(	num	23	SENT_83	[p7l442t679r595b764],
21	kg	NN	O	kg	nn	23	SENT_83	[p7l442t679r595b764],
22	)	NN	O	)	nn	23	SENT_83	[p7l442t679r595b764],
23	b	NN	O	b	dep	14	SENT_83	[p7l442t679r595b764],
24	56.3	CD	NUMBER	56.3	number	25	SENT_83	[p7l727t696r850b749],
25	:1	CD	NUMBER	:1	dep	23	SENT_83	[p7l895t700r940b745],
26	:	:	O	:	_	0	SENT_83	[p7l895t700r940b745],
27	11.5	CD	NUMBER	11.5	number	28	SENT_83	[p7l989t696r1109b749],
28	55.4	CD	NUMBER	55.4	dep	9	SENT_83	[p7l1250t696r1377b749],
29	:1	CD	NUMBER	:1	dep	28	SENT_83	[p7l1418t700r1463b745],
30	:	:	O	:	_	0	SENT_83	[p7l1418t700r1463b745],
31	11.3	CD	NUMBER	11.3	num	33	SENT_83	[p7l1512t696r1632b749],
32	NS	NN	O	n	nn	33	SENT_83	[p7l1746t696r1845b750],
33	INR	NN	O	inr	dep	9	SENT_83	[p7l9t790r155b842],
34	2.22	CD	NUMBER	2.22	number	35	SENT_83	[p7l724t789r853b842],
35	:1	CD	NUMBER	:1	dep	33	SENT_83	[p7l895t793r940b838],
36	:	:	O	:	_	0	SENT_83	[p7l895t793r940b838],
37	0.66	CD	NUMBER	0.66	dep	9	SENT_83	[p7l982t789r1110b843],
38	1.96	CD	NUMBER	1.96	number	39	SENT_83	[p7l1254t789r1376b842],
39	:1	CD	NUMBER	:1	dep	37	SENT_83	[p7l1418t793r1463b838],
40	:	:	O	:	_	0	SENT_83	[p7l1418t793r1463b838],
41	0.60	CD	NUMBER	0.60	num	42	SENT_83	[p7l1505t789r1634b843],
42	NS	NN	O	n	_	0	SENT_83	[p7l1746t789r1845b843],

1	INR	NN	O	inr	nsubj	4	SENT_84	[p7l9t970r172b1034],
2	,	,	O	,	_	0	SENT_84	[p7l9t970r172b1034],
3	international	JJ	O	international	appos	1	SENT_84	[p7l202t968r613b1023],
4	normalized	VBD	O	normalize	_	0	SENT_84	[p7l641t968r997b1023],
5	ratio	NN	O	ratio	dobj	4	SENT_84	[p7l1026t968r1193b1035],
6	;	:	O	;	_	0	SENT_84	[p7l1026t968r1193b1035],
7	NS	NN	O	n	dep	5	SENT_84	[p7l1223t969r1342b1034],
8	,	,	O	,	_	0	SENT_84	[p7l1223t969r1342b1034],
9	not	RB	O	not	neg	10	SENT_84	[p7l1373t976r1479b1023],
10	signiﬁcant	NN	O	signiﬁcant	appos	7	SENT_84	[p7l1508t968r1845b1038],
11	.	.	O	.	_	0	SENT_84	[p7l1508t968r1845b1038],
12	"	''	O	"	punct	4	SENT_84	[p7l8t1059r34b1083],

1	Signiﬁcance	NN	O	signiﬁcance	nsubj	2	SENT_85	[p7l65t1061r438b1132],
2	determined	VBN	O	determine	_	0	SENT_85	[p7l484t1061r840b1117],
3	by	IN	O	by	_	0	SENT_85	[p7l885t1061r962b1132],
4	Mann	NNP	PERSON	Mann	prep_by	2	SENT_85	[p7l1007t1061r1509b1132],
5	.	.	O	.	_	0	SENT_85	[p7l1007t1061r1509b1132],

1	—	NN	O	—	_	0	SENT_86	[p7l1007t1061r1509b1132],
2	.	.	O	.	_	0	SENT_86	[p7l1007t1061r1509b1132],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_87	[p7l1007t1061r1509b1132],
2	U-test	NNP	O	U-test	_	0	SENT_87	[p7l1562t1065r1746b1117],
3	or	CC	O	or	_	0	SENT_87	[p7l1791t1080r1858b1117],
4	Fisher	NNP	PERSON	Fisher	poss	7	SENT_87	[p7l1904t1061r2151b1117],
5	’s	POS	O	’s	_	0	SENT_87	[p7l1904t1061r2151b1117],
6	exact	JJ	O	exact	amod	7	SENT_87	[p7l8t1162r172b1208],
7	test	NN	O	test	conj_or	2	SENT_87	[p7l200t1162r325b1208],
8	.	.	O	.	_	0	SENT_87	[p7l200t1162r325b1208],

1	I	PRP	O	I	nsubj	2	SENT_88	[p7l8t1232r33b1268],
2	’	VBP	O	’	_	0	SENT_88	[p7l8t1232r33b1268],
3	Data	NNS	O	datum	nsubjpass	5	SENT_88	[p7l62t1249r221b1302],
4	are	VBP	O	be	auxpass	5	SENT_88	[p7l250t1265r345b1302],
5	expressed	VBN	O	express	ccomp	2	SENT_88	[p7l373t1247r676b1317],
6	as	IN	O	as	_	0	SENT_88	[p7l705t1265r767b1302],
7	mean	JJ	O	mean	amod	8	SENT_88	[p7l795t1265r966b1302],
8	i	FW	O	i	prep_as	5	SENT_88	[p7l1008t1252r1053b1297],
9	standard	JJ	O	standard	amod	10	SENT_88	[p7l1096t1247r1374b1302],
10	deviation	NN	O	deviation	dobj	5	SENT_88	[p7l1402t1247r1713b1302],
11	.	.	O	.	_	0	SENT_88	[p7l1402t1247r1713b1302],

1	Warfarin	NNP	O	Warfarin	_	0	SENT_89	[p7l8t2435r57b2680],
2	dose	NN	O	dose	nn	4	SENT_89	[p7l9t2273r57b2411],
3	(	NN	O	(	nn	4	SENT_89	[p7l8t1996r71b2249],
4	mg/day	NN	O	mg/day	dep	1	SENT_89	[p7l8t1996r71b2249],
5	)	CD	NUMBER	)	dep	1	SENT_89	[p7l8t1996r71b2249],

1	INR	NN	O	inr	_	0	SENT_90	[p7l1158t3307r1264b3352],

1	Fig	NN	O	fig	_	0	SENT_91	[p7l7t3462r126b3531],
2	.	.	O	.	_	0	SENT_91	[p7l7t3462r126b3531],

1	1	LS	NUMBER	1	_	0	SENT_92	[p7l161t3462r209b3516],
2	.	.	O	.	_	0	SENT_92	[p7l161t3462r209b3516],

1	Effect	NN	O	effect	dep	6	SENT_93	[p7l254t3461r436b3516],
2	of	IN	O	of	_	0	SENT_93	[p7l473t3461r542b3516],
3	1173C	NN	O	1173c	prep_of	1	SENT_93	[p7l578t3462r772b3516],
4	>	JJR	O	>	amod	5	SENT_93	[p7l823t3471r865b3507],
5	T	NN	O	t	dep	6	SENT_93	[p7l917t3463r964b3515],
6	polymorphism	NN	O	polymorphism	dep	15	SENT_93	[p7l999t3461r1465b3531],
7	in	IN	O	in	_	0	SENT_93	[p7l1500t3461r1559b3515],
8	VKORC1	NN	O	vkorc1	prep_in	6	SENT_93	[p7l1604t3463r1900b3516],
9	on	IN	O	on	_	0	SENT_93	[p7l1941t3479r2019b3516],
10	the	DT	O	the	det	11	SENT_93	[p7l2056t3461r2151b3516],
11	relationship	NN	O	relationship	prep_on	8	SENT_93	[p7l8t3554r385b3623],
12	of	IN	O	of	_	0	SENT_93	[p7l426t3554r496b3608],
13	prothrombin	NN	O	prothrombin	nn	14	SENT_93	[p7l527t3554r939b3623],
14	time	NN	O	time	prep_of	11	SENT_93	[p7l979t3554r1115b3608],
15	international	JJ	O	international	dep	16	SENT_93	[p7l1154t3554r1566b3608],
16	normalized	VBD	O	normalize	_	0	SENT_93	[p7l1605t3554r1962b3608],
17	ratio	NN	O	ratio	nn	20	SENT_93	[p7l2001t3554r2150b3608],
18	(	CD	NUMBER	(	num	20	SENT_93	[p7l10t3647r195b3716],
19	INR	NN	O	inr	nn	20	SENT_93	[p7l10t3647r195b3716],
20	)	NN	O	)	dobj	16	SENT_93	[p7l10t3647r195b3716],
21	and	CC	O	and	_	0	SENT_93	[p7l230t3647r347b3701],
22	maintenance	NN	O	maintenance	nn	23	SENT_93	[p7l379t3647r781b3701],
23	dose	NN	O	dose	dobj	16	SENT_93	[p7l816t3647r957b3701],
24	of	IN	O	of	_	0	SENT_93	[p7l992t3647r1061b3701],
25	Warfarin	NNP	O	Warfarin	prep_of	23	SENT_93	[p7l1086t3647r1374b3701],
26	.	.	O	.	_	0	SENT_93	[p7l1086t3647r1374b3701],

1	Circles	NNS	O	circle	_	0	SENT_94	[p7l1415t3647r1644b3713],
2	,	,	O	,	_	0	SENT_94	[p7l1415t3647r1644b3713],
3	T/T	NN	O	t/t	nn	4	SENT_94	[p7l1680t3647r1802b3716],
4	homozygotes	NNS	O	homozygote	appos	1	SENT_94	[p7l1835t3647r2150b3716, p7l10t3748r151b3807],
5	;	:	O	;	_	0	SENT_94	[p7l1835t3647r2150b3716, p7l10t3748r151b3807],
6	Squares	NNS	O	square	dep	1	SENT_94	[p7l185t3742r445b3810],
7	,	,	O	,	_	0	SENT_94	[p7l185t3742r445b3810],
8	C/T	NN	O	c/t	nn	9	SENT_94	[p7l478t3740r602b3810],
9	heterozygotes	NNS	O	heterozygote	appos	6	SENT_94	[p7l630t3740r1082b3810],
10	.	.	O	.	_	0	SENT_94	[p7l630t3740r1082b3810],

1	Italian	JJ	MISC	italian	amod	2	SENT_95	[p8l9t165r270b234],
2	patients	NNS	O	patient	_	0	SENT_95	[p8l305t165r640b252],
3	.	.	O	.	_	0	SENT_95	[p8l305t165r640b252],

1	The	DT	O	the	det	3	SENT_96	[p8l681t165r833b234],
2	genotype	NN	O	genotype	nn	3	SENT_96	[p8l871t175r1229b252],
3	frequency	NN	O	frequency	nsubj	13	SENT_96	[p8l1266t165r1657b252],
4	of	IN	O	of	_	0	SENT_96	[p8l1695t165r1781b234],
5	ll73T/T	NN	O	ll73t/t	nn	6	SENT_96	[p8l1818t165r2150b252],
6	homozygotes	NNS	O	homozygote	prep_of	3	SENT_96	[p8l9t272r533b359],
7	in	IN	O	in	_	0	SENT_96	[p8l580t272r654b339],
8	our	PRP$	O	we	poss	10	SENT_96	[p8l701t294r836b340],
9	Japanese	JJ	MISC	japanese	amod	10	SENT_96	[p8l881t274r1234b359],
10	population	NN	O	population	prep_in	6	SENT_96	[p8l1280t272r1719b359],
11	was	VBD	O	be	cop	13	SENT_96	[p8l1763t294r1909b340],
12	90	CD	PERCENT	90	num	13	SENT_96	[p8l1958t272r2147b354],
13	%	NN	PERCENT	%	_	0	SENT_96	[p8l1958t272r2147b354],
14	,	,	O	,	_	0	SENT_96	[p8l1958t272r2147b354],
15	whereas	IN	O	whereas	mark	23	SENT_96	[p8l7t377r326b446],
16	that	DT	O	that	nsubj	23	SENT_96	[p8l370t377r528b446],
17	in	IN	O	in	_	0	SENT_96	[p8l569t377r643b445],
18	the	DT	O	the	det	20	SENT_96	[p8l686t377r805b446],
19	Italian	JJ	MISC	italian	amod	20	SENT_96	[p8l849t377r1109b446],
20	study	NN	O	study	prep_in	16	SENT_96	[p8l1154t377r1367b464],
21	was	VBD	O	be	cop	23	SENT_96	[p8l1408t399r1555b446],
22	16	CD	PERCENT	16	num	23	SENT_96	[p8l1608t377r1766b446],
23	%	NN	PERCENT	%	advcl	13	SENT_96	[p8l1608t377r1766b446],
24	[	CD	NUMBER	[	number	25	SENT_96	[p8l1813t378r1924b463],
25	3	CD	NUMBER	3	num	26	SENT_96	[p8l1813t378r1924b463],
26	]	NN	O	]	dep	23	SENT_96	[p8l1813t378r1924b463],
27	.	.	O	.	_	0	SENT_96	[p8l1813t378r1924b463],

1	Furthermore	RB	O	furthermore	advmod	14	SENT_97	[p8l1974t380r2148b446, p8l9t483r395b566],
2	,	,	O	,	_	0	SENT_97	[p8l1974t380r2148b446, p8l9t483r395b566],
3	the	DT	O	the	det	5	SENT_97	[p8l471t483r590b551],
4	allele	NN	O	allele	nn	5	SENT_97	[p8l664t483r864b551],
5	frequency	NN	O	frequency	nsubj	14	SENT_97	[p8l937t483r1328b570],
6	of	IN	O	of	_	0	SENT_97	[p8l1401t483r1488b551],
7	1173T	NN	O	1173t	prep_of	5	SENT_97	[p8l1559t485r1797b552],
8	in	IN	O	in	_	0	SENT_97	[p8l1868t483r1943b550],
9	our	PRP$	O	we	poss	11	SENT_97	[p8l2017t505r2151b551],
10	Japanese	JJ	MISC	japanese	amod	11	SENT_97	[p8l8t592r362b676],
11	population	NN	O	population	prep_in	7	SENT_97	[p8l400t589r839b676],
12	was	VBD	O	be	cop	14	SENT_97	[p8l875t612r1023b658],
13	91.2	CD	PERCENT	91.2	num	14	SENT_97	[p8l1063t590r1326b672],
14	%	NN	PERCENT	%	_	0	SENT_97	[p8l1063t590r1326b672],
15	,	,	O	,	_	0	SENT_97	[p8l1063t590r1326b672],
16	whereas	IN	O	whereas	mark	24	SENT_97	[p8l1366t589r1684b658],
17	that	DT	O	that	nsubj	24	SENT_97	[p8l1723t589r1881b658],
18	in	IN	O	in	_	0	SENT_97	[p8l1918t590r1992b657],
19	the	DT	O	the	det	21	SENT_97	[p8l2030t589r2150b658],
20	Italian	JJ	MISC	italian	amod	21	SENT_97	[p8l9t695r270b763],
21	study	NN	O	study	prep_in	17	SENT_97	[p8l325t695r538b782],
22	was	VBD	O	be	cop	24	SENT_97	[p8l588t717r735b764],
23	39.8	CD	PERCENT	39.8	num	24	SENT_97	[p8l792t695r1029b764],
24	%	NN	PERCENT	%	advcl	14	SENT_97	[p8l792t695r1029b764],
25	[	CD	NUMBER	[	number	26	SENT_97	[p8l1086t696r1197b781],
26	3	CD	NUMBER	3	num	27	SENT_97	[p8l1086t696r1197b781],
27	]	NN	O	]	dep	24	SENT_97	[p8l1086t696r1197b781],
28	.	.	O	.	_	0	SENT_97	[p8l1086t696r1197b781],

1	Because	IN	O	because	mark	4	SENT_98	[p8l1257t697r1572b763],
2	1173T/T	NN	O	1173t/t	nn	3	SENT_98	[p8l1634t695r1967b782],
3	homozygotes	NNS	O	homozygote	nsubj	4	SENT_98	[p8l2019t695r2149b763, p8l7t811r430b888],
4	required	VBD	O	require	advcl	27	SENT_98	[p8l473t801r805b888],
5	less	JJR	O	less	amod	6	SENT_98	[p8l847t801r980b870],
6	warfarin	NN	O	warfarin	dobj	4	SENT_98	[p8l1022t801r1362b870],
7	than	IN	O	than	_	0	SENT_98	[p8l1405t801r1582b870],
8	patients	NNS	O	patient	prep_than	4	SENT_98	[p8l1622t801r1935b888],
9	with	IN	O	with	_	0	SENT_98	[p8l1977t801r2151b870],
10	other	JJ	O	other	amod	11	SENT_98	[p8l11t908r219b976],
11	genotypes	NNS	O	genotype	prep_with	8	SENT_98	[p8l250t917r644b995],
12	in	IN	O	in	_	0	SENT_98	[p8l677t908r751b975],
13	both	DT	O	both	det	17	SENT_98	[p8l783t908r966b976],
14	Japanese	JJ	MISC	japanese	amod	17	SENT_98	[p8l997t910r1351b995],
15	and	CC	O	and	_	0	SENT_98	[p8l1384t908r1530b976],
16	Italian	JJ	MISC	italian	conj_and	14	SENT_98	[p8l1563t908r1822b976],
17	studies	NNS	O	study	prep_in	4	SENT_98	[p8l1856t908r2147b990],
18	,	,	O	,	_	0	SENT_98	[p8l1856t908r2147b990],
19	the	DT	O	the	det	20	SENT_98	[p8l9t1013r129b1082],
20	difference	NN	O	difference	nsubj	27	SENT_98	[p8l185t1013r566b1082],
21	in	IN	O	in	_	0	SENT_98	[p8l623t1013r696b1081],
22	the	DT	O	the	det	25	SENT_98	[p8l752t1013r871b1082],
23	ll73T	NN	O	ll73t	nn	25	SENT_98	[p8l936t1015r1174b1082],
24	allele	NN	O	allele	nn	25	SENT_98	[p8l1231t1013r1430b1082],
25	frequency	NN	O	frequency	prep_in	20	SENT_98	[p8l1486t1013r1877b1100],
26	could	MD	O	could	aux	27	SENT_98	[p8l1932t1013r2150b1082],
27	account	VB	O	account	_	0	SENT_98	[p8l10t1130r323b1189],
28	for	IN	O	for	_	0	SENT_98	[p8l357t1121r473b1189],
29	the	DT	O	the	det	31	SENT_98	[p8l508t1121r627b1189],
30	well-established	JJ	O	well-established	amod	31	SENT_98	[p8l662t1120r1291b1189],
31	observation	NN	O	observation	prep_for	27	SENT_98	[p8l1329t1121r1796b1189],
32	that	IN	O	that	complm	39	SENT_98	[p8l1832t1121r2011b1203],
33	,	,	O	,	_	0	SENT_98	[p8l1832t1121r2011b1203],
34	on	IN	O	on	_	0	SENT_98	[p8l2053t1143r2151b1189],
35	average	NN	O	average	prep_on	39	SENT_98	[p8l10t1248r334b1313],
36	,	,	O	,	_	0	SENT_98	[p8l10t1248r334b1313],
37	Asian	JJ	MISC	asian	amod	38	SENT_98	[p8l393t1226r623b1294],
38	patients	NNS	O	patient	nsubj	39	SENT_98	[p8l678t1226r991b1313],
39	require	VBP	O	require	ccomp	27	SENT_98	[p8l1049t1226r1328b1313],
40	less	JJR	O	less	amod	41	SENT_98	[p8l1385t1226r1519b1294],
41	warfarin	NN	O	warfarin	dobj	39	SENT_98	[p8l1575t1226r1916b1294],
42	than	IN	O	than	_	0	SENT_98	[p8l1972t1226r2151b1294],
43	Caucasian	JJ	MISC	caucasian	amod	44	SENT_98	[p8l10t1333r421b1401],
44	patients	NNS	O	patient	prep_than	39	SENT_98	[p8l459t1333r772b1419],
45	to	TO	O	to	aux	46	SENT_98	[p8l813t1342r889b1401],
46	elicit	VB	O	elicit	xcomp	39	SENT_98	[p8l932t1333r1118b1401],
47	the	DT	O	the	det	49	SENT_98	[p8l1158t1332r1277b1401],
48	same	JJ	O	same	amod	49	SENT_98	[p8l1319t1355r1514b1401],
49	degree	NN	O	degree	dobj	46	SENT_98	[p8l1555t1332r1808b1419],
50	of	IN	O	of	_	0	SENT_98	[p8l1850t1333r1937b1401],
51	anticoagulation	NN	O	anticoagulation	nn	52	SENT_98	[p8l1969t1333r2148b1401, p8l8t1438r478b1525],
52	[	NN	O	[	prep_of	49	SENT_98	[p8l517t1439r604b1524],
53	2	CD	NUMBER	2	num	52	SENT_98	[p8l517t1439r604b1524],
54	,	,	O	,	_	0	SENT_98	[p8l517t1439r604b1524],
55	13	CD	NUMBER	13	num	56	SENT_98	[p8l652t1439r779b1524],
56	]	NN	O	]	appos	49	SENT_98	[p8l652t1439r779b1524],
57	.	.	O	.	_	0	SENT_98	[p8l652t1439r779b1524],

1	The	DT	O	the	det	2	SENT_99	[p8l177t1544r328b1613],
2	limitations	NNS	O	limitation	nsubj	7	SENT_99	[p8l364t1544r788b1613],
3	of	IN	O	of	_	0	SENT_99	[p8l826t1544r912b1613],
4	the	DT	O	the	det	6	SENT_99	[p8l938t1544r1057b1613],
5	current	JJ	DATE	current	amod	6	SENT_99	[p8l1092t1554r1379b1613],
6	study	NN	O	study	prep_of	2	SENT_99	[p8l1415t1544r1628b1631],
7	are	VBP	O	be	_	0	SENT_99	[p8l1663t1567r1782b1613],
8	twofold	RB	O	twofold	advmod	7	SENT_99	[p8l1817t1544r2145b1613],
9	.	.	O	.	_	0	SENT_99	[p8l1817t1544r2145b1613],

1	First	RB	ORDINAL	first	advmod	16	SENT_100	[p8l10t1651r219b1733],
2	,	,	O	,	_	0	SENT_100	[p8l10t1651r219b1733],
3	previously	RB	DATE	previously	advmod	4	SENT_100	[p8l263t1651r677b1738],
4	known	VBN	O	know	amod	5	SENT_100	[p8l719t1651r990b1719],
5	covariates	NNS	O	covariate	nsubjpass	16	SENT_100	[p8l1032t1651r1432b1719],
6	that	WDT	O	that	nsubj	8	SENT_100	[p8l1476t1651r1634b1719],
7	could	MD	O	could	aux	8	SENT_100	[p8l1676t1651r1894b1719],
8	affect	VB	O	affect	rcmod	5	SENT_100	[p8l1938t1651r2151b1719],
9	the	DT	O	the	det	11	SENT_100	[p8l9t1756r129b1825],
10	maintenance	NN	O	maintenance	nn	11	SENT_100	[p8l167t1756r672b1825],
11	dose	NN	O	dose	dobj	8	SENT_100	[p8l711t1756r887b1825],
12	of	IN	O	of	_	0	SENT_100	[p8l929t1756r1015b1825],
13	warfarin	NN	O	warfarin	prep_of	11	SENT_100	[p8l1043t1756r1384b1825],
14	were	VBD	O	be	auxpass	16	SENT_100	[p8l1421t1779r1604b1825],
15	not	RB	O	not	neg	16	SENT_100	[p8l1643t1766r1775b1825],
16	included	VBN	O	include	_	0	SENT_100	[p8l1813t1756r2150b1825],
17	in	IN	O	in	_	0	SENT_100	[p8l8t1864r82b1931],
18	the	DT	O	the	det	20	SENT_100	[p8l118t1864r238b1932],
19	ANCOVA	NN	O	ancova	nn	20	SENT_100	[p8l273t1864r702b1932],
20	analysis	NN	O	analysis	prep_in	16	SENT_100	[p8l738t1864r1049b1949],
21	because	IN	O	because	_	0	SENT_100	[p8l1086t1863r1393b1932],
22	of	IN	O	of	_	0	SENT_100	[p8l1431t1864r1517b1932],
23	the	DT	O	the	det	25	SENT_100	[p8l1544t1864r1663b1932],
24	limited	JJ	O	limited	amod	25	SENT_100	[p8l1700t1863r1974b1932],
25	size	NN	O	size	prep_because_of	16	SENT_100	[p8l2012t1864r2150b1932],
26	of	IN	O	of	_	0	SENT_100	[p8l9t2213r95b2282],
27	the	DT	O	the	det	29	SENT_100	[p8l129t2213r248b2282],
28	patient	NN	O	patient	nn	29	SENT_100	[p8l289t2213r567b2300],
29	population	NN	O	population	prep_of	25	SENT_100	[p8l608t2213r1066b2300],
30	.	.	O	.	_	0	SENT_100	[p8l608t2213r1066b2300],

1	Such	JJ	O	such	amod	2	SENT_101	[p8l1116t2213r1307b2282],
2	factors	NNS	O	factor	nsubj	3	SENT_101	[p8l1349t2213r1618b2282],
3	include	VBP	O	include	_	0	SENT_101	[p8l1661t2213r1946b2282],
4	age	NN	O	age	dobj	3	SENT_101	[p8l1990t2236r2141b2300],
5	,	,	O	,	_	0	SENT_101	[p8l1990t2236r2141b2300],
6	gender	NN	O	gender	dobj	3	SENT_101	[p8l8t2320r295b2407],
7	,	,	O	,	_	0	SENT_101	[p8l8t2320r295b2407],
8	body	NN	O	body	nn	9	SENT_101	[p8l345t2320r544b2406],
9	weight	NN	O	weight	conj_and	4	SENT_101	[p8l589t2320r871b2407],
10	,	,	O	,	_	0	SENT_101	[p8l589t2320r871b2407],
11	and	CC	O	and	_	0	SENT_101	[p8l923t2320r1068b2388],
12	indications	NNS	O	indication	conj_and	4	SENT_101	[p8l1114t2320r1550b2388],
13	of	IN	O	of	_	0	SENT_101	[p8l1599t2320r1686b2388],
14	anticoagulation	NN	O	anticoagulation	nn	15	SENT_101	[p8l1724t2320r2143b2407, p8l7t2426r237b2495],
15	[	NN	O	[	prep_of	12	SENT_101	[p8l289t2428r400b2512],
16	7	CD	NUMBER	7	num	17	SENT_101	[p8l289t2428r400b2512],
17	]	NN	O	]	dep	12	SENT_101	[p8l289t2428r400b2512],
18	.	.	O	.	_	0	SENT_101	[p8l289t2428r400b2512],

1	Second	RB	ORDINAL	second	advmod	5	SENT_102	[p8l458t2426r763b2509],
2	,	,	O	,	_	0	SENT_102	[p8l458t2426r763b2509],
3	we	PRP	O	we	nsubj	5	SENT_102	[p8l815t2449r920b2495],
4	were	VBD	O	be	cop	5	SENT_102	[p8l970t2449r1152b2495],
5	unable	JJ	O	unable	_	0	SENT_102	[p8l1202t2426r1467b2495],
6	to	TO	O	to	aux	7	SENT_102	[p8l1519t2436r1595b2495],
7	evaluate	VB	O	evaluate	xcomp	5	SENT_102	[p8l1647t2426r1974b2495],
8	the	DT	O	the	det	9	SENT_102	[p8l2025t2426r2144b2495],
9	phenotype	NN	O	phenotype	dobj	7	SENT_102	[p8l6t2533r423b2620],
10	of	IN	O	of	_	0	SENT_102	[p8l459t2533r545b2601],
11	C/C	NN	O	c/c	nn	12	SENT_102	[p8l570t2533r730b2620],
12	homozygotes	NNS	O	homozygote	prep_of	9	SENT_102	[p8l763t2533r1287b2620],
13	because	IN	O	because	_	0	SENT_102	[p8l1322t2533r1627b2601],
14	of	IN	O	of	_	0	SENT_102	[p8l1663t2533r1749b2601],
15	the	DT	O	the	det	16	SENT_102	[p8l1773t2533r1893b2601],
16	rarity	NN	O	rarity	prep_because_of	7	SENT_102	[p8l1926t2533r2145b2619],
17	of	IN	O	of	_	0	SENT_102	[p8l9t2638r95b2707],
18	this	DT	O	this	det	19	SENT_102	[p8l114t2638r253b2707],
19	genotype	NN	O	genotype	prep_of	16	SENT_102	[p8l283t2648r641b2725],
20	in	IN	O	in	_	0	SENT_102	[p8l669t2638r743b2706],
21	the	DT	O	the	det	23	SENT_102	[p8l771t2638r890b2707],
22	Japanese	JJ	MISC	japanese	amod	23	SENT_102	[p8l917t2641r1271b2725],
23	population	NN	O	population	prep_in	19	SENT_102	[p8l1299t2638r1757b2725],
24	.	.	O	.	_	0	SENT_102	[p8l1299t2638r1757b2725],

1	Since	IN	O	since	_	0	SENT_103	[p8l1793t2638r1996b2707],
2	the	DT	O	the	det	3	SENT_103	[p8l2025t2638r2144b2707],
3	Hardy	NNP	PERSON	Hardy	pobj	1	SENT_103	[p8l8t2744r698b2831],
4	.	.	O	.	_	0	SENT_103	[p8l8t2744r698b2831],

1	—	NN	O	—	_	0	SENT_104	[p8l8t2744r698b2831],
2	.	.	O	.	_	0	SENT_104	[p8l8t2744r698b2831],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_105	[p8l8t2744r698b2831],
2	formula	NN	O	formulum	nsubj	3	SENT_105	[p8l734t2745r1052b2813],
3	predicts	VBZ	O	predict	ccomp	19	SENT_105	[p8l1087t2744r1398b2831],
4	that	IN	O	that	complm	14	SENT_105	[p8l1436t2745r1594b2813],
5	the	DT	O	the	det	7	SENT_105	[p8l1630t2745r1749b2813],
6	genotype	NN	O	genotype	nn	7	SENT_105	[p8l1786t2754r2144b2831],
7	frequency	NN	O	frequency	nsubj	14	SENT_105	[p8l7t2851r398b2937],
8	of	IN	O	of	_	0	SENT_105	[p8l451t2851r537b2919],
9	C/C	NN	O	c/c	nn	10	SENT_105	[p8l581t2851r741b2938],
10	homozygotes	NNS	O	homozygote	prep_of	7	SENT_105	[p8l793t2851r1317b2937],
11	would	MD	O	would	aux	14	SENT_105	[p8l1368t2850r1614b2919],
12	be	VB	O	be	cop	14	SENT_105	[p8l1666t2850r1754b2919],
13	approximately	RB	O	approximately	quantmod	14	SENT_105	[p8l1808t2851r2143b2937, p8l6t2956r273b3043],
14	1/100	CD	NUMBER	1/100	ccomp	3	SENT_105	[p8l311t2956r539b3043],
15	,	,	O	,	_	0	SENT_105	[p8l311t2956r539b3043],
16	a	DT	O	a	det	18	SENT_105	[p8l575t2978r616b3024],
17	larger	JJR	O	larger	amod	18	SENT_105	[p8l646t2956r876b3043],
18	study	NN	O	study	nsubj	19	SENT_105	[p8l908t2956r1120b3043],
19	needs	VBZ	O	need	_	0	SENT_105	[p8l1149t2956r1366b3024],
20	to	TO	O	to	aux	22	SENT_105	[p8l1398t2966r1474b3024],
21	be	VB	O	be	auxpass	22	SENT_105	[p8l1507t2956r1595b3024],
22	conducted	VBN	O	conduct	xcomp	19	SENT_105	[p8l1625t2956r2035b3024],
23	to	TO	O	to	aux	24	SENT_105	[p8l2066t2966r2143b3024],
24	evaluate	VB	O	evaluate	xcomp	22	SENT_105	[p8l7t3062r334b3131],
25	the	DT	O	the	det	27	SENT_105	[p8l380t3062r499b3131],
26	warfarin	NN	O	warfarin	nn	27	SENT_105	[p8l543t3062r883b3131],
27	requirements	NNS	O	requirement	dobj	24	SENT_105	[p8l928t3062r1446b3149],
28	among	IN	O	among	_	0	SENT_105	[p8l1493t3085r1763b3149],
29	C/C	NN	O	c/c	nn	30	SENT_105	[p8l1809t3063r1969b3149],
30	homozygotes	NNS	O	homozygote	prep_among	24	SENT_105	[p8l2014t3062r2143b3131, p8l6t3178r449b3256],
31	.	.	O	.	_	0	SENT_105	[p8l2014t3062r2143b3131, p8l6t3178r449b3256],

1	Despite	IN	O	despite	_	0	SENT_106	[p8l489t3169r788b3256],
2	these	DT	O	these	det	3	SENT_106	[p8l824t3169r1020b3237],
3	shortcomings	NNS	O	shortcoming	prep_despite	19	SENT_106	[p8l1058t3169r1612b3256],
4	,	,	O	,	_	0	SENT_106	[p8l1058t3169r1612b3256],
5	the	DT	O	the	det	6	SENT_106	[p8l1652t3169r1771b3237],
6	fact	NN	O	fact	nsubj	19	SENT_106	[p8l1806t3169r1954b3237],
7	that	IN	O	that	complm	17	SENT_106	[p8l1988t3169r2145b3237],
8	the	DT	O	the	det	10	SENT_106	[p8l7t3274r126b3343],
9	initial	JJ	O	initial	amod	10	SENT_106	[p8l166t3274r394b3343],
10	observation	NN	O	observation	nsubjpass	17	SENT_106	[p8l436t3274r902b3343],
11	made	VBN	O	make	partmod	10	SENT_106	[p8l940t3274r1154b3343],
12	in	IN	O	in	_	0	SENT_106	[p8l1193t3274r1267b3342],
13	a	DT	O	a	det	15	SENT_106	[p8l1306t3296r1348b3343],
14	Caucasian	JJ	LOCATION	caucasian	amod	15	SENT_106	[p8l1389t3274r1798b3343],
15	population	NN	O	population	prep_in	11	SENT_106	[p8l1837t3274r2143b3361, p8l7t3381r163b3449],
16	was	VBD	O	be	auxpass	17	SENT_106	[p8l212t3403r358b3449],
17	replicated	VBN	O	replicate	dep	6	SENT_106	[p8l410t3381r797b3468],
18	in	IN	O	in	prep	17	SENT_106	[p8l848t3381r921b3448],
19	contribute	VBP	O	contribute	_	0	SENT_106	[p8l970t3381r1380b3449],
20	to	TO	O	to	_	0	SENT_106	[p8l1431t3390r1507b3449],
21	interindividual	JJ	O	interindividual	amod	22	SENT_106	[p8l1559t3381r2145b3449],
22	variability	NN	O	variability	prep_to	19	SENT_106	[p8l6t3486r413b3573],
23	in	IN	O	in	_	0	SENT_106	[p8l448t3486r522b3554],
24	response	NN	O	response	prep_in	22	SENT_106	[p8l557t3508r899b3573],
25	to	TO	O	to	_	0	SENT_106	[p8l936t3496r1012b3555],
26	warfarin	NN	O	warfarin	prep_to	19	SENT_106	[p8l1049t3486r1409b3555],
27	.	.	O	.	_	0	SENT_106	[p8l1049t3486r1409b3555],

1	Currently	RB	DATE	currently	advmod	15	SENT_107	[p8l177t3592r582b3679],
2	,	,	O	,	_	0	SENT_107	[p8l177t3592r582b3679],
3	the	DT	O	the	det	5	SENT_107	[p8l625t3592r744b3661],
4	biological	JJ	O	biological	amod	5	SENT_107	[p8l783t3592r1172b3679],
5	relevance	NN	O	relevance	nsubj	15	SENT_107	[p8l1211t3592r1578b3661],
6	of	IN	O	of	_	0	SENT_107	[p8l1619t3592r1706b3661],
7	the	DT	O	the	det	8	SENT_107	[p8l1735t3592r1854b3661],
8	1173C	NN	O	1173c	prep_of	5	SENT_107	[p8l1902t3593r2144b3661],
9	>	JJR	O	>	amod	11	SENT_107	[p8l26t3711r78b3756],
10	T	NN	O	t	nn	11	SENT_107	[p8l143t3701r202b3766],
11	polymorphism	NN	O	polymorphism	dep	8	SENT_107	[p8l247t3699r830b3785],
12	in	IN	O	in	_	0	SENT_107	[p8l875t3699r949b3766],
13	VKORCI	NNP	ORGANIZATION	VKORCI	prep_in	11	SENT_107	[p8l1008t3701r1377b3767],
14	is	VBZ	O	be	cop	15	SENT_107	[p8l1427t3699r1484b3767],
15	unknown	JJ	O	unknown	_	0	SENT_107	[p8l1531t3698r1906b3767],
16	since	IN	O	since	mark	22	SENT_107	[p8l1955t3699r2144b3767],
17	the	DT	O	the	det	18	SENT_107	[p9l7t16r126b84],
18	1173C	NN	O	1173c	nsubj	22	SENT_107	[p9l165t17r408b85],
19	>	JJR	O	>	amod	21	SENT_107	[p9l457t28r509b74],
20	T	NN	O	t	nn	21	SENT_107	[p9l557t19r616b83],
21	polymorphism	NN	O	polymorphism	dep	18	SENT_107	[p9l644t16r1226b103],
22	resides	VBZ	O	reside	advcl	15	SENT_107	[p9l1255t16r1519b84],
23	within	IN	O	within	_	0	SENT_107	[p9l1547t16r1799b84],
24	intron	NN	O	intron	prep_within	22	SENT_107	[p9l1828t16r2073b84],
25	1	CD	NUMBER	1	num	24	SENT_107	[p9l2111t18r2136b83],
26	and	CC	O	and	_	0	SENT_107	[p9l8t123r154b191],
27	does	VBZ	O	do	aux	29	SENT_107	[p9l194t123r369b191],
28	not	RB	O	not	neg	29	SENT_107	[p9l409t132r541b191],
29	affect	VB	O	affect	advcl	15	SENT_107	[p9l581t123r793b191],
30	mRNA	NN	O	mrna	nn	31	SENT_107	[p9l829t123r1128b191],
31	processing	NN	O	processing	dobj	29	SENT_107	[p9l1165t123r1581b210],
32	[	CD	NUMBER	[	number	33	SENT_107	[p9l1623t124r1733b209],
33	3	CD	NUMBER	3	num	34	SENT_107	[p9l1623t124r1733b209],
34	]	NN	O	]	dobj	22	SENT_107	[p9l1623t124r1733b209],
35	.	.	O	.	_	0	SENT_107	[p9l1623t124r1733b209],

1	Since	IN	O	since	mark	5	SENT_108	[p9l1781t123r1985b192],
2	the	DT	O	the	det	4	SENT_108	[p9l2025t123r2144b191],
3	VKORCI	NN	O	vkorcus	nn	4	SENT_108	[p9l19t231r389b297],
4	locus	NN	O	locus	nsubj	5	SENT_108	[p9l421t228r622b297],
5	spans	VBZ	O	span	advcl	39	SENT_108	[p9l653t251r869b315],
6	only	RB	O	only	quantmod	7	SENT_108	[p9l900t228r1071b315],
7	5	CD	NUMBER	5	num	8	SENT_108	[p9l1102t231r1138b297],
8	kbp	NN	O	kbp	dobj	5	SENT_108	[p9l1168t228r1319b315],
9	and	CC	O	and	_	0	SENT_108	[p9l1349t228r1494b297],
10	the	DT	O	the	det	11	SENT_108	[p9l1522t228r1642b297],
11	373OG	NN	O	373og	dobj	5	SENT_108	[p9l1673t230r1932b297],
12	>	JJR	O	>	amod	11	SENT_108	[p9l1978t241r2030b286],
13	A	DT	O	a	det	14	SENT_108	[p9l2076t228r2145b296],
14	polymorphism	NN	O	polymorphism	nsubj	21	SENT_108	[p9l6t335r589b422],
15	in	IN	O	in	_	0	SENT_108	[p9l635t335r709b402],
16	the	DT	O	the	det	20	SENT_108	[p9l755t335r874b403],
17	3	CD	NUMBER	3	num	18	SENT_108	[p9l925t333r989b403],
18	’	NN	O	’	npadvmod	19	SENT_108	[p9l925t333r989b403],
19	untranslated	JJ	O	untranslated	amod	20	SENT_108	[p9l1034t335r1535b403],
20	region	NN	O	region	prep_in	14	SENT_108	[p9l1582t335r1832b422],
21	was	VBD	O	be	ccomp	12	SENT_108	[p9l1877t357r2024b403],
22	in	IN	O	in	_	0	SENT_108	[p9l2071t335r2145b402],
23	complete	JJ	O	complete	amod	24	SENT_108	[p9l7t440r364b527],
24	linkage	NN	O	linkage	prep_in	21	SENT_108	[p9l393t440r678b527],
25	with	IN	O	with	_	0	SENT_108	[p9l705t440r879b509],
26	the	DT	O	the	det	27	SENT_108	[p9l907t440r1026b509],
27	1173C	NN	O	1173c	prep_with	12	SENT_108	[p9l1064t441r1306b509],
28	>	JJR	O	>	amod	30	SENT_108	[p9l1354t452r1405b498],
29	T	NN	O	t	nn	30	SENT_108	[p9l1452t443r1510b508],
30	polymorphism	NN	O	polymorphism	dep	27	SENT_108	[p9l1537t440r2142b527],
31	,	,	O	,	_	0	SENT_108	[p9l1537t440r2142b527],
32	the	DT	O	the	det	34	SENT_108	[p9l7t547r126b615],
33	causative	JJ	O	causative	amod	34	SENT_108	[p9l154t547r518b615],
34	change	NN	O	change	nsubj	39	SENT_108	[p9l545t546r820b633],
35	deﬁning	VBG	O	deﬁning	partmod	34	SENT_108	[p9l848t546r1165b633],
36	warfarin	NN	O	warfarin	nn	37	SENT_108	[p9l1190t547r1529b615],
37	sensitivity	NN	O	sensitivity	dobj	35	SENT_108	[p9l1559t547r1952b633],
38	may	MD	O	may	aux	39	SENT_108	[p9l1976t569r2145b633],
39	occur	VB	O	occur	_	0	SENT_108	[p9l9t674r226b720],
40	close	RB	O	close	_	0	SENT_108	[p9l257t652r448b720],
41	to	TO	O	to	_	0	SENT_108	[p9l481t662r558b720],
42	the	DT	O	the	det	44	SENT_108	[p9l593t652r712b720],
43	VKORCI	NN	O	vkorcus	nn	44	SENT_108	[p9l756t654r1125b721],
44	locus	NN	O	locus	prep_close_to	39	SENT_108	[p9l1162t652r1386b735],
45	,	,	O	,	_	0	SENT_108	[p9l1162t652r1386b735],
46	possibly	RB	O	possibly	advmod	39	SENT_108	[p9l1422t652r1745b739],
47	including	VBG	O	include	_	0	SENT_108	[p9l1776t652r2145b739],
48	the	DT	O	the	det	50	SENT_108	[p9l7t758r126b827],
49	promoter	NN	O	promoter	nn	50	SENT_108	[p9l164t768r540b845],
50	region	NN	O	region	prep_including	39	SENT_108	[p9l578t758r847b845],
51	.	.	O	.	_	0	SENT_108	[p9l578t758r847b845],

1	An	DT	O	a	nsubj	14	SENT_109	[p9l890t758r1011b826],
2	in	FW	O	in	nn	3	SENT_109	[p9l1053t764r1117b827],
3	vitro	FW	O	vitro	advmod	4	SENT_109	[p9l1159t764r1332b827],
4	study	NN	O	study	dep	1	SENT_109	[p9l1373t758r1585b845],
5	conducted	VBN	O	conduct	partmod	1	SENT_109	[p9l1623t758r2034b827],
6	in	IN	O	in	_	0	SENT_109	[p9l2071t759r2145b826],
7	parallel	NN	O	parallel	prep_in	5	SENT_109	[p9l6t864r303b951],
8	with	IN	O	with	_	0	SENT_109	[p9l330t864r503b933],
9	a	DT	O	a	det	12	SENT_109	[p9l533t886r574b932],
10	deliberate	JJ	O	deliberate	amod	11	SENT_109	[p9l602t864r990b932],
11	epidemiological	JJ	O	epidemiological	amod	12	SENT_109	[p9l1019t864r1646b951],
12	study	NN	O	study	prep_with	5	SENT_109	[p9l1676t864r1888b951],
13	might	MD	O	might	aux	14	SENT_109	[p9l1915t864r2145b951],
14	unravel	VB	O	unravel	_	0	SENT_109	[p9l6t970r304b1039],
15	the	DT	O	the	det	16	SENT_109	[p9l335t970r454b1039],
16	relevance	NN	O	relevance	dobj	14	SENT_109	[p9l487t971r854b1039],
17	of	IN	O	of	_	0	SENT_109	[p9l887t970r974b1039],
18	the	DT	O	the	det	20	SENT_109	[p9l996t970r1115b1039],
19	VKORCI	NNP	O	VKORCI	nn	20	SENT_109	[p9l1159t973r1528b1039],
20	polymorphism	NN	O	polymorphism	prep_of	16	SENT_109	[p9l1563t970r2145b1057],
21	in	IN	O	in	_	0	SENT_109	[p9l6t1077r80b1144],
22	deﬁning	VBG	O	deﬁning	prepc_in	14	SENT_109	[p9l120t1077r436b1164],
23	warfarin	NN	O	warfarin	nn	24	SENT_109	[p9l474t1077r813b1145],
24	sensitivity	NN	O	sensitivity	dobj	22	SENT_109	[p9l855t1077r1248b1163],
25	and	CC	O	and	_	0	SENT_109	[p9l1288t1077r1433b1145],
26	might	MD	O	might	aux	28	SENT_109	[p9l1470t1077r1701b1164],
27	eventually	RB	O	eventually	advmod	28	SENT_109	[p9l1739t1077r2145b1163],
28	lead	VB	O	lead	conj_and	14	SENT_109	[p9l7t1182r168b1251],
29	to	TO	O	to	_	0	SENT_109	[p9l206t1192r283b1251],
30	personalized	JJ	O	personalized	amod	32	SENT_109	[p9l321t1182r820b1269],
31	warfarin	NN	O	warfarin	nn	32	SENT_109	[p9l856t1182r1196b1251],
32	prescriptions	NNS	O	prescription	prep_to	28	SENT_109	[p9l1233t1182r1746b1269],
33	based	VBN	O	base	_	0	SENT_109	[p9l1784t1182r2008b1251],
34	on	IN	O	on	prepc_based_on	28	SENT_109	[p9l2047t1204r2145b1251],
35	an	DT	O	a	det	36	SENT_109	[p9l8t1310r102b1357],
36	individual	JJ	O	individual	poss	39	SENT_109	[p9l137t1288r598b1357],
37	’s	POS	O	’s	_	0	SENT_109	[p9l137t1288r598b1357],
38	VKQRC1	NN	O	vkqrc1	nn	39	SENT_109	[p9l646t1291r1016b1375],
39	genotype	NN	O	genotype	pobj	28	SENT_109	[p9l1057t1298r1436b1375],
40	.	.	O	.	_	0	SENT_109	[p9l1057t1298r1436b1375],

1	Genotyping	NN	O	genotyping	nsubj	12	SENT_110	[p9l177t1394r649b1481],
2	of	IN	O	of	_	0	SENT_110	[p9l685t1394r771b1462],
3	the	DT	O	the	det	4	SENT_110	[p9l797t1394r917b1462],
4	1173C	NN	O	1173c	prep_of	1	SENT_110	[p9l961t1395r1203b1463],
5	>	JJR	O	>	amod	7	SENT_110	[p9l1258t1406r1309b1452],
6	T	NN	O	t	nn	7	SENT_110	[p9l1363t1397r1421b1461],
7	poylmorphism	NN	O	poylmorphism	dep	4	SENT_110	[p9l1455t1394r2038b1481],
8	in	IN	O	in	_	0	SENT_110	[p9l2071t1394r2145b1461],
9	VKORCI	NNP	O	VKORCI	prep_in	7	SENT_110	[p9l19t1503r389b1569],
10	may	MD	O	may	aux	12	SENT_110	[p9l453t1523r622b1587],
11	potentially	RB	O	potentially	advmod	12	SENT_110	[p9l682t1501r1110b1587],
12	have	VB	O	have	_	0	SENT_110	[p9l1171t1501r1353b1569],
13	a	DT	O	a	det	15	SENT_110	[p9l1417t1523r1458b1569],
14	clinical	JJ	O	clinical	amod	15	SENT_110	[p9l1519t1501r1798b1569],
15	role	NN	O	role	dobj	12	SENT_110	[p9l1860t1501r2010b1569],
16	in	IN	O	in	_	0	SENT_110	[p9l2071t1501r2145b1568],
17	predicting	VBG	O	predict	prepc_in	12	SENT_110	[p9l6t1606r407b1693],
18	the	DT	O	the	det	20	SENT_110	[p9l466t1606r586b1674],
19	required	VBN	O	require	amod	20	SENT_110	[p9l645t1606r977b1693],
20	dose	NN	O	dose	dobj	17	SENT_110	[p9l1037t1606r1213b1674],
21	of	IN	O	of	_	0	SENT_110	[p9l1275t1606r1362b1674],
22	warfarin	NN	O	warfarin	prep_of	20	SENT_110	[p9l1409t1606r1750b1674],
23	prior	RB	O	prior	_	0	SENT_110	[p9l1808t1606r2007b1693],
24	to	TO	O	to	_	0	SENT_110	[p9l2066t1616r2143b1674],
25	initiation	NN	O	initiation	prep_prior_to	12	SENT_110	[p9l6t1712r370b1781],
26	of	IN	O	of	_	0	SENT_110	[p9l404t1712r491b1781],
27	the	DT	O	the	det	29	SENT_110	[p9l514t1712r633b1781],
28	anticoagulant	JJ	O	anticoagulant	amod	29	SENT_110	[p9l668t1712r1214b1799],
29	therapy	NN	O	therapy	prep_of	25	SENT_110	[p9l1245t1712r1568b1799],
30	.	.	O	.	_	0	SENT_110	[p9l1245t1712r1568b1799],

1	Furthermore	RB	O	furthermore	advmod	7	SENT_111	[p9l1607t1712r2141b1795],
2	,	,	O	,	_	0	SENT_111	[p9l1607t1712r2141b1795],
3	such	JJ	O	such	amod	4	SENT_111	[p9l9t1819r184b1887],
4	genotyping	NN	O	genotyping	nsubj	7	SENT_111	[p9l239t1819r682b1906],
5	would	MD	O	would	aux	7	SENT_111	[p9l735t1819r980b1887],
6	be	VB	O	be	cop	7	SENT_111	[p9l1035t1819r1123b1887],
7	feasable	JJ	O	feasable	_	0	SENT_111	[p9l1178t1819r1494b1887],
8	to	TO	O	to	aux	9	SENT_111	[p9l1550t1828r1626b1887],
9	incorporate	VB	O	incorporate	xcomp	7	SENT_111	[p9l1682t1819r2144b1906],
10	into	IN	O	into	_	0	SENT_111	[p9l6t1924r161b1993],
11	clinical	JJ	O	clinical	amod	12	SENT_111	[p9l192t1924r471b1993],
12	practice	NN	O	practice	prep_into	9	SENT_111	[p9l499t1924r811b2011],
13	with	IN	O	with	_	0	SENT_111	[p9l839t1924r1013b1993],
14	costs	NNS	O	cost	prep_with	9	SENT_111	[p9l1041t1934r1233b1993],
15	estimated	VBN	O	estimate	partmod	14	SENT_111	[p9l1263t1924r1642b1993],
16	to	TO	O	to	aux	21	SENT_111	[p9l1671t1934r1748b1993],
17	be	VB	O	be	cop	21	SENT_111	[p9l1779t1924r1867b1993],
18	as	RB	O	as	quantmod	21	SENT_111	[p9l1898t1946r1974b1993],
19	low	JJ	O	low	quantmod	21	SENT_111	[p9l2004t1924r2146b1993],
20	as	IN	O	as	quantmod	21	SENT_111	[p9l8t2053r85b2099],
21	$	$	MONEY	$	xcomp	15	SENT_111	[p9l140t2031r224b2105],
22	5	CD	MONEY	5	number	21	SENT_111	[p9l140t2031r224b2105],
23	per	IN	O	per	_	0	SENT_111	[p9l277t2053r404b2117],
24	test	NN	O	test	prep_per	21	SENT_111	[p9l454t2040r612b2113],
25	,	,	O	,	_	0	SENT_111	[p9l454t2040r612b2113],
26	and	CC	O	and	_	0	SENT_111	[p9l668t2030r813b2099],
27	test	NN	O	test	nn	28	SENT_111	[p9l864t2040r1000b2099],
28	results	NNS	O	result	nsubj	31	SENT_111	[p9l1051t2031r1304b2099],
29	would	MD	O	would	aux	31	SENT_111	[p9l1355t2030r1601b2099],
30	be	VB	O	be	cop	31	SENT_111	[p9l1652t2030r1740b2099],
31	available	JJ	O	available	conj_and	7	SENT_111	[p9l1793t2030r2144b2099],
32	within	IN	O	within	_	0	SENT_111	[p9l6t2136r257b2205],
33	a	DT	DURATION	a	det	35	SENT_111	[p9l293t2158r335b2205],
34	few	JJ	DURATION	few	amod	35	SENT_111	[p9l369t2136r506b2205],
35	hours	NNS	DURATION	hour	prep_within	31	SENT_111	[p9l540t2136r785b2205],
36	.	.	O	.	_	0	SENT_111	[p9l540t2136r785b2205],

1	However	RB	O	however	advmod	31	SENT_112	[p9l826t2139r1205b2219],
2	,	,	O	,	_	0	SENT_112	[p9l826t2139r1205b2219],
3	the	DT	O	the	det	5	SENT_112	[p9l1244t2136r1363b2205],
4	predictive	JJ	O	predictive	amod	5	SENT_112	[p9l1398t2136r1787b2223],
5	value	NN	O	value	nsubjpass	31	SENT_112	[p9l1822t2136r2030b2205],
6	of	IN	O	of	_	0	SENT_112	[p9l2068t2136r2154b2205],
7	VKORCI	NNP	ORGANIZATION	VKORCI	prep_of	5	SENT_112	[p9l19t2245r389b2311],
8	genotyping	VBG	O	genotype	partmod	7	SENT_112	[p9l434t2243r876b2329],
9	needs	NNS	O	need	dobj	8	SENT_112	[p9l916t2242r1133b2311],
10	to	TO	O	to	aux	12	SENT_112	[p9l1175t2252r1251b2311],
11	be	VB	O	be	auxpass	12	SENT_112	[p9l1294t2243r1381b2311],
12	validated	VBN	O	validate	xcomp	8	SENT_112	[p9l1421t2242r1786b2311],
13	through	IN	O	through	_	0	SENT_112	[p9l1827t2243r2145b2329],
14	prospective	JJ	O	prospective	amod	15	SENT_112	[p9l6t2348r458b2435],
15	studies	NNS	O	study	prep_through	12	SENT_112	[p9l494t2348r761b2417],
16	of	IN	O	of	_	0	SENT_112	[p9l797t2348r884b2417],
17	a	DT	O	a	det	19	SENT_112	[p9l909t2371r951b2417],
18	larger	JJR	O	larger	amod	19	SENT_112	[p9l985t2349r1214b2435],
19	group	NN	O	group	prep_of	15	SENT_112	[p9l1247t2371r1481b2435],
20	of	IN	O	of	_	0	SENT_112	[p9l1517t2348r1603b2417],
21	patients	NNS	O	patient	prep_of	19	SENT_112	[p9l1625t2348r1938b2435],
22	with	IN	O	with	_	0	SENT_112	[p9l1972t2348r2145b2417],
23	diverse	JJ	O	diverse	amod	25	SENT_112	[p9l7t2455r282b2523],
24	ethnic	JJ	O	ethnic	amod	25	SENT_112	[p9l333t2455r572b2523],
25	backgrounds	NNS	O	background	prep_with	21	SENT_112	[p9l623t2455r1137b2542],
26	before	IN	O	before	_	0	SENT_112	[p9l1189t2455r1438b2523],
27	VKORCI	NN	O	vkorcus	nn	28	SENT_112	[p9l1501t2457r1871b2524],
28	genotyping	NN	O	genotyping	prep_before	12	SENT_112	[p9l1926t2477r2143b2542, p9l7t2560r257b2647],
29	can	MD	O	can	aux	31	SENT_112	[p9l293t2583r429b2629],
30	be	VB	O	be	auxpass	31	SENT_112	[p9l465t2560r554b2629],
31	considered	VBN	O	consider	_	0	SENT_112	[p9l589t2560r1015b2629],
32	as	IN	O	as	_	0	SENT_112	[p9l1052t2583r1128b2629],
33	a	DT	O	a	det	35	SENT_112	[p9l1167t2583r1208b2629],
34	clinical	JJ	O	clinical	amod	35	SENT_112	[p9l1243t2560r1523b2629],
35	test	NN	O	test	prep_as	31	SENT_112	[p9l1559t2570r1714b2629],
36	.	.	O	.	_	0	SENT_112	[p9l1559t2570r1714b2629],

1	Conclusion	NN	O	conclusion	_	0	SENT_113	[p9l9t2817r435b2884],

1	Genotyping	NN	O	genotyping	nsubj	21	SENT_114	[p9l9t3031r480b3118],
2	of	IN	O	of	_	0	SENT_114	[p9l517t3031r603b3100],
3	the	DT	O	the	det	7	SENT_114	[p9l629t3031r749b3100],
4	C	NN	O	c	amod	7	SENT_114	[p9l785t3033r846b3100],
5	>	JJR	O	>	dep	4	SENT_114	[p9l900t3044r952b3089],
6	T	NN	O	t	nn	7	SENT_114	[p9l1006t3034r1064b3099],
7	polymorphism	NN	O	polymorphism	prep_of	1	SENT_114	[p9l1098t3031r1680b3118],
8	at	IN	O	at	_	0	SENT_114	[p9l1716t3041r1789b3100],
9	position	NN	O	position	prep_at	7	SENT_114	[p9l1821t3031r2145b3118],
10	1173	CD	DATE	1173	num	9	SENT_114	[p9l16t3140r186b3207],
11	in	IN	O	in	_	0	SENT_114	[p9l230t3138r304b3206],
12	intron	NN	O	intron	prep_in	9	SENT_114	[p9l343t3138r588b3206],
13	1	CD	NUMBER	1	num	12	SENT_114	[p9l636t3140r661b3205],
14	of	IN	O	of	_	0	SENT_114	[p9l711t3138r798b3206],
15	VKORCI	NN	O	vkorcus	prep_of	12	SENT_114	[p9l840t3140r1210b3207],
16	among	IN	O	among	_	0	SENT_114	[p9l1255t3160r1525b3225],
17	31	CD	NUMBER	31	num	18	SENT_114	[p9l1568t3140r1645b3206],
18	patients	NNS	O	patient	prep_among	15	SENT_114	[p9l1692t3138r2005b3225],
19	on	IN	O	on	_	0	SENT_114	[p9l2047t3160r2145b3206],
20	warfarin	NN	O	warfarin	prep_on	18	SENT_114	[p9l6t3245r346b3314],
21	revealed	VBD	O	reveal	_	0	SENT_114	[p9l396t3245r723b3314],
22	that	IN	O	that	complm	30	SENT_114	[p9l772t3245r930b3314],
23	26	CD	NUMBER	26	num	24	SENT_114	[p9l979t3247r1068b3314],
24	patients	NNS	O	patient	nsubj	30	SENT_114	[p9l1117t3245r1430b3332],
25	(	IN	O	(	_	0	SENT_114	[p9l1483t3246r1709b3332],
26	84	CD	PERCENT	84	num	27	SENT_114	[p9l1483t3246r1709b3332],
27	%	NN	PERCENT	%	prep_(	24	SENT_114	[p9l1483t3246r1709b3332],
28	)	CD	NUMBER	)	dep	27	SENT_114	[p9l1483t3246r1709b3332],
29	were	VBD	O	be	cop	30	SENT_114	[p9l1760t3268r1942b3314],
30	T/T	NN	O	t/t	ccomp	21	SENT_114	[p9l1992t3246r2145b3332],

1	homozygotes	NNS	O	homozygote	_	0	SENT_115	[p10l7t17r531b104],
2	at	IN	O	at	_	0	SENT_115	[p10l589t26r662b85],
3	nucleotide	NN	O	nucleotide	prep_at	1	SENT_115	[p10l716t17r1124b85],
4	1173	CD	DATE	1173	num	3	SENT_115	[p10l1189t18r1386b99],
5	,	,	O	,	_	0	SENT_115	[p10l1189t18r1386b99],
6	whereas	IN	O	whereas	mark	14	SENT_115	[p10l1443t17r1760b85],
7	5	CD	PERCENT	5	number	8	SENT_115	[p10l1820t20r1856b85],
8	(	CD	PERCENT	(	nsubj	14	SENT_115	[p10l1916t17r2143b104],
9	16	CD	PERCENT	16	num	10	SENT_115	[p10l1916t17r2143b104],
10	%	NN	PERCENT	%	dep	8	SENT_115	[p10l1916t17r2143b104],
11	)	CD	NUMBER	)	dep	8	SENT_115	[p10l1916t17r2143b104],
12	were	VBD	O	be	cop	14	SENT_115	[p10l6t146r189b192],
13	C/T	NN	O	c/t	nn	14	SENT_115	[p10l228t123r383b210],
14	heterozygotes	NNS	O	heterozygote	dep	3	SENT_115	[p10l420t123r986b210],
15	.	.	O	.	_	0	SENT_115	[p10l420t123r986b210],

1	The	DT	O	the	det	3	SENT_116	[p10l1028t123r1179b192],
2	C/T	NN	O	c/t	nn	3	SENT_116	[p10l1218t123r1374b210],
3	heterozyogtes	NNS	O	heterozyogte	nsubj	4	SENT_116	[p10l1410t123r1955b210],
4	tended	VBD	O	tend	_	0	SENT_116	[p10l1994t133r2143b192, p10l7t230r148b299],
5	to	TO	O	to	aux	6	SENT_116	[p10l190t240r267b299],
6	required	VBN	O	require	xcomp	4	SENT_116	[p10l310t230r642b317],
7	more	JJR	O	more	amod	8	SENT_116	[p10l683t253r886b299],
8	warfarin	NN	O	warfarin	dobj	6	SENT_116	[p10l927t230r1267b299],
9	than	IN	O	than	_	0	SENT_116	[p10l1309t230r1487b299],
10	the	DT	O	the	det	12	SENT_116	[p10l1529t230r1648b299],
11	T/T	NN	O	t/t	nn	12	SENT_116	[p10l1691t230r1843b317],
12	homozygotes	NNS	O	homozygote	prep_than	6	SENT_116	[p10l1884t230r2143b299, p10l6t347r298b424],
13	when	WRB	O	when	advmod	14	SENT_116	[p10l327t337r537b406],
14	adjusted	VBN	O	adjust	advcl	4	SENT_116	[p10l568t337r900b424],
15	for	IN	O	for	_	0	SENT_116	[p10l929t338r1045b406],
16	INR	NN	O	inr	nn	18	SENT_116	[p10l1075t340r1257b406],
17	(	CD	NUMBER	(	num	18	SENT_116	[p10l1288t338r1360b425],
18	p	NN	O	p	prep_for	14	SENT_116	[p10l1288t338r1360b425],
19	=	JJ	O	=	amod	21	SENT_116	[p10l1412t363r1468b382],
20	0.003	CD	NUMBER	0.003	tmod	19	SENT_116	[p10l1522t338r1783b424],
21	)	NN	O	)	dobj	14	SENT_116	[p10l1522t338r1783b424],
22	.	.	O	.	_	0	SENT_116	[p10l1522t338r1783b424],

1	The	DT	O	the	det	2	SENT_117	[p10l1817t338r1968b406],
2	fact	NN	O	fact	nsubj	20	SENT_117	[p10l1999t338r2146b406],
3	that	IN	O	that	complm	13	SENT_117	[p10l7t445r165b513],
4	the	DT	O	the	det	6	SENT_117	[p10l225t445r345b513],
5	initial	JJ	O	initial	amod	6	SENT_117	[p10l405t445r633b513],
6	observation	NN	O	observation	nsubjpass	13	SENT_117	[p10l696t445r1162b513],
7	made	VBN	O	make	partmod	6	SENT_117	[p10l1221t445r1436b513],
8	in	IN	O	in	_	0	SENT_117	[p10l1496t445r1570b513],
9	a	DT	O	a	det	11	SENT_117	[p10l1632t467r1673b513],
10	Caucasian	JJ	LOCATION	caucasian	amod	11	SENT_117	[p10l1735t445r2145b514],
11	population	NN	O	population	prep_in	7	SENT_117	[p10l6t552r444b639],
12	was	VBD	O	be	auxpass	13	SENT_117	[p10l498t575r645b621],
13	replicated	VBN	O	replicate	dep	2	SENT_117	[p10l702t552r1089b639],
14	in	IN	O	in	_	0	SENT_117	[p10l1145t552r1218b620],
15	an	DT	O	a	det	17	SENT_117	[p10l1275t575r1368b621],
16	Asian	JJ	LOCATION	asian	amod	17	SENT_117	[p10l1423t552r1653b621],
17	population	NN	O	population	prep_in	13	SENT_117	[p10l1707t552r2145b639],
18	does	VBZ	O	do	aux	20	SENT_117	[p10l7t660r183b728],
19	not	RB	O	not	neg	20	SENT_117	[p10l218t669r350b728],
20	prove	VB	O	prove	_	0	SENT_117	[p10l382t682r606b747],
21	but	CC	O	but	_	0	SENT_117	[p10l641t660r772b728],
22	strongly	RB	O	strongly	advmod	23	SENT_117	[p10l807t660r1129b747],
23	supports	VBZ	O	support	conj_but	20	SENT_117	[p10l1164t669r1505b747],
24	the	DT	O	the	det	25	SENT_117	[p10l1539t660r1659b728],
25	notion	NN	O	notion	dobj	23	SENT_117	[p10l1693t660r1954b728],
26	that	IN	O	that	complm	30	SENT_117	[p10l1988t660r2145b728],
27	polymorphisms	NNS	O	polymorphism	nsubj	30	SENT_117	[p10l6t766r623b853],
28	in	IN	O	in	_	0	SENT_117	[p10l665t766r738b834],
29	VKORC1	NN	O	vkorc1	prep_in	27	SENT_117	[p10l791t769r1161b835],
30	contribute	VBP	O	contribute	dep	25	SENT_117	[p10l1205t766r1615b835],
31	to	TO	O	to	_	0	SENT_117	[p10l1657t776r1734b835],
32	interindiVidual	JJ	O	interindividual	amod	33	SENT_117	[p10l1776t766r2143b835, p10l6t874r252b942],
33	Variability	NN	O	variability	prep_to	30	SENT_117	[p10l287t874r693b960],
34	in	IN	O	in	_	0	SENT_117	[p10l728t874r802b941],
35	response	NN	O	response	prep_in	33	SENT_117	[p10l838t896r1180b961],
36	to	TO	O	to	_	0	SENT_117	[p10l1216t883r1293b942],
37	warfarin	NN	O	warfarin	prep_to	30	SENT_117	[p10l1330t874r1690b942],
38	.	.	O	.	_	0	SENT_117	[p10l1330t874r1690b942],

1	688	CD	NUMBER	688	_	0	SENT_118	[p10l9t1000r114b1053],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_119	[p10l6t1223r581b1292],
2	.	.	O	.	_	0	SENT_119	[p10l6t1223r581b1292],

1	We	PRP	O	we	nsubj	4	SENT_120	[p10l627t1225r732b1278],
2	are	VBP	O	be	cop	4	SENT_120	[p10l777t1241r871b1278],
3	greatly	RB	O	greatly	advmod	4	SENT_120	[p10l915t1223r1132b1293],
4	indebted	JJ	O	indebted	_	0	SENT_120	[p10l1174t1223r1448b1278],
5	to	TO	O	to	_	0	SENT_120	[p10l1492t1231r1553b1278],
6	the	DT	O	the	det	7	SENT_120	[p10l1598t1223r1693b1278],
7	patients	NNS	O	patient	prep_to	4	SENT_120	[p10l1736t1223r1985b1293],
8	and	CC	O	and	_	0	SENT_120	[p10l2030t1223r2146b1278],
9	families	NNS	O	family	prep_to	4	SENT_120	[p10l7t1316r250b1371],
10	for	IN	O	for	_	0	SENT_120	[p10l278t1316r371b1371],
11	generously	RB	O	generously	advmod	12	SENT_120	[p10l397t1316r738b1386],
12	donating	VBG	O	donate	prepc_for	7	SENT_120	[p10l765t1316r1048b1386],
13	samples	NNS	O	sample	dobj	12	SENT_120	[p10l1076t1317r1322b1386],
14	and	CC	O	and	_	0	SENT_120	[p10l1351t1316r1468b1371],
15	clinical	JJ	O	clinical	amod	16	SENT_120	[p10l1494t1317r1718b1371],
16	information	NN	O	information	conj_and	13	SENT_120	[p10l1744t1316r2142b1371],
17	.	.	O	.	_	0	SENT_120	[p10l1744t1316r2142b1371],

1	We	PRP	O	we	nsubj	2	SENT_121	[p10l6t1411r110b1464],
2	thank	VBP	O	thank	_	0	SENT_121	[p10l143t1409r326b1464],
3	Dr.	NNP	O	Dr.	nn	5	SENT_121	[p10l358t1411r461b1463],
4	Atsutoshi	NNP	PERSON	Atsutoshi	nn	5	SENT_121	[p10l496t1409r804b1464],
5	Tsuji	NNP	PERSON	Tsuji	dobj	2	SENT_121	[p10l835t1409r993b1479],
6	for	IN	O	for	_	0	SENT_121	[p10l1024t1409r1117b1464],
7	helpuful	JJ	O	helpuful	amod	8	SENT_121	[p10l1148t1409r1409b1479],
8	discussion	NN	O	discussion	prep_for	5	SENT_121	[p10l1441t1409r1778b1464],
9	.	.	O	.	_	0	SENT_121	[p10l1441t1409r1778b1464],

1	This	DT	O	this	det	2	SENT_122	[p10l1814t1409r1951b1464],
2	work	NN	O	work	nsubjpass	4	SENT_122	[p10l1983t1409r2146b1464],
3	was	VBD	O	be	auxpass	4	SENT_122	[p10l6t1520r123b1557],
4	supported	VBN	O	support	_	0	SENT_122	[p10l150t1502r467b1572],
5	by	IN	O	by	_	0	SENT_122	[p10l491t1502r568b1572],
6	grants	NNS	O	grant	agent	4	SENT_122	[p10l591t1510r786b1572],
7	from	IN	O	from	_	0	SENT_122	[p10l811t1502r981b1557],
8	:	:	O	:	_	0	SENT_122	[p10l811t1502r981b1557],
9	the	DT	O	the	det	10	SENT_122	[p10l1009t1502r1104b1557],
10	Ministry	NNP	ORGANIZATION	Ministry	prep_from	6	SENT_122	[p10l1130t1502r1403b1572],
11	of	IN	ORGANIZATION	of	_	0	SENT_122	[p10l1427t1502r1497b1557],
12	Education	NNP	ORGANIZATION	Education	prep_of	10	SENT_122	[p10l1514t1502r1859b1568],
13	,	,	O	,	_	0	SENT_122	[p10l1514t1502r1859b1568],
14	Culture	NNP	O	Culture	conj_and	12	SENT_122	[p10l1887t1502r2143b1568],
15	,	,	O	,	_	0	SENT_122	[p10l1887t1502r2143b1568],
16	Sports	NNP	O	Sports	conj_and	12	SENT_122	[p10l9t1596r229b1665],
17	,	,	O	,	_	0	SENT_122	[p10l9t1596r229b1665],
18	Science	NNP	ORGANIZATION	Science	conj_and	12	SENT_122	[p10l255t1595r484b1650],
19	&	CC	ORGANIZATION	&	_	0	SENT_122	[p10l507t1596r561b1650],
20	Technology	NNP	ORGANIZATION	Technology	conj_and	12	SENT_122	[p10l583t1595r957b1665],
21	of	IN	ORGANIZATION	of	_	0	SENT_122	[p10l979t1595r1049b1650],
22	Japan	NNP	ORGANIZATION	Japan	prep_of	10	SENT_122	[p10l1063t1597r1251b1665],
23	and	CC	O	and	_	0	SENT_122	[p10l1273t1595r1390b1650],
24	the	DT	O	the	det	25	SENT_122	[p10l1412t1595r1507b1650],
25	Ministry	NNP	ORGANIZATION	Ministry	conj_and	10	SENT_122	[p10l1530t1595r1803b1665],
26	of	IN	ORGANIZATION	of	_	0	SENT_122	[p10l1826t1595r1895b1650],
27	Health	NNP	ORGANIZATION	Health	prep_of	25	SENT_122	[p10l1911t1595r2144b1661],
28	,	,	ORGANIZATION	,	_	0	SENT_122	[p10l1911t1595r2144b1661],
29	Labour	NNP	ORGANIZATION	Labour	prep_of	25	SENT_122	[p10l8t1688r262b1755],
30	,	,	O	,	_	0	SENT_122	[p10l8t1688r262b1755],
31	and	CC	O	and	_	0	SENT_122	[p10l294t1688r410b1743],
32	Welfare	NNP	O	Welfare	prep_of	25	SENT_122	[p10l437t1688r686b1744],
33	of	IN	O	of	_	0	SENT_122	[p10l716t1688r785b1743],
34	Japan	NNP	LOCATION	Japan	prep_of	25	SENT_122	[p10l805t1690r1010b1758],
35	.	.	O	.	_	0	SENT_122	[p10l805t1690r1010b1758],

1	References	NNS	O	reference	_	0	SENT_123	[p10l7t1928r428b1996],

1	1	LS	NUMBER	1	_	0	SENT_124	[p10l51t2137r95b2190],
2	.	.	O	.	_	0	SENT_124	[p10l51t2137r95b2190],

1	Aithal	NNP	O	Aithal	nn	2	SENT_125	[p10l138t2136r339b2190],
2	GP	NNP	O	GP	_	0	SENT_125	[p10l363t2137r484b2202],
3	,	,	O	,	_	0	SENT_125	[p10l363t2137r484b2202],
4	Day	NNP	DURATION	Day	nn	5	SENT_125	[p10l510t2138r643b2205],
5	CP	NNP	O	CP	appos	2	SENT_125	[p10l667t2137r780b2202],
6	,	,	O	,	_	0	SENT_125	[p10l667t2137r780b2202],
7	Kesteven	NNP	O	Kesteven	nn	8	SENT_125	[p10l806t2138r1096b2190],
8	PJ	NNP	O	PJ	appos	2	SENT_125	[p10l1118t2138r1211b2202],
9	,	,	O	,	_	0	SENT_125	[p10l1118t2138r1211b2202],
10	Daly	NNP	ORGANIZATION	Daly	nn	11	SENT_125	[p10l1237t2136r1391b2205],
11	AK	NNP	ORGANIZATION	AK	appos	2	SENT_125	[p10l1413t2136r1532b2189],
12	(	CD	NUMBER	(	num	15	SENT_125	[p10l1555t2136r1749b2205],
13	1999	CD	DATE	1999	num	15	SENT_125	[p10l1555t2136r1749b2205],
14	)	NNP	O	)	nn	15	SENT_125	[p10l1555t2136r1749b2205],
15	Association	NNP	O	Association	dep	11	SENT_125	[p10l1772t2136r2146b2190],
16	of	IN	O	of	_	0	SENT_125	[p10l141t2228r210b2283],
17	polymorphisms	NNS	O	polymorphism	prep_of	15	SENT_125	[p10l251t2228r744b2297],
18	in	IN	O	in	_	0	SENT_125	[p10l794t2228r853b2282],
19	the	DT	O	the	det	22	SENT_125	[p10l903t2228r999b2283],
20	cytochrome	NN	O	cytochrome	nn	22	SENT_125	[p10l1049t2228r1422b2297],
21	P450	NN	O	p450	nn	22	SENT_125	[p10l1471t2229r1625b2283],
22	CYP2C9	NN	O	cyp2c9	prep_in	17	SENT_125	[p10l1677t2229r1957b2283],
23	with	IN	O	with	_	0	SENT_125	[p10l2008t2228r2146b2283],
24	warfarin	NN	O	warfarin	nn	26	SENT_125	[p10l139t2321r410b2376],
25	dose	NN	O	dose	nn	26	SENT_125	[p10l437t2321r578b2376],
26	requirement	NN	O	requirement	prep_with	22	SENT_125	[p10l605t2322r989b2391],
27	and	CC	O	and	_	0	SENT_125	[p10l1016t2321r1132b2376],
28	risk	NN	O	risk	appos	2	SENT_125	[p10l1159t2321r1276b2376],
29	of	IN	O	of	_	0	SENT_125	[p10l1304t2321r1373b2376],
30	bleeding	VBG	O	bleed	amod	31	SENT_125	[p10l1392t2321r1658b2391],
31	complications	NNS	O	complication	prep_of	28	SENT_125	[p10l1683t2322r2142b2391],
32	.	.	O	.	_	0	SENT_125	[p10l1683t2322r2142b2391],

1	Lancet	NNP	O	Lancet	_	0	SENT_126	[p10l139t2418r353b2469],
2	353:7	CD	NUMBER	353:7	num	3	SENT_126	[p10l380t2416r771b2469],
3	l7	NN	O	l7	dep	1	SENT_126	[p10l380t2416r771b2469],
4	—	CD	NUMBER	—	num	5	SENT_126	[p10l380t2416r771b2469],
5	7l9	CD	NUMBER	7l9	dep	1	SENT_126	[p10l380t2416r771b2469],

1	2	LS	NUMBER	2	_	0	SENT_127	[p10l44t2508r95b2561],
2	.	.	O	.	_	0	SENT_127	[p10l44t2508r95b2561],

1	Chenhsu	NNP	PERSON	Chenhsu	nn	2	SENT_128	[p10l141t2507r418b2562],
2	RY	NNP	O	RY	_	0	SENT_128	[p10l454t2509r582b2573],
3	,	,	O	,	_	0	SENT_128	[p10l454t2509r582b2573],
4	Chiang	NNP	ORGANIZATION	Chiang	nn	5	SENT_128	[p10l620t2507r848b2576],
5	SC	NNP	ORGANIZATION	SC	appos	2	SENT_128	[p10l884t2508r991b2573],
6	,	,	O	,	_	0	SENT_128	[p10l884t2508r991b2573],
7	Chou	NNP	O	Chou	nn	8	SENT_128	[p10l1030t2507r1204b2562],
8	MH	NNP	O	MH	appos	2	SENT_128	[p10l1238t2509r1388b2573],
9	,	,	O	,	_	0	SENT_128	[p10l1238t2509r1388b2573],
10	Lin	NNP	PERSON	Lin	nn	11	SENT_128	[p10l1426t2507r1534b2561],
11	MF	NN	PERSON	mf	appos	2	SENT_128	[p10l1569t2509r1688b2561],
12	(	CD	NUMBER	(	num	13	SENT_128	[p10l1725t2507r1919b2576],
13	2000	CD	DATE	2000	dep	11	SENT_128	[p10l1725t2507r1919b2576],
14	)	CD	NUMBER	)	num	16	SENT_128	[p10l1725t2507r1919b2576],
15	Longterm	NN	O	longterm	nn	16	SENT_128	[p10l1956t2509r2145b2576, p10l140t2608r285b2655],
16	treatment	NN	O	treatment	dep	2	SENT_128	[p10l334t2608r642b2655],
17	with	IN	O	with	_	0	SENT_128	[p10l689t2600r828b2655],
18	warfarin	NN	O	warfarin	prep_with	16	SENT_128	[p10l876t2600r1148b2655],
19	in	IN	O	in	_	0	SENT_128	[p10l1196t2600r1255b2654],
20	Chinese	JJ	LOCATION	chinese	amod	21	SENT_128	[p10l1306t2600r1552b2655],
21	population	NN	O	population	prep_in	18	SENT_128	[p10l1601t2600r1967b2670],
22	.	.	O	.	_	0	SENT_128	[p10l1601t2600r1967b2670],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_129	[p10l2020t2602r2145b2655],
2	Pharmacpther	NNP	PERSON	Pharmacpther	_	0	SENT_129	[p10l140t2694r581b2763],
3	34	CD	NUMBER	34	num	2	SENT_129	[p10l608t2696r696b2749],
4	:	:	O	:	_	0	SENT_129	[p10l608t2696r696b2749],
5	1395-1401	CD	DATE	1395-1401	dep	2	SENT_129	[p10l711t2695r1030b2749],

1	3	LS	NUMBER	3	_	0	SENT_130	[p10l47t2787r95b2841],
2	.	.	O	.	_	0	SENT_130	[p10l47t2787r95b2841],

1	D’Andrea	NN	O	d’andrea	nn	2	SENT_131	[p10l140t2786r459b2840],
2	G	NN	O	g	nsubjpass	23	SENT_131	[p10l497t2787r572b2852],
3	,	,	O	,	_	0	SENT_131	[p10l497t2787r572b2852],
4	D’Ambrosio	NNP	O	D’Ambrosio	nn	5	SENT_131	[p10l613t2786r1012b2840],
5	RL	NNP	O	RL	appos	2	SENT_131	[p10l1053t2788r1173b2852],
6	,	,	O	,	_	0	SENT_131	[p10l1053t2788r1173b2852],
7	Di	NNP	PERSON	Di	nn	9	SENT_131	[p10l1214t2786r1292b2840],
8	Perna	NNP	PERSON	Perna	nn	9	SENT_131	[p10l1330t2788r1514b2840],
9	P	NN	O	p	appos	5	SENT_131	[p10l1551t2788r1611b2852],
10	,	,	O	,	_	0	SENT_131	[p10l1551t2788r1611b2852],
11	et	FW	O	et	nn	13	SENT_131	[p10l1651t2794r1707b2840],
12	al.	FW	O	al.	nn	13	SENT_131	[p10l1745t2786r1815b2840],
13	(	FW	O	(	dep	23	SENT_131	[p10l1858t2786r2052b2856],
14	2005	CD	DATE	2005	num	15	SENT_131	[p10l1858t2786r2052b2856],
15	)	CD	NUMBER	)	dobj	13	SENT_131	[p10l1858t2786r2052b2856],
16	A	DT	O	a	det	17	SENT_131	[p10l2091t2786r2147b2840],
17	polymorphism	NN	O	polymorphism	dep	15	SENT_131	[p10l138t2879r604b2948],
18	in	IN	O	in	_	0	SENT_131	[p10l632t2879r691b2933],
19	the	DT	O	the	det	20	SENT_131	[p10l720t2879r815b2934],
20	VKORC1	NN	O	vkorc1	prep_in	13	SENT_131	[p10l843t2880r1157b2934],
21	gene	NN	O	gene	nsubjpass	23	SENT_131	[p10l1193t2897r1334b2948],
22	is	VBZ	O	be	auxpass	23	SENT_131	[p10l1363t2879r1408b2934],
23	associated	VBN	O	associate	_	0	SENT_131	[p10l1440t2879r1762b2934],
24	with	IN	O	with	_	0	SENT_131	[p10l1790t2879r1929b2934],
25	an	DT	O	a	det	27	SENT_131	[p10l1958t2897r2033b2934],
26	interindividual	JJ	O	interindividual	amod	27	SENT_131	[p10l2062t2879r2145b2933, p10l140t2972r545b3027],
27	Variability	NN	O	variability	prep_with	23	SENT_131	[p10l592t2972r917b3041],
28	in	IN	O	in	_	0	SENT_131	[p10l964t2972r1023b3026],
29	the	DT	O	the	det	31	SENT_131	[p10l1072t2972r1167b3027],
30	dose-anticoagulant	JJ	O	dose-anticoagulant	amod	31	SENT_131	[p10l1216t2972r1822b3042],
31	effect	NN	O	effect	prep_in	27	SENT_131	[p10l1869t2972r2035b3027],
32	of	IN	O	of	_	0	SENT_131	[p10l2085t2972r2154b3027],
33	warfarin	NN	O	warfarin	prep_of	31	SENT_131	[p10l138t3064r426b3118],
34	.	.	O	.	_	0	SENT_131	[p10l138t3064r426b3118],

1	Blood	NN	O	blood	_	0	SENT_132	[p10l458t3064r644b3118],
2	1	CD	NUMBER	1	num	3	SENT_132	[p10l669t3066r697b3118],
3	05 2645-649	CD	NUMBER	05 2645-649	dep	1	SENT_132	[p10l782t3065r1057b3118],[p10l704t3066r775b3119],

1	4	LS	NUMBER	4	_	0	SENT_133	[p10l44t3158r95b3212],
2	.	.	O	.	_	0	SENT_133	[p10l44t3158r95b3212],

1	Finhn	NNP	O	Finhn	nn	2	SENT_134	[p10l141t3157r331b3211],
2	SD	NN	O	sd	_	0	SENT_134	[p10l357t3158r471b3223],
3	,	,	O	,	_	0	SENT_134	[p10l357t3158r471b3223],
4	Callahan	NNP	PERSON	Callahan	nn	5	SENT_134	[p10l498t3157r784b3212],
5	CM	NN	O	cm	conj_and	2	SENT_134	[p10l807t3158r949b3223],
6	,	,	O	,	_	0	SENT_134	[p10l807t3158r949b3223],
7	Martin	NNP	ORGANIZATION	Martin	nn	8	SENT_134	[p10l975t3157r1199b3212],
8	DC	NNP	ORGANIZATION	DC	conj_and	2	SENT_134	[p10l1221t3158r1351b3223],
9	,	,	O	,	_	0	SENT_134	[p10l1221t3158r1351b3223],
10	McDonell	NNP	PERSON	McDonell	nn	11	SENT_134	[p10l1377t3157r1698b3212],
11	MB	NNP	O	MB	conj_and	2	SENT_134	[p10l1722t3159r1860b3223],
12	,	,	O	,	_	0	SENT_134	[p10l1722t3159r1860b3223],
13	Henkoff	NNP	O	Henkoff	nn	14	SENT_134	[p10l1886t3157r2154b3212],
14	JG	NNP	O	JG	conj_and	2	SENT_134	[p10l139t3251r248b3316],
15	,	,	O	,	_	0	SENT_134	[p10l139t3251r248b3316],
16	White	NNP	O	White	nn	17	SENT_134	[p10l288t3250r479b3305],
17	RH	NNP	O	RH	conj_and	2	SENT_134	[p10l519t3252r632b3304],
18	(	CD	NUMBER	(	num	17	SENT_134	[p10l672t3250r866b3320],
19	1996	CD	DATE	1996	num	20	SENT_134	[p10l672t3250r866b3320],
20	)	CD	NUMBER	)	rcmod	17	SENT_134	[p10l672t3250r866b3320],
21	The	DT	O	the	det	22	SENT_134	[p10l905t3250r1026b3305],
22	risk	NN	O	risk	dep	20	SENT_134	[p10l1064t3250r1181b3305],
23	for	IN	O	for	dep	20	SENT_134	[p10l1218t3250r1311b3305],
24	and	CC	O	and	_	0	SENT_134	[p10l1349t3250r1465b3305],
25	severity	NN	O	severity	conj_and	2	SENT_134	[p10l1504t3250r1743b3319],
26	of	IN	O	of	_	0	SENT_134	[p10l1782t3250r1851b3305],
27	bleeding	VBG	O	bleed	amod	28	SENT_134	[p10l1881t3250r2147b3320],
28	complications	NNS	O	complication	prep_of	2	SENT_134	[p10l139t3343r581b3412],
29	in	IN	O	in	_	0	SENT_134	[p10l621t3343r680b3397],
30	elderly	JJ	O	elderly	amod	31	SENT_134	[p10l719t3343r931b3412],
31	patients	NNS	O	patient	prep_in	28	SENT_134	[p10l969t3343r1218b3412],
32	treated	VBN	O	treat	partmod	2	SENT_134	[p10l1259t3343r1478b3398],
33	with	IN	O	with	_	0	SENT_134	[p10l1517t3343r1656b3398],
34	warfarin	NN	O	warfarin	prep_with	32	SENT_134	[p10l1694t3343r1982b3398],
35	.	.	O	.	_	0	SENT_134	[p10l1694t3343r1982b3398],

1	The	DT	O	the	det	3	SENT_135	[p10l2025t3343r2145b3398],
2	National	NNP	O	National	nn	3	SENT_135	[p10l139t3436r422b3491],
3	Consortium	NNP	O	Consortium	_	0	SENT_135	[p10l458t3436r839b3491],
4	of	IN	O	of	_	0	SENT_135	[p10l876t3436r944b3491],
5	Anticoagulation	NNP	O	Anticoagulation	nn	6	SENT_135	[p10l972t3436r1491b3505],
6	Clinics	NNP	O	Clinics	prep_of	3	SENT_135	[p10l1528t3436r1758b3491],
7	.	.	O	.	_	0	SENT_135	[p10l1528t3436r1758b3491],

1	Ann	NNP	O	Ann	nn	3	SENT_136	[p10l1796t3438r1922b3490],
2	Intern	NNP	O	Intern	nn	3	SENT_136	[p10l1958t3439r2145b3491],
3	Med	NNP	O	Med	_	0	SENT_136	[p10l140t3528r288b3583],
4	I24	NN	O	i24	dep	3	SENT_136	[p10l312t3529r700b3583],
5	:970	CD	NUMBER	:970	num	4	SENT_136	[p10l312t3529r700b3583],
6	—	NN	O	—	dep	3	SENT_136	[p10l312t3529r700b3583],
7	979	CD	NUMBER	979	num	6	SENT_136	[p10l312t3529r700b3583],

1	5	CD	NUMBER	5	_	0	SENT_137	[p10l48t3623r95b3676],
2	.	.	O	.	_	0	SENT_137	[p10l48t3623r95b3676],

1	British	NNP	O	British	nn	2	SENT_138	[p10l141t3621r352b3676],
2	Committee	NNP	ORGANIZATION	Committee	dep	10	SENT_138	[p10l379t3621r730b3676],
3	for	IN	ORGANIZATION	for	_	0	SENT_138	[p10l757t3621r850b3676],
4	Standard	NNP	ORGANIZATION	Standard	prep_for	2	SENT_138	[p10l879t3621r1168b3676],
5	in	IN	ORGANIZATION	in	_	0	SENT_138	[p10l1195t3621r1254b3675],
6	Hematology	NNP	ORGANIZATION	Hematology	prep_in	4	SENT_138	[p10l1282t3621r1676b3691],
7	(	CD	NUMBER	(	num	6	SENT_138	[p10l1704t3622r1898b3691],
8	1998	CD	DATE	1998	dep	10	SENT_138	[p10l1704t3622r1898b3691],
9	)	NNP	O	)	nn	10	SENT_138	[p10l1704t3622r1898b3691],
10	Guidelines	NNS	O	guideline	dep	16	SENT_138	[p10l1928t3621r2144b3676, p10l139t3714r279b3769],
11	on	IN	O	on	_	0	SENT_138	[p10l323t3732r402b3769],
12	oral	JJ	O	oral	amod	13	SENT_138	[p10l445t3714r568b3769],
13	anticoagulation	NN	O	anticoagulation	prep_on	10	SENT_138	[p10l610t3714r1123b3783],
14	:	:	O	:	_	0	SENT_138	[p10l610t3714r1123b3783],
15	third	JJ	ORDINAL	third	amod	16	SENT_138	[p10l1169t3714r1322b3769],
16	edition	NN	O	edition	_	0	SENT_138	[p10l1364t3714r1600b3769],
17	.	.	O	.	_	0	SENT_138	[p10l1364t3714r1600b3769],

1	Br	NN	O	br	_	0	SENT_139	[p10l1646t3717r1722b3768],
2	J	NN	O	j	nn	3	SENT_139	[p10l1763t3717r1804b3769],
3	Haematol	NN	O	haematol	dep	1	SENT_139	[p10l1839t3714r2151b3769],

1	6	CD	NUMBER	6	_	0	SENT_140	[p11l46t113r95b166],
2	.	.	O	.	_	0	SENT_140	[p11l46t113r95b166],

1	Harrington	NNP	PERSON	Harrington	nn	2	SENT_141	[p11l140t111r501b181],
2	DJ	NNP	O	DJ	_	0	SENT_141	[p11l536t113r644b177],
3	,	,	O	,	_	0	SENT_141	[p11l536t113r644b177],
4	Underwood	NNP	PERSON	Underwood	nn	5	SENT_141	[p11l684t111r1064b166],
5	S	NNP	O	S	appos	2	SENT_141	[p11l1101t112r1155b177],
6	,	,	O	,	_	0	SENT_141	[p11l1101t112r1155b177],
7	Morse	NNP	PERSON	Morse	nn	8	SENT_141	[p11l1194t113r1396b166],
8	C	NNP	O	C	appos	2	SENT_141	[p11l1433t112r1500b177],
9	,	,	O	,	_	0	SENT_141	[p11l1433t112r1500b177],
10	et	FW	O	et	appos	2	SENT_141	[p11l1538t111r1671b166],
11	.	.	O	.	_	0	SENT_141	[p11l1538t111r1671b166],

1	al	NNP	O	al	nn	2	SENT_142	[p11l1538t111r1671b166],
2	(	NNP	O	(	_	0	SENT_142	[p11l1740t112r1934b181],
3	2005	CD	DATE	2005	num	4	SENT_142	[p11l1740t112r1934b181],
4	)	CD	NUMBER	)	dep	2	SENT_142	[p11l1740t112r1934b181],
5	Pharmacodynamic	JJ	O	pharmacodynamic	dep	2	SENT_142	[p11l1971t111r2145b166, p11l138t204r583b273],

1	resistance	NN	O	resistance	nsubj	4	SENT_143	[p11l614t204r920b259],
2	to	TO	O	to	_	0	SENT_143	[p11l952t212r1013b259],
3	warfarin	NN	O	warfarin	prep_to	1	SENT_143	[p11l1045t204r1317b259],
4	associated	VBN	O	associate	_	0	SENT_143	[p11l1349t204r1672b259],
5	with	IN	O	with	_	0	SENT_143	[p11l1702t204r1841b259],
6	a	DT	O	a	det	9	SENT_143	[p11l1873t222r1906b259],
7	Val66Pediatric	JJ	O	val66pediatric	amod	9	SENT_143	[p11l1937t204r2145b259, p11l786t315r1070b370],
8	Cardiology	NNP	O	Cardiology	nn	9	SENT_143	[p11l1099t315r1456b385],
9	Vol	NNP	O	Vol	prep_with	4	SENT_143	[p11l1482t316r1612b370],
10	.	.	O	.	_	0	SENT_143	[p11l1482t316r1612b370],

1	27	CD	NUMBER	27	_	0	SENT_144	[p11l1645t317r1734b382],
2	,	,	O	,	_	0	SENT_144	[p11l1645t317r1734b382],
3	No.	NN	O	no.	appos	1	SENT_144	[p11l1765t317r1882b370],
4	6	CD	NUMBER	6	num	3	SENT_144	[p11l1916t317r1966b382],
5	,	,	O	,	_	0	SENT_144	[p11l1916t317r1966b382],
6	2006	CD	DATE	2006	appos	1	SENT_144	[p11l1997t317r2143b371],

1	Met	NNP	O	Met	nn	2	SENT_145	[p11l133t557r262b610],
2	substitution	NN	O	substitution	_	0	SENT_145	[p11l311t555r688b610],
3	in	IN	O	in	_	0	SENT_145	[p11l735t555r795b609],
4	Vitamin	NN	O	vitamin	nn	9	SENT_145	[p11l842t555r1084b610],
5	K	NN	O	k	nn	9	SENT_145	[p11l1132t557r1191b609],
6	epoxide	NN	O	epoxide	nn	9	SENT_145	[p11l1239t555r1484b624],
7	reductase	NN	O	reductase	nn	9	SENT_145	[p11l1532t555r1831b610],
8	complex	NN	O	complex	nn	9	SENT_145	[p11l1879t555r2145b624],
9	subunit	NN	O	subunit	prep_in	2	SENT_145	[p11l134t648r370b703],
10	1	CD	NUMBER	1	dep	9	SENT_145	[p11l405t649r448b703],
11	.	.	O	.	_	0	SENT_145	[p11l405t649r448b703],

1	T	NN	O	t	nn	3	SENT_146	[p11l487t651r536b703],
2	hromb	NN	O	hromb	nn	3	SENT_146	[p11l531t648r727b704],
3	Haemost	NN	O	haemost	_	0	SENT_146	[p11l756t651r1036b704],
4	93:23	CD	NUMBER	93:23	num	5	SENT_146	[p11l1062t649r1343b704],
5	-26	CD	NUMBER	-26	dep	3	SENT_146	[p11l1062t649r1343b704],

1	.	.	O	.	_	0	SENT_147	[p11l79t788r88b797],

1	James	NNP	PERSON	James	nn	2	SENT_148	[p11l132t744r323b797],
2	AH	NNP	O	AH	_	0	SENT_148	[p11l371t742r506b809],
3	,	,	O	,	_	0	SENT_148	[p11l371t742r506b809],
4	Britt	NNP	PERSON	Britt	nn	5	SENT_148	[p11l558t742r704b797],
5	RP	NNP	PERSON	RP	appos	2	SENT_148	[p11l754t744r870b808],
6	,	,	O	,	_	0	SENT_148	[p11l754t744r870b808],
7	Raskino	NNP	O	Raskino	nn	8	SENT_148	[p11l923t742r1185b797],
8	CL	NN	O	cl	appos	2	SENT_148	[p11l1236t743r1354b809],
9	,	,	O	,	_	0	SENT_148	[p11l1236t743r1354b809],
10	Thompson	NNP	PERSON	Thompson	nn	11	SENT_148	[p11l1405t742r1750b812],
11	SG	NNP	O	SG	appos	2	SENT_148	[p11l1801t743r1900b797],
12	(	CD	NUMBER	(	num	15	SENT_148	[p11l1949t743r2143b812],
13	1992	CD	DATE	1992	num	15	SENT_148	[p11l1949t743r2143b812],
14	)	CD	NUMBER	)	num	15	SENT_148	[p11l1949t743r2143b812],
15	Factors	NNS	O	factor	dep	11	SENT_148	[p11l133t837r374b890],
16	affecting	VBG	O	affect	partmod	2	SENT_148	[p11l418t835r688b904],
17	the	DT	O	the	det	19	SENT_148	[p11l730t835r825b890],
18	maintenance	NN	O	maintenance	nn	19	SENT_148	[p11l867t835r1270b890],
19	dose	NN	O	dose	dobj	16	SENT_148	[p11l1314t835r1455b890],
20	of	IN	O	of	_	0	SENT_148	[p11l1499t835r1569b890],
21	warfarin	NN	O	warfarin	prep_of	19	SENT_148	[p11l1603t835r1891b890],
22	.	.	O	.	_	0	SENT_148	[p11l1603t835r1891b890],

1	J	NNP	O	J	nn	3	SENT_149	[p11l1937t838r1979b890],
2	Clin	NNP	O	Clin	nn	3	SENT_149	[p11l2019t835r2144b890],
3	Pathol	NNP	O	Pathol	_	0	SENT_149	[p11l133t928r342b984],
4	45	CD	NUMBER	45	number	5	SENT_149	[p11l365t930r437b984],
5	:704	CD	NUMBER	:704	dep	3	SENT_149	[p11l445t929r721b984],
6	—	NN	O	—	dep	5	SENT_149	[p11l445t929r721b984],
7	706	CD	NUMBER	706	num	6	SENT_149	[p11l445t929r721b984],

1	.	.	O	.	_	0	SENT_150	[p11l79t1068r88b1077],

1	Meyer	NNP	ORGANIZATION	Meyer	nn	2	SENT_151	[p11l133t1024r336b1092],
2	UA	NNP	ORGANIZATION	UA	nsubj	3	SENT_151	[p11l375t1022r491b1077],
3	(	VBD	O	(	_	0	SENT_151	[p11l530t1023r724b1092],
4	2000	CD	DATE	2000	num	6	SENT_151	[p11l530t1023r724b1092],
5	)	CD	NUMBER	)	num	6	SENT_151	[p11l530t1023r724b1092],
6	Pharmacogenetics	NNS	O	pharmacogenetic	dobj	3	SENT_151	[p11l762t1022r1338b1092],
7	and	CC	O	and	_	0	SENT_151	[p11l1377t1022r1494b1077],
8	adverse	JJ	O	adverse	amod	10	SENT_151	[p11l1532t1022r1768b1077],
9	drug	NN	O	drug	nn	10	SENT_151	[p11l1807t1022r1953b1092],
10	reactions	NNS	O	reaction	dobj	3	SENT_151	[p11l1990t1040r2143b1077, p11l133t1115r303b1170],
11	.	.	O	.	_	0	SENT_151	[p11l1990t1040r2143b1077, p11l133t1115r303b1170],

1	Lancet	NNP	O	Lancet	_	0	SENT_152	[p11l335t1118r550b1170],
2	356	CD	NUMBER	356	num	1	SENT_152	[p11l576t1116r1037b1171],
3	:	:	O	:	_	0	SENT_152	[p11l576t1116r1037b1171],
4	l667	CD	NUMBER	l667	num	6	SENT_152	[p11l576t1116r1037b1171],
5	—	CD	NUMBER	—	num	6	SENT_152	[p11l576t1116r1037b1171],
6	l67l	NN	O	l67l	dep	1	SENT_152	[p11l576t1116r1037b1171],

1	.	.	O	.	_	0	SENT_153	[p11l79t1255r88b1263],

1	Rettie	NNP	O	Rettie	nn	2	SENT_154	[p11l134t1209r323b1264],
2	AE	NNP	O	AE	dep	17	SENT_154	[p11l347t1209r470b1275],
3	,	,	O	,	_	0	SENT_154	[p11l347t1209r470b1275],
4	Wienkers	NNP	O	Wienkers	nn	5	SENT_154	[p11l496t1209r795b1264],
5	LC	NNP	O	LC	appos	2	SENT_154	[p11l822t1210r939b1275],
6	,	,	O	,	_	0	SENT_154	[p11l822t1210r939b1275],
7	Gonzalez	NNP	PERSON	Gonzalez	nn	9	SENT_154	[p11l967t1209r1265b1264],
8	F	NN	PERSON	f	nn	9	SENT_154	[p11l1289t1211r1335b1263],
9	J	NN	PERSON	j	appos	2	SENT_154	[p11l1338t1211r1368b1264],
10	,	,	O	,	_	0	SENT_154	[p11l1374t1255r1386b1275],
11	Trager	NNP	O	Trager	nn	12	SENT_154	[p11l1413t1211r1627b1279],
12	WF	NNP	O	WF	appos	2	SENT_154	[p11l1649t1211r1789b1275],
13	,	,	O	,	_	0	SENT_154	[p11l1649t1211r1789b1275],
14	Korzekwa	NNP	O	Korzekwa	nn	15	SENT_154	[p11l1817t1209r2145b1264],
15	KR	NNP	O	KR	appos	2	SENT_154	[p11l133t1304r250b1356],
16	(	CD	NUMBER	(	dep	17	SENT_154	[p11l277t1303r472b1372],
17	1994	CD	DATE	1994	dep	21	SENT_154	[p11l277t1303r472b1372],
18	)	NNP	O	)	dep	17	SENT_154	[p11l277t1303r472b1372],
19	Impaired	JJ	O	impaired	amod	21	SENT_154	[p11l501t1302r791b1372],
20	(	NN	O	(	nn	21	SENT_154	[p11l819t1302r1205b1372],
21	S	NN	O	s	_	0	SENT_154	[p11l819t1302r1205b1372],
22	)	SYM	O	)	dep	25	SENT_154	[p11l819t1302r1205b1372],
23	-	:	O	-	_	0	SENT_154	[p11l819t1302r1205b1372],
24	warfarin	NN	O	warfarin	nn	25	SENT_154	[p11l819t1302r1205b1372],
25	metabolism	NN	O	metabolism	dep	21	SENT_154	[p11l1230t1302r1601b1357],
26	catalysed	VBN	O	catalyse	partmod	25	SENT_154	[p11l1627t1302r1919b1372],
27	by	IN	O	by	_	0	SENT_154	[p11l1945t1302r2022b1372],
28	the	DT	O	the	det	29	SENT_154	[p11l2048t1302r2144b1357],
29	R144C	NN	O	r144c	agent	26	SENT_154	[p11l134t1396r354b1450],
30	allelic	JJ	O	allelic	amod	31	SENT_154	[p11l383t1395r564b1450],
31	Variant	JJ	O	variant	amod	29	SENT_154	[p11l591t1395r819b1450],
32	of	IN	O	of	_	0	SENT_154	[p11l847t1395r917b1450],
33	CYP2C9	NN	O	cyp2c9	prep_of	29	SENT_154	[p11l939t1396r1237b1450],
34	.	.	O	.	_	0	SENT_154	[p11l939t1396r1237b1450],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_155	[p11l1270t1396r1836b1465],
2	4:39	CD	TIME	4:39	number	3	SENT_155	[p11l1863t1397r2106b1450],
3	-42	CD	NUMBER	-42	num	28	SENT_155	[p11l1863t1397r2106b1450],
4	Rost	NNP	PERSON	Rost	nn	28	SENT_155	[p11l134t1490r283b1543],
5	S	NN	O	s	nn	28	SENT_155	[p11l320t1489r373b1554],
6	,	,	O	,	_	0	SENT_155	[p11l320t1489r373b1554],
7	Fregin	NN	O	fregin	nn	8	SENT_155	[p11l411t1488r619b1558],
8	A	NN	O	a	nn	28	SENT_155	[p11l652t1488r725b1554],
9	,	,	O	,	_	0	SENT_155	[p11l652t1488r725b1554],
10	Ivaskevicius	NNP	MISC	Ivaskevicius	nn	11	SENT_155	[p11l763t1488r1147b1543],
11	V	NNP	O	V	nn	28	SENT_155	[p11l1182t1490r1251b1554],
12	,	,	O	,	_	0	SENT_155	[p11l1182t1490r1251b1554],
13	et	FW	O	et	nn	15	SENT_155	[p11l1288t1496r1343b1543],
14	al.	FW	O	al.	nn	15	SENT_155	[p11l1378t1488r1448b1543],
15	(	FW	O	(	nn	28	SENT_155	[p11l1489t1488r1683b1558],
16	2004	CD	DATE	2004	num	18	SENT_155	[p11l1489t1488r1683b1558],
17	)	CD	NUMBER	)	num	18	SENT_155	[p11l1489t1488r1683b1558],
18	Mutations	NNS	O	mutation	npadvmod	15	SENT_155	[p11l1720t1488r2050b1543],
19	in	IN	O	in	_	0	SENT_155	[p11l2085t1488r2144b1542],
20	VKORC1	NN	O	vkorc1	nn	23	SENT_155	[p11l131t1582r446b1636],
21	cause	NN	O	cause	nn	23	SENT_155	[p11l484t1599r655b1636],
22	warfarin	NN	O	warfarin	nn	23	SENT_155	[p11l686t1581r958b1636],
23	resistance	NN	O	resistance	prep_in	15	SENT_155	[p11l990t1581r1296b1636],
24	and	CC	O	and	_	0	SENT_155	[p11l1329t1581r1446b1636],
25	multiple	JJ	O	multiple	nn	28	SENT_155	[p11l1477t1581r1738b1651],
26	coagulation	NN	O	coagulation	nn	27	SENT_155	[p11l1770t1581r2144b1651],
27	factor	NN	O	factor	dep	5	SENT_155	[p11l132t1674r321b1729],
28	deﬁciency	NN	O	deﬁciency	dep	1	SENT_155	[p11l349t1674r660b1744],
29	type	NN	O	type	amod	28	SENT_155	[p11l688t1682r821b1744],
30	2	CD	NUMBER	2	number	29	SENT_155	[p11l850t1676r900b1729],
31	.	.	O	.	_	0	SENT_155	[p11l850t1676r900b1729],

1	Nature	NNP	O	Nature	nn	5	SENT_156	[p11l932t1677r1150b1729],
2	427:537	CD	NUMBER	427:537	num	5	SENT_156	[p11l1177t1676r1564b1730],
3	-541	CD	NUMBER	-541	num	5	SENT_156	[p11l1177t1676r1564b1730],
4	Steward	NNP	O	Steward	nn	5	SENT_156	[p11l135t1767r391b1823],
5	DJ	NNP	O	DJ	nsubj	15	SENT_156	[p11l429t1769r538b1834],
6	,	,	O	,	_	0	SENT_156	[p11l429t1769r538b1834],
7	Haining	NNP	ORGANIZATION	Haining	nn	8	SENT_156	[p11l579t1768r837b1837],
8	RL	NNP	ORGANIZATION	RL	appos	5	SENT_156	[p11l876t1769r997b1834],
9	,	,	O	,	_	0	SENT_156	[p11l876t1769r997b1834],
10	Henne	NNP	PERSON	Henne	nn	11	SENT_156	[p11l1038t1770r1245b1822],
11	KR	NNP	O	KR	appos	8	SENT_156	[p11l1284t1769r1418b1834],
12	,	,	O	,	_	0	SENT_156	[p11l1284t1769r1418b1834],
13	et	FW	O	et	nn	15	SENT_156	[p11l1459t1775r1514b1822],
14	al.	FW	O	al.	nn	15	SENT_156	[p11l1553t1768r1622b1822],
15	(	FW	O	(	_	0	SENT_156	[p11l1666t1768r1861b1837],
16	1997	CD	DATE	1997	num	17	SENT_156	[p11l1666t1768r1861b1837],
17	)	CD	NUMBER	)	nn	19	SENT_156	[p11l1666t1768r1861b1837],
18	Genetic	JJ	O	genetic	amod	19	SENT_156	[p11l1901t1768r2145b1822],
19	association	NN	O	association	dobj	15	SENT_156	[p11l133t1860r486b1915],
20	between	IN	O	between	_	0	SENT_156	[p11l520t1860r778b1915],
21	sensitivity	NN	O	sensitivity	prep_between	19	SENT_156	[p11l813t1860r1127b1929],
22	to	TO	O	to	_	0	SENT_156	[p11l1161t1868r1223b1915],
23	warfarin	NN	O	warfarin	prep_to	15	SENT_156	[p11l1257t1860r1529b1915],
24	and	CC	O	and	_	0	SENT_156	[p11l1564t1860r1681b1915],
25	expression	NN	O	expression	prep_to	15	SENT_156	[p11l1715t1860r2047b1930],
26	of	IN	O	of	_	0	SENT_156	[p11l2082t1860r2152b1915],
27	CYP2C9	NN	O	cyp2c9	prep_of	23	SENT_156	[p11l133t1953r508b2008],
28	*	CD	NUMBER	*	number	29	SENT_156	[p11l133t1953r508b2008],
29	3	CD	NUMBER	3	num	27	SENT_156	[p11l133t1953r508b2008],
30	.	.	O	.	_	0	SENT_156	[p11l133t1953r508b2008],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_157	[p11l540t1954r1106b2022],
2	7:361	CD	NUMBER	7:361	num	5	SENT_157	[p11l1139t1955r1450b2009],
3	-367	CD	NUMBER	-367	num	5	SENT_157	[p11l1139t1955r1450b2009],
4	Stubbins	NNP	ORGANIZATION	Stubbins	nn	5	SENT_157	[p11l135t2046r410b2102],
5	MJ	NNP	ORGANIZATION	MJ	dep	1	SENT_157	[p11l450t2048r571b2113],
6	,	,	O	,	_	0	SENT_157	[p11l450t2048r571b2113],
7	Harries	NNP	PERSON	Harries	nn	8	SENT_157	[p11l613t2047r848b2102],
8	LW	NNP	O	LW	appos	5	SENT_157	[p11l888t2048r1025b2113],
9	,	,	O	,	_	0	SENT_157	[p11l888t2048r1025b2113],
10	Smith	NNP	PERSON	Smith	nn	11	SENT_157	[p11l1069t2046r1254b2102],
11	G	NNP	O	G	appos	5	SENT_157	[p11l1293t2047r1368b2113],
12	,	,	O	,	_	0	SENT_157	[p11l1293t2047r1368b2113],
13	Tarbit	NNP	O	Tarbit	nn	14	SENT_157	[p11l1409t2046r1610b2102],
14	MH	NNP	O	MH	appos	5	SENT_157	[p11l1648t2048r1798b2113],
15	,	,	O	,	_	0	SENT_157	[p11l1648t2048r1798b2113],
16	Wolf	NNP	PERSON	Wolf	nn	17	SENT_157	[p11l1838t2046r2005b2102],
17	CR	NN	O	cr	appos	5	SENT_157	[p11l2037t2047r2145b2102],
18	(	CD	NUMBER	(	num	19	SENT_157	[p11l134t2140r328b2209],
19	1996	CD	DATE	1996	dep	1	SENT_157	[p11l134t2140r328b2209],
20	)	NNP	O	)	dep	19	SENT_157	[p11l134t2140r328b2209],
21	Genetic	JJ	O	genetic	amod	22	SENT_157	[p11l390t2140r634b2195],
22	analysis	NN	O	analysis	dep	1	SENT_157	[p11l692t2140r941b2209],
23	of	IN	O	of	_	0	SENT_157	[p11l1002t2140r1071b2194],
24	the	DT	O	the	det	29	SENT_157	[p11l1123t2140r1218b2194],
25	human	JJ	O	human	amod	29	SENT_157	[p11l1277t2140r1499b2194],
26	cytochrome	NN	O	cytochrome	nn	29	SENT_157	[p11l1557t2140r1931b2209],
27	P450	NN	O	p450	nn	29	SENT_157	[p11l1989t2141r2144b2195],
28	CYP2C9	NN	O	cyp2c9	nn	29	SENT_157	[p11l133t2233r415b2287],
29	locus	NN	O	locus	prep_of	22	SENT_157	[p11l444t2232r622b2287],
30	.	.	O	.	_	0	SENT_157	[p11l444t2232r622b2287],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_158	[p11l655t2233r1221b2301],
2	6:429	CD	NUMBER	6:429	num	5	SENT_158	[p11l1248t2234r1564b2288],
3	-439	CD	NUMBER	-439	num	5	SENT_158	[p11l1248t2234r1564b2288],
4	Takahashi	NNP	PERSON	Takahashi	nn	5	SENT_158	[p11l132t2325r467b2381],
5	H	NNP	PERSON	H	dep	1	SENT_158	[p11l496t2328r571b2393],
6	,	,	O	,	_	0	SENT_158	[p11l496t2328r571b2393],
7	Ieiri	NNP	O	Ieiri	appos	5	SENT_158	[p11l604t2326r731b2381],
8	I	PRP	O	I	nn	7	SENT_158	[p11l762t2328r805b2393],
9	,	,	O	,	_	0	SENT_158	[p11l762t2328r805b2393],
10	Wilkinson	NNP	PERSON	Wilkinson	nn	11	SENT_158	[p11l836t2325r1164b2381],
11	GR	NN	O	gr	appos	7	SENT_158	[p11l1195t2326r1328b2393],
12	,	,	O	,	_	0	SENT_158	[p11l1195t2326r1328b2393],
13	et	FW	O	et	dep	7	SENT_158	[p11l1360t2326r1494b2381],
14	.	.	O	.	_	0	SENT_158	[p11l1360t2326r1494b2381],

1	al	NNP	O	al	nn	2	SENT_159	[p11l1360t2326r1494b2381],
2	(	NNP	O	(	_	0	SENT_159	[p11l1550t2326r1745b2396],
3	2004	CD	DATE	2004	num	4	SENT_159	[p11l1550t2326r1745b2396],
4	)	CD	NUMBER	)	dep	2	SENT_159	[p11l1550t2326r1745b2396],
5	5	CD	NUMBER	5	rcmod	4	SENT_159	[p11l1779t2324r2145b2396],
6	’	SYM	O	’	dep	5	SENT_159	[p11l1779t2324r2145b2396],
7	-	:	O	-	_	0	SENT_159	[p11l1779t2324r2145b2396],
8	Flanking	NN	O	flanking	nn	10	SENT_159	[p11l1779t2324r2145b2396],
9	region	NN	O	region	nn	10	SENT_159	[p11l132t2420r332b2489],
10	polymorphisms	NNS	O	polymorphism	npadvmod	5	SENT_159	[p11l356t2420r850b2489],
11	of	IN	O	of	_	0	SENT_159	[p11l878t2420r947b2474],
12	CYP2C9	NN	O	cyp2c9	prep_of	10	SENT_159	[p11l967t2421r1248b2475],
13	and	CC	O	and	_	0	SENT_159	[p11l1276t2419r1392b2474],
14	their	PRP$	O	they	poss	15	SENT_159	[p11l1418t2420r1564b2474],
15	relationship	NN	O	relationship	npadvmod	5	SENT_159	[p11l1589t2420r1965b2489],
16	to	TO	O	to	_	0	SENT_159	[p11l1992t2427r2053b2475],
17	Swarfarin	NN	O	swarfarin	nn	18	SENT_159	[p11l2084t2421r2143b2475, p11l131t2512r404b2567],
18	metabolism	NN	O	metabolism	prep_to	15	SENT_159	[p11l444t2512r815b2567],
19	in	IN	O	in	_	0	SENT_159	[p11l855t2512r914b2566],
20	white	JJ	O	white	amod	23	SENT_159	[p11l955t2512r1127b2567],
21	and	CC	O	and	_	0	SENT_159	[p11l1169t2512r1286b2567],
22	Japanese	JJ	MISC	japanese	conj_and	20	SENT_159	[p11l1327t2514r1611b2582],
23	patients	NNS	O	patient	prep_in	5	SENT_159	[p11l1651t2512r1918b2582],
24	.	.	O	.	_	0	SENT_159	[p11l1651t2512r1918b2582],

1	Blood	NN	O	blood	_	0	SENT_160	[p11l1964t2513r2151b2567],
2	103:3055	CD	NUMBER	103:3055	num	1	SENT_160	[p11l135t2607r600b2660],
3	—	CD	NUMBER	—	number	4	SENT_160	[p11l135t2607r600b2660],
4	3057	CD	DATE	3057	dep	1	SENT_160	[p11l135t2607r600b2660],
5	Takahashi	NNP	PERSON	Takahashi	dep	4	SENT_160	[p11l132t2698r466b2753],
6	H	NN	O	h	dep	1	SENT_160	[p11l501t2701r577b2765],
7	,	,	O	,	_	0	SENT_160	[p11l501t2701r577b2765],
8	Wilkinson	NNP	PERSON	Wilkinson	nn	9	SENT_160	[p11l613t2698r942b2753],
9	GR	NN	O	gr	appos	6	SENT_160	[p11l977t2699r1110b2765],
10	,	,	O	,	_	0	SENT_160	[p11l977t2699r1110b2765],
11	Caraco	NNP	ORGANIZATION	Caraco	appos	1	SENT_160	[p11l1149t2699r1376b2753],
12	Y	NN	ORGANIZATION	y	nn	11	SENT_160	[p11l1411t2700r1484b2765],
13	,	,	O	,	_	0	SENT_160	[p11l1411t2700r1484b2765],
14	et	FW	O	et	dep	11	SENT_160	[p11l1522t2698r1655b2753],
15	.	.	O	.	_	0	SENT_160	[p11l1522t2698r1655b2753],

1	al	NNP	O	al	nn	2	SENT_161	[p11l1522t2698r1655b2753],
2	(	NNP	O	(	_	0	SENT_161	[p11l1722t2699r1916b2768],
3	2003	CD	DATE	2003	num	6	SENT_161	[p11l1722t2699r1916b2768],
4	)	CD	NUMBER	)	num	6	SENT_161	[p11l1722t2699r1916b2768],
5	Population	NNP	O	Population	nn	6	SENT_161	[p11l1952t2701r2143b2768, p11l132t2792r316b2847],
6	differences	NNS	O	difference	dep	2	SENT_161	[p11l347t2792r681b2847],
7	in	IN	O	in	_	0	SENT_161	[p11l713t2792r772b2846],
8	S-warfarin	NN	MISC	s-warfarin	nn	9	SENT_161	[p11l806t2792r1141b2847],
9	metabolism	NN	O	metabolism	prep_in	6	SENT_161	[p11l1171t2792r1542b2847],
10	between	IN	O	between	_	0	SENT_161	[p11l1572t2792r1830b2847],
11	CYP2C9	NN	O	cyp2c9	prep_between	9	SENT_161	[p11l1862t2793r2143b2847],
12	genotype-matched	JJ	O	genotype-matched	amod	13	SENT_161	[p11l133t2885r718b2955],
13	Caucasian	JJ	MISC	caucasian	dep	6	SENT_161	[p11l779t2886r1107b2940],
14	and	CC	O	and	_	0	SENT_161	[p11l1167t2885r1284b2940],
15	Japanese	JJ	MISC	japanese	amod	16	SENT_161	[p11l1343t2887r1626b2955],
16	patients	NNS	O	patient	dep	6	SENT_161	[p11l1684t2886r1951b2955],
17	.	.	O	.	_	0	SENT_161	[p11l1684t2886r1951b2955],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_162	[p11l2020t2886r2144b2941],
2	Pharmacol	NNP	PERSON	Pharmacol	nn	3	SENT_162	[p11l133t2978r475b3032],
3	T	NN	O	t	_	0	SENT_162	[p11l504t2980r553b3031],
4	her	PRP$	O	she	poss	7	SENT_162	[p11l548t2978r646b3032],
5	732253-263	CD	NUMBER	732253-263	num	7	SENT_162	[p11l674t2979r1026b3032],
6	Taube	NN	ORGANIZATION	taube	nn	7	SENT_162	[p11l132t3071r333b3126],
7	J	NN	ORGANIZATION	j	dep	3	SENT_162	[p11l354t3073r401b3137],
8	,	,	O	,	_	0	SENT_162	[p11l354t3073r401b3137],
9	Halsall	NNP	PERSON	Halsall	nn	13	SENT_162	[p11l427t3071r651b3125],
10	D	NNP	O	D	nn	13	SENT_162	[p11l672t3073r748b3137],
11	,	,	O	,	_	0	SENT_162	[p11l672t3073r748b3137],
12	Baglin	NNP	PERSON	Baglin	appos	13	SENT_162	[p11l773t3071r977b3140],
13	T	NN	PERSON	t	appos	7	SENT_162	[p11l998t3073r1045b3125],
14	(	CD	NUMBER	(	num	13	SENT_162	[p11l1068t3071r1262b3140],
15	2000	CD	DATE	2000	num	17	SENT_162	[p11l1068t3071r1262b3140],
16	)	CD	NUMBER	)	num	17	SENT_162	[p11l1068t3071r1262b3140],
17	Inﬂuence	NN	O	inﬂuence	dep	3	SENT_162	[p11l1286t3071r1576b3125],
18	of	IN	O	of	_	0	SENT_162	[p11l1599t3071r1668b3125],
19	cytochrome	NN	O	cytochrome	nn	20	SENT_162	[p11l1682t3071r2055b3140],
20	P450	NN	O	p450	prep_of	17	SENT_162	[p11l2076t3073r2143b3125, p11l132t3164r241b3218],
21	CYP2C9	NN	O	cyp2c9	nn	22	SENT_162	[p11l276t3164r557b3218],
22	polymorphisms	NNS	O	polymorphism	dep	3	SENT_162	[p11l588t3163r1082b3232],
23	on	IN	O	on	_	0	SENT_162	[p11l1117t3181r1195b3218],
24	warfarin	NN	O	warfarin	nn	25	SENT_162	[p11l1226t3163r1498b3218],
25	sensitivity	NN	O	sensitivity	prep_on	22	SENT_162	[p11l1532t3163r1847b3232],
26	and	CC	O	and	_	0	SENT_162	[p11l1879t3163r1995b3218],
27	risk	NN	O	risk	prep_on	22	SENT_162	[p11l2028t3163r2145b3218],
28	of	IN	O	of	_	0	SENT_162	[p11l134t3256r203b3311],
29	over-anticoagulation	NN	O	over-anticoagulation	prep_of	22	SENT_162	[p11l240t3257r904b3326],
30	in	IN	O	in	_	0	SENT_162	[p11l945t3257r1005b3310],
31	patients	NNS	O	patient	prep_in	29	SENT_162	[p11l1046t3256r1296b3326],
32	on	IN	O	on	_	0	SENT_162	[p11l1341t3274r1420b3311],
33	long-term	JJ	O	long-term	amod	34	SENT_162	[p11l1462t3257r1775b3326],
34	treatment	NN	O	treatment	prep_on	31	SENT_162	[p11l1817t3264r2141b3311],
35	.	.	O	.	_	0	SENT_162	[p11l1817t3264r2141b3311],

1	Blood	NN	O	blood	_	0	SENT_163	[p11l132t3349r319b3403],
2	96	CD	NUMBER	96	num	1	SENT_163	[p11l340t3350r771b3403],
3	:	:	O	:	_	0	SENT_163	[p11l340t3350r771b3403],
4	l816	CD	NUMBER	l816	dep	1	SENT_163	[p11l340t3350r771b3403],
5	—	CD	NUMBER	—	number	6	SENT_163	[p11l340t3350r771b3403],
6	1819	CD	DATE	1819	dep	4	SENT_163	[p11l340t3350r771b3403],

